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Abstract 
A collaboration between Bracco Imaging S.p.A. and Durham University allowed 
the work described in this thesis on the design and synthesis o f new contrast 
agents for M R I . 
Significant enhancements in the relaxivity o f contrast agents for M R I can be 
gained by increasing the complex rotational correlation time (TR). Incorporating a 
Gd 1 " ion within a ligand structure possessing a suitably large dendritic framework, 
inspired the first part o f this project. Thus, the periphery o f a Gd-DOTA derivative 
was adorned with carbohydrate containing wedges. The symmetry o f the mono-
aqua tetra-substituted structure places the gadolinium-water vector at the centre o f 
any tumbling motion, allowing a coherent tumbling o f the macromolecule and an 
optimization o f its rotational correlation time. The carbohydrates ensured high 
water solubility and favoured a large second sphere hydration contribution to the 
relaxivity. 
A n increase in the hydration around the metal centre and a rapid exchange of the 
water molecules with the bulk solvent can also significantly increase the contrast 
agent efficacy, by efficiently transmitting the paramagnetic effect from the Gd" 1 to 
the solvent. In a second part o f the work, the development was undertaken o f 
diaqua systems based on the seven-membered heterocycle 6-amino-6-methyl-
perhydro-1,4-diazepin (AMPED). The three Appositions were substituted with 
different phosphinate and carboxylate groups and lanthanide complexes (Eu 1 1 1, 
Gd 1 1 1, Yb 1 ") prepared and studied by multinuclear N M R methods The alkylation o f 
the amino groups with chiral 1,5-dicarboxylate pendant arms led to complex 
diastereisomers, possessing different water exchange rates. The individual water 
exchange rates o f each isomer were determined, and differed by a factor of six. 
Furthermore, the periphery o f the isomer possessing a faster water exchange rate 
was adorned with carbohydrate containing wedges, and the relaxation properties 
studied. 
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Introduction 
Introduction 
I. An Outline of 
Contrast Agents (CA) for Magnetic Resonance Imaging 
(MRI) 
MRI has been discovered and developed as a powerful technique for application in 
diagnostic clinical medicine and biomedical research. It is a non-invasive procedure 
that uses strong magnets and radio-frequencies to construct three dimensional images 
of the body. Unlike conventional radiography and computed tomographic (CT) 
imaging, which make use o f potentially harmful (X-ray) radiation, MRI is based on 
the magnetic properties of hydrogen nuclei in water. 
1.1 MRI in clinical diagnostic medicine 
"Clinical Magnetic Resonance Imaging (MRI) is essentially an elaborate proton 
nuclear magnetic resonance (NMR) experiment that visualizes water molecules".1 
Water is abundant in the human body and, with M R I , the three-dimensional images 
of the distribution o f the water protons can be observed in vivo, described by the 
values of the longitudinal relaxation time (T/), the transverse relaxation time (T2) and 
the spin density. The relaxation times T\ and T2 are dependent on the local 
environment of the water molecules and the spin density depends on the 
concentration of water in the tissue considered. Consequently, different types of 
biological tissue have different water concentrations (Table 1.1), leading to different 
relaxation times. 
Tissue Water content 
Kidney 8 1 % 
Liver 7 1 % 
Teeth/Bones 10% 
Table 1.1: Water content of some tissue types. 
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The discovery in the 1970's that the Tt of tumours experimentally induced in tissues 
of laboratory animals were significantly longer than T\ values o f the corresponding 
normal tissues, led to an extension o f the study to humans. Soon, the N M R analysis 
of 106 tumours taken at surgery was completed (Ti relaxations in some malignant and 
normal human tissues are reported in Table I.2) 3 and an N M R catalogue o f human 
neoplasm was started, with the aim of forming a database to design an instrument to 
detect internal malignancies. 
Tissue Ti tumour (s) 7\ normal (s) 
Bone 1.027 0.554 
Breast 1.080 0.367 
Liver 0.832 0.570 
Lung 1.110 0.788 
Skin 1.047 0.616 
T a b l e 1.2: T, relaxation times in some malignant and normal human tissues. 
There is no ionizing radiation involved in M R I , and there have been no documented 
significant side effects o f the magnetic fields and radio waves used on the human 
body to date. Although MRI was initially hoped to provide a means o f making 
definitive diagnoses non-invasively, it was found that the addition o f contrast agents 
(CAs) in many cases improved sensitivity and/or specificity. Currently, more than 10 
million MRI studies are performed each year with gadolinium based contrast agents 
(GBCAs), 4 which are the magnetic resonance equivalent of a dye: they are injected 
into the body to enhance the contrast between normal and diseased tissue. The 
intensity of the signal in MR! increases with the local values o f the longitudinal 
relaxation rate o f water protons (Ri = 1/Ti (s' 1)) and contrast agents in MRI should 
catalytically accelerate the relaxation time of nearby water molecules in the 
surrounding tissue, providing contrast to those areas where the rates remain 
unaffected. This objective can be achieved by paramagnetic substances, and the 
unique magnetic properties of lanthanides (in particular gadolinium) make these 
3 
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metal ions near ideal for the purpose. The most common intravenous contrast agents 
are based on complexes o f gadolinium. 
1.2 Lanthanides and their paramagnetic properties 
The lanthanides are commonly thought o f as trace constituents of the terrestrial 
environment. Although rare in comparison to the more common "earths" (the old 
term for water-insoluble strongly basic oxides of electropositive metals) such as lime 
or magnesia, these elements are as abundant in the solar system as many heavy 
elements (such as tungsten, tantalum, iridium). 5 For example thulium, the least 
common naturally-occurring lanthanoid, is more abundant than iodine, cerium is the 
26th most abundant element in the Earth's crust, and neodymium is more abundant 
than gold. 
Mendeleev's periodic classification of the elements places the lanthanides in the first 
period of the f-block, starting from lanthanum (Z = 57), with electronic configuration 
[Xe] 5d '6s 2 , to lutetium (Z = 71), [ X e ] 4 f 1 4 5d '6s 2 . The similar physicochemical 
properties shown by these elements is attributed to their common existence in the 
more stable oxidation state as trivalent ions, given by the loss of a single 4f electron 
and two 6s electrons (with the exception of lanthanum, lutetium and gadolinium 
which, because o f the electronic configuration including 5d orbitals, lose one 5d 
electron and two 6s electrons). The lanthanide trications possess a Xe core electronic 
configuration with the addition of n 4f electrons, protected by closed 5s2 and 5p 6 sub-
shells. The shielded 4 f orbitals of the lanthanides only slightly overlap with the ligand 
atom orbitals, suggesting a predominant electrostatic character for the interaction 
between the lanthanide trication and the ligand's atoms. The lanthanides behave in 
their complexes as "hard" acids, which interact preferentially with "hard" bases, such 
as fluoride, oxygen and nitrogen. The resulting complexes adopt irregular geometries, 
reflecting a balance between electrostatic and steric demand around the highly 
coordinated metal. The more common coordination numbers for lanthanides in 
aqueous solutions are 8 and 9, and the lanthanide contraction theory explains how the 
4 
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size of the ion affects its coordination number: the smaller the ionic radius becomes 
along the series from L a 3 + towards L u 3 + , the more contracted the 5s and 5p orbitals 
are and a lessening in the coordination number (CN) is observed (CN ~ 10 for La 3 + , 
CN ~ 8 for L u 3 + ) . 
Furthermore, the one or more unpaired 4 f electrons confer paramagnetic properties 
upon the trivalent lanthanide cations; only L a 3 + and L u 3 + are diamagnetic. This 
important characteristic has made lanthanide complexation chemistry a subject of 
intense study over the last 20 years. In this thesis we wi l l mainly focus on the 
extraordinary properties o f gadolinium complexes as potential intravenous contrast 
agents for enhancing image intensities in MRI . The most common intravenous CAs 
used in clinical practice are nowadays based on G d m which, because of its half-filled 
f-shell, has a large magnetic moment. Owing to the symmetric S-state which is an 
hospitable environment for electron spins, this metal ion possesses a high spin 
paramagnetism and also an exceptionally long electron spin relaxation times (~ 10"9 s 
at the magnetic field strengths of interest for MRI applications),6 typically 3-4 orders 
of magnitude longer than for other lanthanides (except Eu", which is a very strong 
reducing agent).7 
1.3 Characteristics for a CA suitable for medical use 
In clinical applications, small dosage, reasonable aqueous solubility, good metal 
retention and hydrophilicity are required physico-chemical properties. 
Solubility- Since the amount of metal chelate necessary for a significant increase in 
image contrast is relatively high (for low molecular weight G d m complexes, a typical 
dose is 0.05 - 0.3 mmol kg"1 total body weight) 8 the concentration of the injected 
solution must also be high. To obtain the necessary water solubility o f the non-ionic 
Gd 1" complex (~ 0.5 M ) , the introduction of hydrophilic OH groups as side chains or 
functional groups in the ligand structure is a typically adopted synthetic strategy (e.g. 
D03A-butrol and HP-D03A -Figure I.1-). 
5 
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[Gd(D03A-butrol)(H20)] 
Gadovist TM 
O. 
N 
O 
N 
o 
G d ^ - 0 
N ^ O H 2 
J 
O 
[Gd(HP-D03A)(H20)] 
Prohance™ 
Figure 1.1: Structure of Gadovist and Prohance , two contrast agents currently 
in clinical use. 
Stability - On account o f its high in vivo toxicity, LD 5o ~ 0.1 mmol kg' 1 , the Gd 1" ion 
must be encapsulated by a strong multidentate organic ligand, forming a chelate 
stable under biological conditions. This feature should avoid the dissociation of the 
complex into free metal ion and ligand species once administered to the patient.9 
Since the lanthanide ions are classified as hard acids, binding to multidentate 
structures possessing hard cr-donor atoms (eg. nitrogen and oxygen) is favoured. This, 
together with the chelate effect, enhances both the thermodynamic and kinetic 
stability of the complex. 1 0 The thermodynamic stability of a metal-ligand (ML) 
complex is expressed by the equilibrium constant shown in Equation (1.1) 
KML = [ M L ] / [M] [L] (Eq.I.l) 
where KML refers to a specific equilibrium constant (called the stability constant), [ M ] , 
[L] and [ M L ] are the equilibrium concentrations o f the metal ion, deprotonated ligand 
and complex (the charges of the ions are omitted for simplicity). The classical method 
for determining M L stability constants is a pH-potentiometric titration of the ligand, 
carried out in the presence and in the absence of M . This works extremely well for 
systems that reach equilibrium quickly (a few minutes) after addition of acid or base. 
6 
Introduction 
Hydrophilicity - The biodistribution of a CA largely depends on its relative 
lipophilicity and/or its hydrophilic properties. Some of the most widely used first 
generation CA, like [GdDTPA] 2", [GdDOTA]", [GdHP-D03A] and [GdDTPA-BMA] 
(see Scheme 1.1), are all relatively hydrophilic and distribute non-specifically 
throughout the plasma and interstitial spaces, before being excreted via the renal 
system. The half-time for excretion of [GdDTPA] 2" (typical o f hydrophilic CAs) is ~ 
1.6 h in man. Different structures, containing lipophilic groups, are preferred for 
lanthanide complexes used as imaging agents for the biliary pathway and the liver, 
like ( [Gd(BOPTA)(H 2 0) ] 2 \ [Gd(EOB-DTPA)(H 2 0)] \ in Figure 1.3); they are 
partially excreted through the hepatobiliary system. 
1.4 Commercially available MRI Contrast Agents (CAs) 
The steady progress accomplished over the last decades by medical research in 
diagnostic M R I has been translated into the large number of CAs currently in 
widespread clinical use, here categorized according to their magnetic properties and 
biodistribution. 
They all work by enhancing both the longitudinal (Ti) and the transverse (T2) 
relaxation times of the water protons in the examined tissue. However, they are 
divided into two large groups: the T\ or positive contrast agents and the 7^ or negative 
contrast agents. The Tj contrast agents, such as the paramagnetic gadolinium based 
ones, work on altering \/T/ of tissue more than 1/72, owing to the fast endogenous 
transverse relaxation in tissue. With most pulse sequences, this dominant Tt lowering 
effect results in increases in the signal intensity.4 Examples o f the second category, 
the T2 contrast agents, are the ferromagnetic large iron oxide particles," which 
operate mainly by increasing the 1/72 of the tissue, causing a reduction in the signal's 
intensity. 
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1.4.1 T2 contrast agents 
The superparamagnetic agents are made up o f iron oxide particles (Fe 304). When 
exposed to an external magnetic field, the thousands o f magnetic ions mutually align, 
resulting in a very large magnetic moment, greater than that o f a single molecule of a 
Gd"1 chelate.8 The iron oxide particles are divided into two groups, depending on 
their dimensions: the super paramagnetics (SPIO), with diameter (d) > 50 nm, and the 
ultra smalls (USPIO), d < 50 nm. 
Commercial name Type of particle d(nm) r,(mM"1 s"1) r2(mM"1 s"1) 
Endorem (Guerbet) SPIO 200 24 107 
Resovist (Schering) SPIO 62 20 197 
Abdoscan (GEHealthcare) USPIO 3500 - -
Lumirem (Guerbet) USPIO 300 3.4* 3.8* 
'measured at 1Tesla 
Table 1.3: Commercially available super-paramagnetic agents. Relaxivity measured at 
37 °C, 0.5T. 
1.4.2 T/ contrast agents 
The paramagnetic contrast agents consist o f G d m or, less commonly, Mn" 1 2 or Fe1" 
based complexes, where the ligand is a chelate structure which binds strongly the 
metal ion in a stable balance of electrostatic forces. 
First generation contrast agents 
The molecular structures of some "first generation" commercially available contrast 
agents are shown respectively in Scheme 1.1 and in Table 1.4. 
Chemical name Generic name Brand name Company 
(Gd(DTPA)(H 20)] gadopentetate dimeglumine Magnevist 
[Gd(DOTA)(H 20)]" gadoterate meglumine Dotarem 
[Gd(DTPA-BMA)(H 20)] gadodiamide Omniscan 
[Gd(HP-D03A)(H 20)] gadoteridol ProHance 
[Gd(D03A-butrol)(H 20)] gadobutrol Gadovist 
(Gd(DTPA-BMEA)(H20)]gadoversetamide OptiMARK 
Schering(Germany) 
Guerbet (France) 
GE Healthcare 
Bracco (Italy) 
Schering(Germany) 
Mallinckrodt (U. S.) 
Table 1.4: Extracellular contrast agents commercially available 
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q 
N Get 
|2Q 
-9.) 
[GdfDTPAXH^lf 
T M Magnevisl 
[Gd(BOPTA)(H20)|2 
I M M u i t l H a n c e O H I 
17 r \ O i l r n W N N N N N N r G d — K > H 0-, G d — t u " 
UJ 
o [GdlDOTAMHjOir 
IG^DOaA-bulrolXHjO)] [Gd(HP-D03A)(H20)] TM Doterem 1M ru Gadovist Prohance 
• N 
) > 
( .0 
Gd 
NH 
N H 
\ / 
, - 0 
[GdtDTPA-BMEAKHoO)] [GdtDTPA-BMAKHoO)] 
OpIiMARK Omniscan 
Scheme 1.1: Commercially available contrst agents 
A l l these gadolinium based contrast agents (GBCAs) are nine-coordinate complexes, 
in which a low molecular weight (< 1000 Da) ligand occupies eight binding sites at 
the metal centre and one water molecule, supplied by the solvent, corresponds to the 
ninth. They are all based on one of two ligand systems: DOTA (macrocycle) and 
DTPA (acyclic ligand system), which have proved to be very good ligand skeletons 
for highly kinetically and thermodynamically stable Gd 1 1 1 complexes. 1 3 1 4 Omniscan 
was administered in ascending doses (from 0.05 mmol/kg to 0.3 mmol/kg) in 20 
healthy male volunteers, in order to check its safety and monitor the performance. 
Once the gadodiamide was injected, it diffused into the interstitium with a 
distribution half-life o f about 5 min, and the serum elimination half-life throughout 
the kidneys was approximately 70 min. Only mild post-injection side effects were 
registered on 9 o f the 20 subjects, such as light-headedness, dizziness, and perversion 
of taste or smell. 1 5 Extracellular MRI contrast agents are generally considered very 
safe. However, patients with severe kidney insufficiency or with chronic liver disease 
or just before (or after) liver transplantation are considered to be at risk o f developing 
a rare acquired disease, known as nephrogenic systemic fibrosis (NSF). 1 6 This 
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condition has been reported in the vast majority of cases (> 200), with Omniscan. 
Indeed, the DTPA-bisamide Gd 1 1 1 complex is well known to be the least kinetically 
stable, with respect to acid catalysed dissociation, of all the approved contrast 
agents.17 It has been proved, however, that gadolinium contrast agents can be used 
also in hemodialysis patients, i f hemodialysis is performed immediately after the 
examination to get rid o f the circulating residual contrast agent. From the first to the 
third hemodialysis session, average gadolinium-based contrast clearance rates were 
78%, 96%, and 99%, respectively.1 8 
Five gadolinium-based contrast agents have been approved for clinical use in Europe 
and in the United States: Magnevist (gadopentetate dimeglumine, 
[Gd(DTPA)(H 20)] 2~), Omniscan (gadodiamide, [Gd(DTPA-BMA)(H 2 0)] ) , 
OptiMARK (gadoversetamide, [Gd(DTPA-BMEA)(H 2 0)]) , MultiHance (gadobenate 
dimeglumine, [ G d ( B O P T A ) f ) and Prohance (gadoteridol, [Gd(HP-D03A)(H 2 0)]) . 
Among these, Multihance is classified as a "second generation" contrast agent. 
Gdll l is the lanthanide ion most commonly used for the synthesis o f MRI contrast 
agents, but other lanthanide ions (and different oxidation states i.e. +2) are also 
increasingly considered as alternatives. 19 An example is the [Mn(H2DPDP)]4-, 
commercially produced by GE Healthcare and known as "Telescan" (molecular 
structure illustrated in Figure I .2) . 2 0 
HO OH 
N N N 
X 0 ^ - 0 oo o o \ 
Mn O 
Figure 1.2: "Telcscan" molecular structure. 
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Second generation contrast agents 
Known as "smart" agents, they are Gd" 1 based systems endowed with higher efficacy 
(quantified in higher relaxivity values). They show responsive behaviour to their 
physiochemical environments: their relaxivities can be modulated by changes in the 
pH of the s o l u t i o n , 2 1 ' 2 2 ' 2 3 ' 2 4 by a metal ion concentration (such as calcium, 2 5 z inc, 2 6 , 2 7 
copper ~ 8 ) , by enzyme activity 2 9 ' 3 0 - 3 1 - 3 2 - 3 3 0 r they can be responsive to changes in the 
partial oxygen pressure {pOi responsive CA). 1 Furthermore, these contrast agents can 
be "organ specific''': they are selectively taken up by a particular kind of cell, e.g. 
hepatocytes, before being excreted through the bile. An image enhancement is 
verified only in the organs where these cells are present, such as the liver, spleen or 
lymph nodes. 
Based on a DTPA backbone, adorned with hydrophobic substituents, are the 
structures of two of the most widely used "smart" contrast agents: gadobenate 
dimeglumine, [Gd(BOPTA)] 3" and [Gd(EOBDTPA)] 3" (Figure 1.3). 
/° ^ — 1 3 0 "130 
O 0 , 0 \ ° O 0 . 0 . 
H H H H 
o-^ o0 
Gd[BOPTA] Gd[EOB-DTPA] 
Figure 1.3: Gd(BOPTA) and Gd(EOBDTPA) molecular structures. 
The pharmacological and MRI contrast-enhancing properties o f [Gd(BOPTA)] 2" are 
based both on its utility in the imaging of the liver and the myocardium and on its 
efficiency, greater than [Gd(DTPA)] 2" for those applications which require an 
extracellular agent. Currently ([Gd(BOPTA)] 2") is produced by Bracco Imaging, Italy, 
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with the commercial name "MultiHance", and detailed physiochemical and 
pharmacokinetic studies have been undertaken since the synthesis o f the molecule in 
the early 1990s.34 The performances o f MultiHance have been compared to the 
conventional gadolinium chelate [Gd(DTPA)] 2" for MR imaging in brain tumours. In 
a crossover study o f 22 patients with brain metastases, [Gd(BOPTA)] 2" consistently 
improved the depiction o f tumour margins, revealing larger areas of contrast 
enhancement compared to [Gd(DTPA)] 2 ". 3 5 MultiHance has also found applications 
in perfusion cardiac MR] for the diagnosis of coronary artery disease, cardiac 
tumours, inflammations and different forms of cardiomyopathies. It has been 
demonstrated that, in comparison to the conventional coronary angiography, 
perfusion cardiac MRI considerably increases the specificity and sensitivity of the 
diagnosis.3 6 
Again based on the DTPA ligand structure, is another hepatotropic agent: [Gd(EOB-
DTPA)] 2", whose molecular structure is reported in Figure 1.3. It is produced by 
Schering (Germany) and known on the market as "Eovist™". It increases the signal 
intensity o f normal liver parenchyma on T\ - weighted images, before being excreted 
through both the renal and biliary routes. Eovist injection provides additional 
information regarding lesion detection, their classification and characterization, and it 
also exhibits an acceptable safety profile in clinical trials. 3 7 In addition to its use as a 
liver-specific MR] contrast agent, [Gd(EOB-DTPA)] 2" has been tested successfully in 
patients as a potential contrast agent for computed tomography (CT) . 3 8 
A new class o f M R I contrast agents is represented by the blood-pool agents. They 
display larger size compared to the extracellular fluid agents, which prevents their 
leakage into the interstitium and enhances their efficacy, making the tumbling o f the 
macromolecule (r«) slower. They work by selectively reducing the Ti relaxation time 
of blood, and their relatively long half vascular life translates into longer image 
acquisition time and therefore higher image resolution. These "blood pool contrast 
agents" have been initially developed for use in magnetic resonance angiography 
(MRA). An example o f commercially available blood pool agent is the 
12 
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gadophostriamine trisodium, known as MS-325 and on the market as 
"AngioMARK", described in Section III.2.1, q=l systems. 
Ph 
11.1 Relaxation Rates and Relaxivity 
The image-enhancing capability of a contrast agent, directly proportional to its ability 
to catalyze the relaxation rate of the surrounding water's hydrogen nuclei, is 
quantitatively expressed by its relaxivity. 
Both longitudinal (1/T/) and transverse {MTi) relaxation rates o f the water protons are 
perturbed, but in this discussion only the longitudinal relaxation rates, R/, more 
relevant for the N M R image enhancement, wi l l be considered. In comparison to the 
value for pure water, /?/ is dramatically enhanced for the water protons of an aqueous 
solution containing a paramagnetic metal complex, such as a G d m chelate. The 
observed relaxation rate, Ri,abs, where Ri,0bs = \ITi,0bs, is the sum of a diamagnetic 
contribution {MTij, pure water relaxation rate) and of a paramagnetic contribution 
(\ITi,p) to the water proton relaxation rates, caused by the presence of the lanthanide 
complex, (Equation I I . l ) : 
o. jo Ph 
0 ' r N O 
" 1 3 0 
N 
N Gd O K ( 
o 9 ^ S^o .,6 o 
H H 
MS-325 
Figure 1.4: The structure of MS-323, marked under the name "AngioMARK". 
II The efficacy of a CA: its Relaxivity 
\IT,,obs = \/T,,d+\/T,,p (Eq. I I . l ) 
13 
Introduction 
\ITi p is proportional to the concentration o f the paramagnetic species dissolved in 
solution, and the paramagnetic relaxation enhancement ( R / p ) , when referred to a 1 
mM concentration o f a given G d m chelate, is called its relaxivity (Equation II.2): 
Many parameters affect the relaxivity value of a lanthanide complex dissolved into 
solution: the water molecules interact differently with the paramagnetic centre, 
depending on their distance from it (Figure I I . l ) . The "inner sphere" water molecules 
directly enter the G d m coordination sphere (the water oxygen binds to the Gd 1") and 
then rapidly (nanoseconds) exchange with the bulk; the " 2 n d sphere" water molecules 
arise as a result of hydrogen bonding and similar interactions with ligand and inner 
sphere water molecules, creating a loosely coordinated network o f water molecules 
intermediate between the inner and the outer spheres. They show a finite residence 
time which is longer than the translational diffusion time of the pure water. "Outer 
sphere" water molecules create interactions with second sphere and closely diffusing 
water molecules. Three different relaxation mechanisms may be associated with the 
three types of water molecules just described, respectively: the inner sphere, the 
second sphere and the outer sphere mechanism, which all add together in a total 
paramagnetic relaxation enhancement (Equation II.3): 
\/TLobs= V TLd + r,[Gd] (Eq. 11.2) 
l/T, .para = l/TUs + l / T U s + l/T,, OS (Eq. II.3) 
The same criteria can be used for the relaxivity (Equation II.4): 
s ri = ri + ri + ri OS (Eq. II.4) 
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outer sphere water 
°9 0 
OH 
\ i 
AN-
inner sphere water 
r / * 
N 
<3 H Gd 0 
H N N 
\ 7 O co2 
o,c 
second sphere water 
Figure 11.1: Inner sphere, outer sphere, second sphere water molecules. 
11.2 Inner Sphere Proton Relaxivity 
The longitudinal inner sphere contribution to the relaxivity (Rjp's) is rationalized in 
Equation 11.5 39 
where 
_ Cq 
55.5 
(Eq. II.S) 
Pm = mole fraction of the bound water nuclei 
C = molal concentration of paramagnetic compound 
q = the number of bound water molecules per Gd 1" 
/ / T^in, = proton longitudinal relaxation rate in bound water 
1 / rm = inner sphere exchange rate for bound water molecule(s) 
In order to increase the overall relaxivity o f a contrast agent, the number o f 
coordinated waters (a) can be increased (this aspect w i l l be discussed in section V of 
this introduction: "Survey o f dz'-aqua complexes"). Also, the relaxation o f the bound 
water(s) can become faster by making the 7 ^ / m (or r m ) as short as possible. 7111„ and 
tm show opposite temperature dependencies: on lowering the temperature, j " / m 
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decreases while r„, increases.40 In the first generation contrast agents, r„, < < \ m , 
therefore I*11,„ is the limiting value for the relaxivity of these agents.4 
The term 1/Tip's originates from dipole-dipole and scalar (or contact) mechanisms 
which are modulated only by electron spin relaxation and water exchange, and 
represent a small contribution to 1/Tip's at the low fields used in many M R l 
examinations (usually 1.5 T). This introduction wi l l therefore mainly focus on 
understanding the dipolar interactions between paramagnetic ion and proton nuclei o f 
directly bound water molecules; such interactions are dependent on the magnetic field 
and modulated by the reorientation time of the nuclear spin - electron spin vector 
(TR), by changes in the Gd 1" electron-spin relaxation time (TS) and by water proton 
exchange times (r,„) between the inner and the outer sphere. The dependence of the 
dipolar relaxation (l/Ti„,DD) upon the magnetic field strength, is expressed by the 
modified Solomon-Bloembergen equation4 1 (Equation II.6): 
DD_ 2 S(S + \)g2y2Hri 
i/Tlmuu= — 
15 6 r GdH 
An 
(Eq. II.6) 
where 
S is the magnetic number of electron spin; 
Yz/is the nuclear gyromagnetic ratio of the proton; 
g is the electron g-factor (or Lande factor for the free electron); 
/uH is the Bohr magneton; 
fad-H is the electron spin - proton distance; 
rci (i = 1, 2) is the correlation time relative to the electron spin - proton 
coupling; 
cos and coH (rad/s) are nuclear & electron Larmor frequencies, where cos = 
658(%(and co = yB). 
The relaxation depends on: Gd-H distance, rGdH; proton and electron Larmor 
frequencies, respectively a>s and coH\ correlation times, r„. As a consequence of this 
dependence on the Gd-H distance, the directly bound waters are the most effectively 
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relaxed, and the rapid exchange with the bulk water spreads this effect into the bulk 
solution. This process is referred to as the inner sphere contribution to the overall 
proton relaxivity. Many different dynamic processes occurring on molecular level can 
modulate the electron-nuclear spin interactions (expressed by r C I), including the 
rotational correlation time (TR) of reorientation o f the metal - proton vector, the water 
residence lifetime on the metal ion ( r m ) , the Gd 1" electronic longitudinal (Tu) and 
transverse (T?,,) relaxation times (Equation II.7): 
+ 
< 
(Eq. II.7) 
To make everything even more complex, the electronic relaxation rates (like the 
nuclear relaxation rates) are field dependent. For Gd 1" complexes the rates are 
interpreted in terms o f zero-field splitting (ZFS) interaction, as described in E q . II.8, 
II.9 and 11.10. These equations are referred to as the Bloembergen-Morgan Theory of 
paramagnetic electron-spin relaxation: 
(Eq. 11.8) 
( 1 > 
ZFS 
1 
UJ 1 + Acolz] 
( 1 ] 
Zl-S 
= B 
UJ 
+ 3 (Eq. II.9) 
and 
B 
I O r v o 50 
= ! - [ 4 S ( S + l ) - 3 K (Eq. 11.10) 
where A2 is the mean-square zero field splitting energy and r„is the correlation time 
for the modulation o f the zero field splitting interaction. 
G d - H distance 
Given that the dipole-dipole relaxation term (Eq. II.6) is proportional to \l(rGd-H)6, 
large variations in the relaxivity value could theoretically be obtained with even small 
changes on the metal ion-water proton distance. Experimentally, this parameter is 
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very difficult to measure, and only recently scientists have managed to determine it 
exactly using "direct" methods. In the past, this value was estimated by fitting of 
N M R D data, but many parameters in the fitting where unknown and therefore the 
measured value was not very accurate. Literature values vary over the range between 
2.5 and 3.3 A . 8 ' 4 1 ' 4 2 The term \l(rGd.Hf originates from the anisotropic hyperfine 
interaction (hfi) between the electron and nuclear spins, therefore the most 
appropriate techniques to deal with this factor would be those of magnetic resonance 
because they allow the direct determination of anisotropic hf i . With I D and 2D 
pulsed electron-nuclear double resonance (ENDOR) studies on glassy water/methanol 
solutions of Gd" 1 and one of the commercial contrast agents, G d m H P D 0 3 A 
(Prohance), the Gd-H distance for a range of 8 and 9-coordinate Gd" 1 complexes has 
been estimated to be about 3.1 A and it does not depend on co-ligand or total 
charge.43 
An increasing in the t i l t angle between the Gd-0 bond and the plane o f the water 
molecule could decrease rcd-H- However, in a symmetric complex structure like 
[GdDOTA]", it is unlikely that hydrogen bonding would form preferentially between 
the water molecule and an electronegative atom on a side of the chelate. 
Alternatively, any electronic anisotropy could induce electron localization nearer to 
the water molecule. Unfortunately, this approach is also not feasible in the case o f the 
stable, highly symmetric electronic state of Gd 1 1 1 . 8 
Effect of TR on relaxivity (/•//>) as a function of the magnetic field strength 
The efficiency o f a contrast agent is dependent on the magnetic field strength. In a 
Nuclear Magnetic Resonance Dispersion profile (NMRD), the contrast agent's 
behaviour is monitored over a range of several orders o f magnitude (0.01 - 120 
MHz). The change of the magnetic field strength does not usually modify the 
chemistry o f the sample, unlike other thermodynamic parameters, e.g. temperature or 
pressure. Furthermore, qualitative interpretation o f some relaxivity mechanisms can 
be obtained at low magnetic fields (< 3 MHz), for example the electronic relaxation 
which affects the dipole-dipole interaction and determines the relaxivity; at higher 
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magnetic fields, (> 4 MHz) the r R term can be studied, as this term is dominant at 
around 30 MHz , as shown in Figure II .2 . 
— T r =10 ns 
— TR= 1 ns 
— TR=0.1 ns 
T 60 
0 0.5 1.0 1.5 2.0 2.5 3.0 
Magnetic Field Strength (T) 
Figure II .2 : Effect of rotational correlation time on relaxivity as a function of field strength. 
II.3 Outer Sphere Proton Relaxivity 
Two types o f outer-sphere relaxation 
mechanisms contribute to the overall 
relaxivity observed for a contrast 
agent: the first o f these mechanisms, 
outer sphere, involves the 
modulation o f the dipole-dipole 
interaction between the electron spin, 
S, and the proton spin, I, and is 
caused by the diffusion of water 
molecules nearby the paramagnetic 
centre (Figure 11.3). The outer-
sphere relaxivity (Rip0*) is a complex 
problem in solvation dynamics and 
diffusion, 4 and a theory is available to treat the limiting case where no chemical (or 
electrostatic) interactions occur between water and metal complex. 4 4 The Freed 
equation, 4 5 explains how the outer sphere relaxation is dependent on the fluctuations 
Figure 113: Relaxation mechanisms and main 
relaxation parameters operating in aqueous solution 
containing a paramagnetic G d m chelate.4 
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due to electronic relaxation time of the metal ion (TSI and r ^ ) , on the distance of 
closest approach of solute and solvent (d), on the sum of solvent and solute diffusion 
constants (D) and it is modulated by the magnetic field strength. Equation 11.11 
shows the most general form of the theory for outer sphere relaxivity, 4 5 which shows 
some similarities with the Solomon-Bloembergen equations: 
d*r 
OuierSpher e & 
Where C is a numerical constant that differs slightly between different models used to 
derive the equations, Ns is the number of metal ions per cubic centimeter, rD is the 
relative translational diffusion time, given by Equation 11.11, where DH and Ds are 
the diffusion coefficients of water and the metal complex, respectively. Diffusion 
coefficients can be estimated i f the motion described by the Stokes-Einstein model, in 
which the diffusion o f rigid spheres in a medium of viscosity n is considered, as 
shown in Equation 11.12, where a is the molecular radius: 
D = kT/6nan (Eq.11.12) 
Freed equation can be modified in a form suitable for small paramagnetic metal 
chelates:51 
f 1 \ [JJ(0)S) + 3J(0)H)] (Eq.II.13) 
where C°s is a constant (5.8 • 10"'3 s" 2 M _ 1 ) and the dependence on the electronic 
relaxation times is expressed in the non-Lorentzian spectral density functions -/(co,).46 
The outer sphere contribution, R/pos, can constitute a significant contribution to the 
observed relaxation rate for low molecular weight Gd" 1 complexes.4 6 For small-sized 
complexes with q = 1 [such as Gd(DOTA)" and Gd(DTPA) 2"], R,pos makes a 
contribution of roughly 40-50% to the observed relaxivity. Experimental evidence for 
an even greater contribution to the relaxivity from the outer sphere can be found in 
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the lanthanide complex [Gd-1]", based on the macrocyclic tetrabenzylphosphinate 
ligand (Figure II.4). Its \/T/ N M R D profile is compared in Figure II.5 with the one 
of a similar compound, [Gd-2], where one phosphinate group is substituted with a 
less bulky carboxoamide and the benzyl group on the remaining phosphinate pendant 
arms is replaced with a methyl. The shape and amplitude of the [Gd-1]" N M R D 
profile suggest that the inner sphere does not contribute to the overall relaxivity; the 
steric bulk o f [Gd-1]" phosphinate groups prevents the access o f the water molecules 
onto the metal ion, leading to a q = 0 system, making the outer sphere term the main 
contribution. 4 7 
Ph 
HO 
0 Me P-OH O O Ph 
N N 
N(n-Bu)2 OH HO Me 
Ph 
O o P=0 H O - P Me O 
OH 
Ph 
1 2 
Figure II.4: Ligand structure for the complexes [Gd-l| and |Gd-2]. 
8.5 
4.1 
P- i . i 
• 
outer sphere 
hi 
• -D . O . • . ., 
0.1 1 10 100 
Proton Larmor Frequency (MHz) 
1000 
Figure II.5: NMRD profiles (25 °C) of |Gd-ip (filled squares) and 
|Gd-2| (open squares) and best-fit curves; the dotted line at the bottom 
is the calculated outer-sphere contribution for |Gd-2| 4 8 
(reproduced with permission of the author). 
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11.4 Second Sphere Proton Relaxivity 
The second of these mechanisms involves a region of more strongly associated water 
molecules, which possess limited translational motion but exist nearby the electronic 
spin centre. This type o f water coordination environment is referred to as the second 
sphere. Hydrogen bonding interactions with polar groups o f the ligand leave the water 
molecules of the second coordination sphere free to rotate with the molecule, and 
exposes them to rotationally modulated magnetic field fluctuations o f the dipolar 
electron-nuclear coupling, causing a significant enhancement in the relaxivities. This 
contribution to the observed relaxivity is considered separately from the diffusion 
controlled outer-sphere term only when the residence lifetime of the water molecules 
in the second sphere is longer than the diffusional correlation time rD ( r D = a2/D).48 
Even i f in the past more efforts have been spent in the understanding o f the inner 
sphere and outer sphere relaxation mechanisms, there are cases where the only 
plausible explanation for the high relaxivity values observed can be found in the 
interactions o f the second sphere water molecules. For example, scientists seem to 
agree that in the case of the anionic tetraphosphonate macrocyclic gadolinium 
complex [Gd.3]5" (complex structure in Figure II.6), the 50% increase of the 
relaxivity (r/p= 11.5 mivr's" 1 at 20 MHz, pH 9, 25 °C) versus [Gd.l]" (in Figure II.4) 
is a consequence of solvent molecules in the second shell o f the metal ion, involved 
in H-bonding interactions with the oxygen atoms of the phosphonate groups. 4 9 The 
l 7 0 transverse relaxation rate profile as a function of the temperature gave further 
evidence in support to this theory. The shape of the profile is typical o f a q = 0 
complex, thus excluding any contribution from the inner sphere water molecules. 
O 
O p 
ii 9-0 
N N 
f G d 3 0 
n *—' / 
o .0J=o 
O" 
3 . 
Figure 11.6: Molecular structure for the complex (Gd-3| . 
22 
Introduction 
Since the second sphere water molecules reside closely enough to the inner sphere 
water protons to be strongly relaxed, their relaxation pathways also depend on the 
same parameters, such as rotational correlation time (r«), water residence lifetime on 
the metal ion (r,„), Gd" 1 electronic longitudinal (7/ e ) and transverse (T^) relaxation 
times and magnetic field strength. The relaxivity value measured for the 
tetraphosphonate complex is in fact enhanced by slowing down its rotational mobility 
(i.e. increasing the rotational correlation time, TR, of the whole complex), simply by 
decreasing the temperature. However, unlike the inner sphere water molecules, the 
number o f the second sphere ones can be increased without altering ligand structure 
and complex thermodynamic stability. A considerable enhancement in the relaxivity 
can be obtained by inducing electrostatic interactions between the ligand and a 
substrate. In the example considered here, the interactions are between the negative 
charges on the oxygen atoms of the phosphonate groups and the hydroxyl groups of 
the N-methyl-glucosamine (Figure II .7) . A considerable second sphere contribution 
is evident in the resulting relaxivity observed, which is 15 mlvl 's"1 (20 MHz, 25 °C, 
pH 9) for this adduct. 
•O L G d + J u OH OH 
J p / N N N X X 
O n ^ / ") W-methyl-glucosamine = / ^^^f^^^~o\-\ 
° 0 - P = 0 OH OH 
O" 
[Gd-3]5" 
Figure II.7: yV-methyl-glucosamine interacts with the [Gd-3|5" complex. 
In Figure II.8 it is illustrated how the interaction of the anionic tetraphosphonate 
macrocyclic gadolinium complex [Gd-3]5" with an jV-benzylhexa-aza-l8-crown-6 
analogue, (4) and a y3-cyclodextrin (5) formes a non-covalent ternary complex, q = 0, 
where the optimized contribution of second sphere o f hydration 5 0 results in a 
remarkable r t p value of 18 mlvl 's"1 (at 20 MHz, 25 °C). The existence o f this ternary 
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adduct has only been attested in water, at neutral pH; acidic conditions could possibly 
weaken the interactions which keep the system assembled. 
The second sphere water molecules play an important role in determining the 
relaxivity o f aqueous solutions of Gd" 1 complexes bearing phosphonate or anionic 
groups on the coordination sites of the metal ion. In the case of the DTPA complex, 
the second sphere is estimated to represent roughly the 25% of the observed 
relaxivity. This conclusion has been drawn after the X-ray structure of the complex 
[Yb(DTPA)(H20)] 2" was determined, and variable-field and temperature N M R D 
studies o f the corresponding G d m complex were performed. The studies led to a 
detailed picture o f the three hydration shells around the metal ion: i) one coordinated 
water molecule; i i ) several water molecules in the outer coordination sphere and i i i ) 
one water molecule surprisingly close to the metal centre (4.2 A), acting as a 
hydrogen bond donor to ligand's proximate carboxylate groups and forming part of a 
linear chain of hydration. 5 0 
A substantial second-sphere contribution to the relaxivity has been suggested also for 
the highly stable q = 2 system [Gd(aD03A)(H 2 0) 2 ] 3 " . 5 1 The efficacy of the complex 
in water is maintained in serum solution (rjp = 12.3 mlVf's"', pH 7.2 in serum, 65.6 
MHz, 293 K.) because the binding of proteins and endogenous anions (e.g. HCOy 
represents the positive charge contained 
on the macrocycle upon its protonation 
4 -
H 
N HN N 
HN 
NH N 
H 
CH2O) 
( M ) 
76 0 ( o ( [Gd-3] N 
N 
N 
Figure II.8: Formation of a non-covalent, q = 0, ternary complex 
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/CO3 2") is suppressed by the electrostatic repulsion of the carboxypropyl substituents 
(Figure I I . 9 ) . 5 2 
O - f — G d — r - O H 2 
0 ^ y y l j 
r-0 
O 
Figure II.9: Molecular structure of |Gd(aD03A)| 3 . 
Ill In this thesis, the design and synthesis of new carbohydrate containing Gd 
complexes w i l l be described (Chapter I I ) , and the contribution from the second 
sphere water molecules wi l l be discovered once again to be determinant in the high 
relaxivity values measured for the macromolecules. 
III. Strategies for Enhancing Relaxivity 
111.1 The crucial role of rm in contrast agent design 
The water molecule(s) of inner sphere, directly coordinated to the metal centre o f the 
chelate structure, must be in rapid exchange with the bulk, in order to transmit the 
paramagnetic effect from the G d m to the solvent. In the Solomon-Bloembergen-
Morgan theory, 3 9 ' 4 2 this water molecule(s) exchange rate is expressed by xm (= \lkex). 
The value o f this term can cover a range of more than four orders o f magnitude, from 
the lowest, reported for one isomer of the [ E u ( D O T A M ) ( H 2 0 ) ] 3 + (kex298 = 8.3><103 s" 
' ) , " - • 5 4 to the highest, (kex298 = 8x 108 s"'), attributed to the aqua ion itself. 
A slow water exchange rate results in a poorly transmitted relaxation effect to the 
bulk, this leading to a limited efficacy of the contrast agent. However, i f the exchange 
with the bulk is too fast, the water molecule(s) could not be coordinated to the G d m 
ion long enough to be relaxed, thus not allowing high relaxivity either. However, the 
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effect o f a too fast (or too slow) water exchange can considerably affect the overall 
relaxivity only i f other parameters (eg. r«) are also optimized. For example, when TR 
is 0.1 ns, any residency time between 1-1000 ns wi l l produce a relaxivity within 20% 
of the maximum at this value of TR\ when r« is 10 ns, this range becomes 2-30 ns for 
rm, as shown in Figure I I L 1 . 4 
* - 10 ns 
10 
30 
• , - 1 ns 
a 20 
* - 0 . 1 M 
rm]—I i m m — I ' u » H — ' I nun; 
1 10 100 1000 10000 
Water residency time, rm (ns) 
Figure II1.1: Relationship between t s and tm at 1.5 T for q = 1 system with long (>10 ns) '/',/ 
(reproduced with permission of the author). 
The water exchange can be described as a dissociative/associative mechanism closely 
related, together with the rate o f the process, to the inner-sphere solution structure o f 
the G d m complex. 8 (Figure III.2) . 
°ciati 
Figure III .2: Simplified representation of dissociative/associative water exchange mechanism. 
For lanthanide aqua ions, the coordination number decreases from nine at the 
beginning o f the series to eight at the end, and rm decreases by more than one order o f 
magnitude between [ G d ( H 2 0 ) 8 ] 3 + and [ Y b ( H 2 0 ) g ] 3 + . 5 5 Only for the ions at the centre 
of the lanthanide series the xm ( = 1 / ^ ) is relatively long (Eu = 395 ± 60 //s; Gd = 159 
±4/js). 
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Expanding our look at the lanthanide complexes, the nine coordinated Gd" 1 
poly(aminocarboxylate) possess dissociatively activated water exchange, since in 
their coordination sphere there is no space for a second water molecule to enter 
before the bound water molecule has left. On progressing towards the end of the 
lanthanide series, the eight coordinate transition state becomes more accessible since 
the radius o f the ions decreases, and the result is an increased water exchange rate. 
Also, the rigidity of the inner coordination sphere is an important factor: while in the 
aqua ion the rearrangement o f the flexible coordination sphere is easy, the 
poly(aminocarboxylate) complexes show a more rigid inner shell, whose 
rearrangement requires higher energy. It emerges that the inner sphere structure 
induces different water exchange mechanisms and it also regulates the speed of the 
process, usually much slower in the nine-coordinate lanthanide111 
poly(aminocarboxylate) complexes than in the eight-coordinate [Gd(H 2 0)8] 3 + . 8 
The overall complex charge is also important in determining kex: generally speaking, 
the bound water in positively charged complexes exchanges more slowly than in 
neutral complexes which themselves are slower than negatively charged ones. The 
higher negative charge aids the leaving o f the water molecule in the dissociative 
process. Indeed, a 50% increment in the r„, value was found for [Gd(DOTASA) 
( H 2 0 ) ] 2 " (Figure III.3) compared to [Gd(DOTA) ( H 2 0 ) ] \ 5 6 whose r„, value is already 
considered relatively fast and it corresponds to 15x 106 s"1, at 298 K. 
N N 
Gd 
N/l N"^ 
H?0 
Figure III.3: |Gd(DOTASA) (H 20)| 2 molecular structure. 
However, this assessment cannot be a rule. The steric constraints caused in the inner 
sphere by, for example, the introduction of bulky substituents, can destabilize the 
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water molecule and accelerate the water exchange. In ([Gd(EGTA)(H 2 0)] 2 ", in fact, 
the water exchanges ten time faster than in [Gd(DTPA)(H20)] 2 ") . 5 7 
Indeed, structure dependent factors can affect the r,„ value. For a series o f cationic 
DOTA-tetra-amide europium complexes, it has been proved that rm depends on the 
extent o f second sphere of hydration, determined by the complex hydrophobicity: 5 8 , 5 9 
the introduction o f more hydrophobic substituents inhibits the formation of the 
hydrogen bonded structure which creates the metal ion's second sphere, determinant 
for the water interchange process. 
Large differences in the rm values have been found even in isomers o f the same 
compound. For example, the lanthanide"1 DOTA-based complexes exist as two 
different diastereoisomers: M and m, which assume a squared antiprismatic and a 
twisted square antiprismatic geometry, 6 0 , 5 5 respectively. 
In agreement with the observations on water exchange dynamics on related Eu1"-
amide complexes, 5 4 the rate of water exchange at a Gd" 1 centre is determined by the 
proportion of the isomer with the fastest water exchange rate in solution which, in the 
case o f the DOTA systems (eg. GdDOTA, GdDOTMA, GdgDOTA), is the m isomer, 
obtained mainly through a rotation o f the amide arms in an interchange mechanism, 
as shown in Figure III.4. 
OH 2 ,
Km0 X 4& X o nng N N r r inversion Ln Ln J OH o N N 
x 
UJ o 
o R 
O 
square-antiprisim twisted square-antiprisim 
M-isomer m-isomer 
A - ( U U ) A-(88S8) 
Figure III.4: The interconversion of DOTA-based complexes. 
These observations were confirmed by the diastereomeric gadolinium complexes o f 
tetra(carboxyethyl)DOTA, where a significant difference has been found between the 
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water exchange rate o f the (RRRR-SSSS)-GdgDOTA (r,„ = 68 ns, 298 K) and the 
other isomers, RRRS- and RSRS-GdgDOTA (r„, = 140 and 270 ns, respectively)."1 
The contribution given by these studies to the design of new contrast agents is 
fundamental, since they revealed the necessity of synthesizing complexes which exist 
in solution in well defined isomeric form. 
III.2 Working on r R 
At the magnetic field strengths typically employed in clinical imaging (1.5 T, 64 
MHz proton Larmor frequency),4 the longitudinal relaxation time of the inner sphere 
water protons, Tm, is dominated by the molecular reorientational correlation time, TR. 
Contrast agents possessing a compact structure and high molecular weight should 
exhibit slow molecular tumbling. The slower the Gd 1" complex tumbles, the longer 
the correlation time (r«) becomes, leading to faster relaxation rates and hence higher 
relaxivities.1 Some different approaches have been considered for decreasing the 
tumbling rates, and the most effective one seems to be the linking o f a Gd 1" complex 
to a slowly tumbling macromolecule (such as dendrimers),6 2 or to examine molecular 
complexes conjugated to polysaccharides63 or proteins.6 4' 6 5 
The best relaxivity enhancements have been achieved in non-covalently bound 
systems,6" such as those based on binding o f Gd" 1 complexes to serum albumins. 
III.2.1 Non-Covalent Systems 
- q = 2 systems 
The changes in the relaxivity values generated by the binding interactions of D 0 3 A 
based gadolinium chelates (Figure III.5) to HSA have been investigated by Aime et 
° v \ O O H 2 69 a. O OH 
so, 3U N H o Gd / it \ N •Gd IX Br N N-^OH 'X PChH O 
O 
Gd-5 Gd-4 
Figure III.5: D03A based Gd" 1 complexes. 
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Given that both the systems are endowed with q = 2 and short r,„ values (for Gd-4, r,„ 
= 15 ns and for Gd-5, r„, = 12 ns, at 298 K) surprisingly low relaxivities were 
reported for the macromolecular adducts with HSA: 24 and 21 m M 's'1 for Gd-
4/HSA and Gd-5/HSA, respectively.67 Luminescence measurements and emission 
spectra of the europium analogue adducts with HSA, made clear that the expected 
relaxation enhancement was not observed because of the displacement of the two 
inner sphere water molecules by donor groups (such as a carboxylate group from Glu 
or Asp side chains) o f the proteins and phosphate ions, possibly of the buffer solution. 
Conversely, when the interactions of the Gd-4 and Gd-5 complexes with poly-/?-
cyclodextrin were investigated, no changes in the hydration state o f the metallic 
centre were observed and, in spite o f a much lower TR value, the observed relaxivities 
were higher (28.3 and 27 mlvr's" 1). Recently, the non-covalent interactions between 
Gd'"-complexes and ft- or ^cyclodextrin units (CDs) have been revisited, and supra-
molecular adducts o f chitosan (obtained by deacetylation o f chitin, natural polymer of 
/?-(l-4)-D-glucosamine) functionalized with cyclodextrins were bound to negatively 
charged Gd 1" chelates bearing hydrophobic substituents (Figure I I I . 6 ) . 6 8 
co 2 Me Ph OH 
Me n Q, ,0 Ph 
HO O " v . 
NH 13© NH 
Me N 
N N 
= 0 o N C / - \ ~ 1 3 0 * 0 H > o< ( N N 
9^- P ) >=o o< ( <f ° . . - 0 o o H H 9 ^ o Chitosan - yCD Gd-6 MS-325 H H 
Figure III.6: Gd 1" chelates and CDs adduct. 
Compared to the corresponding analogues with monomeric cyclodextrins, the 
chitosan functionalized ones showed large increases both in terms o f their binding 
affinities towards Gd" 1 complexes and in the relaxivity values (o^chitosan P- C D 'ms-325) = 
27.5; /> ( chiiosan ^CD/Gd-6 ) = 21.6 mM^s" 1). Furthermore, the binding affinity (KA) of the 
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gadolinium chelates towards the exogenous polymer was evaluated, and the chitosan 
y-CD I Gd-6 adduct could be considered for in vivo applications as, it remains mainly 
bound to the polymer even in solution where the concentration o f HSA is equal to the 
albumin in human serum (0.58 mM). 
Further interesting studies focused on the change of the relaxivity values of Gd 1"-
diaqua-triphosphate complexes in the presence o f a protein. 6 9 The relaxivity of the 
triphosphonate (Figure HI.7), based upon the molecule aD03A, was found to be 
significantly enhanced from 7.9 mM" 1 s"1 to 30.0 m M ' V 1 in the presence o f HSA (at a 
concentration 0.6 mM, similar to the in vivo protein concentration). 
Phosphate anions were then added to the protein solution to understand i f the 
complex was able to withstand competition from competing anions when strongly 
bound to serum albumin. The results showed that, unfortunately, the phosphate 
anions were able to displace the complex from the protein adduct, as well as 
displacing bound water in the complex, resulting in a marked reduction of the 
observed relaxivity. 
It emerges from the previously examined examples that it is not straightforward to 
realize the expected relaxivity enhancement upon non-covalent binding of q = 2 
systems to macromolecules. The water molecules of the Gd" 1 ion seem, in fact, to 
make the complex particularly reactive towards other coordinating groups, which can 
replace the metal-bound waters. 
n 3 O . 0 H 2 
r H 
N 
P-OH OH Gd HO-P 1— \\ N N 
\\J 
HO 
Figure III.7: Molecular structure of |Gd(aD03AP)(H 2 0) 2 | 3 . 
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The highest observed r l p value for non-covalent paramagnetic adducts with slow-
moving substrates has been shown, so far, by the lipophilic Gd'"-AAZTAC17 
complex (shown in Figure III.8) bound to HSA. 7 0 
o OH ' . > = O y O H 2 
7° 
3 
r 
O 
Gd 
OH 
n-C 1 7 H V N 7 "35 
0 Y 
o 
GdAAZTAC 1 7 
Figure III.8: Molecular structure of Gd'"-AAZTAC17. 
Functionalisation o f the A A Z T A ligand 7 ' (which synthesis and magnetic properties of 
the corresponding G d m complex wil l be discussed in detail in Chapter I I I - Section 
I H . l and III.4 -) with a C17 aliphatic chain induces the formation o f micelles already 
at submillimolar concentrations (greater than 0.1 mM). A sharp increase in the 
relaxivity value is observed when the system evolves from the monomeric state to 
micellar aggregates: at 20 MHz, 37 °C the r ! p of Gd'"-AAZTAC17 below the critical 
micellar concentration (cmc) is 10.2 mM''s ' ' whereas the r i p o f the self-assembled 
complex above the cmc is 30 m M ' V . 7 2 The interaction with HSA has been 
investigated for both the monomeric gadolinium complex (below the cmc) and the 
aggregated micellar system. While a slight increase in the relaxivity value was 
registered for the bound to HSA form with respect to the free micellar system, very 
similar relaxivity values were observed when the micellar system was bound to fatted 
or defatted HSA. Alternatively, the binding affinity o f monomeric Gd'"-AAZTAC17 
for defatted HSA (nKA = (2.3 ± 0.7) • I0 4 M" 1 ) is significantly higher than for fatted 
HSA (nKA = (7.1 ± 0.7) • 104 M ' 1 ) , whereas the relaxivity o f the paramagnetic 
macromolecular adduct with defatted HSA is markedly higher and reaches the 84 
mW's ' 1 (at 20 MHz, 25 °C); these differences in the relaxivity o f fatted arid defatted 
HSA adducts has been mainly ascribed to changes in the contribution of the second 
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sphere of hydration. The macromolecular adduct given by the binding o f monomeric 
Gd l u -AAZTAC17 to defatted HSA is by far the most efficient reported to date. 
- q = 1 systems 
The compound MS 325 (Figure III.9) developed by Epix Medical (USA), is an 
example o f a non-covalently bound system?1 The molecule, linked via a phosphate 
ester to the DTPA chelate of Gd(III) , bears a diphenyl substituted cyclohexyl group 
for non-covalent binding to the human serum albumin (HSA) protein in the blood 
pool. The rotational rigidity in the protein adduct imparted by this arrangement 
results in an increase in relaxivity for the protein bound complex (24 rnM 's'1, 310 K, 
64 MHz). 
Ph 
P \ —>30 
o r n 
|J—v, 
H H 
Figure III.9: Structure of MS 325 (Epix Medical). 
The highest enhancements in the relaxivity values for q = 1 systems reported to date 
were exhibited by a GdEGTA 7 3 derivative, characterized by small size and 
compactness o f the structure, one inner sphere, fast exchanging water molecule (r„, ~ 
17 ns at 298 K) , and a rigid targeting moiety (an aromatic group) capable o f forming 
non-covalent interactions with the hydrophobic sites o f HSA (Figure III .10) . 7 4 
^
 hnynYV3
 kco>H 
S K ^ < 0 ^ C 0 2 H 
l ^ / N v ^ C 0 2 H 
Figure III. 10: GdEGTA phenylalanine derivative. 
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The relaxivity o f this adduct reaches 68 mM" 1 s"1 (at 298 K, 20 MHz), even higher 
than the value previously reported for the host-guest hydrophobic interaction between 
a [Gd(DOTA)]" system bearing three benzyloxy-propionic substituents and human 
serum albumin (HSA): ca. 56 mM"'s"' at 310 K, 20 MHz. In this case, the increase in 
relaxivity is explained as a consequence of interactions with nearby water molecules 
from the macromolecular hydration sphere and perhaps from exchangeable protein 
protons. 
Remarkably good results have also been obtained with Gd -TTDA-BOM derivatives 
bound to HSA (Figure I I I . l l ) : 7 5 r / p value of 65.8 mM"'s"' has been registered for the 
adduct [ G d I 1 I ( T T D A - B O M ) ( H 2 0 ) f / HSA and 61.5 m M 's"1 for [Gdm(TTDA-7V'-
BOM)(H 2 0) ] 2 " / HSA. 
L J TTDA-A/'-BOM 
F i g u r e I I I . l l : |Gd(TTDA-BOM)(H 2 0)| 2 and |Gd(TTDA-BOM)(H 2 0)) z . 
III.2.2 Covalently Linked Systems 
An alternative strategy to enhance the intrinsic rR of a contrast agent is to construct a 
higher molecular volume complex. However, despite several different attempts, most 
covalently-linked high molecular weigh conjugates do not significantly increase the 
relaxivity of the macromolecule. In a 2001 study, 7 6 the attachment of Gd" 1 complexes 
to polymers was performed in order to increase the value of rR. For example, 
poly(ethylene glycol) (PEG) moieties of average molecular weights 2000 and 5000 
Da respectively were attached to the ligand TREN-HOPO-TAM (Figure 111.12). 
HO,C 
\ H 0 2 C N N N CO->H N N N X 0 2 H 
f C 0 2 H 
O 
C 0 2 H \ o 2 H 
HO,C CO,H 
COo C 0 2 H 
6TTDA-BOM - /' 
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Figure 111.12: The ligands TREN-HOPO-TAIV1 (I) and TREN-HOPO-TAM-PEG (2). 
The high water solubility of PEG chains increased the rather low solubility of the 
ligand, and it was also demonstrated that PEG chains can bind to human serum 
77 
albumin across a wide pH range. The complexes [Gd-TREN-HOPO-TAM-PEG-
2000] (1) and [Gd-TREN-HOPO-TAM-PEG-5000] (2) were found to be highly 
soluble in H2O. The TM and the number of coordinated water molecules (q = 1) were 
determined by a variable temperature l 7 0 N M R R.2P study o f the transverse relaxation 
rate o f H 2 1 7 0 (R2) at 2.1 T. The observed increase in r M as the PEG chain is 
lengthened (with values of ~ I 9 and -31 ns for (1) and (2), respectively), can be 
accounted for by considering the concentration of water molecules in the immediate 
vicinity of the Gd" 1 complex. The increase in relaxivity observed upon addition of the 
PEG chain, however, was very modest considering the large increase in molecular 
weight, largely because o f inefficient motional coupling between the Gd-centre and 
the macromolecular complex as a whole. Indeed, the relaxivity o f the Gd'"-complex 
with "PEG-5000 chain" at pH 7.5 is 9.1 mM 's"1 (20 MHz, 25 °C), which compares to 
8.8 m M 's'1 (20 MHz, 25 °C) for the "simple" Gd'"-complex. 
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Recent research has focused on increasing the efficiency of motional coupling 
between the Gd" 1 centre and the motion of the whole complex, by placing the metal 
ion at the barycentre of the structure. In this way, the Gd" 1 should always lie on any 
axis o f reorientational motion and be always coupled to the motion o f the 
macromolecule as a whole. Such a situation wi l l exist in a dendrimer as it approaches 
a spherical overall shape, wherein the Gd 1" ion resides at the centre. 
IV. Dendrimers 
IV.1 Structure and strategies of synthesis 
Dehdrimers are monodisperse polymeric macromolecules with a high degree of 
molecular uniformity and a highly branched three-dimensional structure, consisting 
78 
of three major architectural components: core, branches and end groups. The 
structure of the dendrimers is often represented as being symmetrical, with all 
dendritic arms radiating outwards from the core and all end groups located at the 
surface. Some studies, 7 9 ' 8 0 however, revealed the occurrence o f a considerable degree 
of backfolding, which can cause a distribution of terminal functionalities throughout 
the volume of the dendrimer. 
Dendrimers are synthesised by iterative reaction sequences, with each sequence 
leading to increasingly higher generations o f dendrimers. 
The convergent and the divergent synthesis approach 
Two different strategies have been introduced for the synthesis of these 
macromolecules. The first example o f a divergent synthesis was reported by Vogtle, 8 1 
followed by the poly(amido-amine) ( P A M A M ) dendrimers (Figure I V . l ) of 
Tomal ia 8 2 , 8 3 and Newkome's arborol systems.84 To prepare the P A M A M dendrimer, 
a multifunctional core was iteratively functionalised and extended to form the various 
generations. P A M A M dendrimers represent a class o f macromolecular architecture 
called "dense star" polymers which feature larger molecular diameters, twice the 
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number of reactive surface sites, and approximately double the molecular weight of 
their preceding smaller generation. 
The opposite convergent approach was introduced by Frechet in 1990, 8 5 ' 8 6 where the 
synthesis is commenced at the periphery and iteratively elaborated inwards to the 
core. Both the convergent and the divergent approaches to dendrimer synthesis 
involve the repetition o f reaction steps, but purities of the resulting products can be 
very different. With divergent synthesis, the dendrimer is constructed outwards from 
a central core. Increasing numbers of functional groups are introduced at the 
periphery and extended outwards successfully in the subsequent step, to achieve the 
next generation; this strategy can lead to defects and imperfections, even for reactions 
with high yield and selectivity. Unfortunately, the small structural differences 
between defective and defect free molecules do not allow easy purification of the 
resulting products, which wil l consequently show a number of statistical 
imperfections. N H i 
Figure IV. 1 : Generation 2 PAIV1AIV1 Dendrimer. 
The synthesis of dendrimers by the convergent approach starts at the periphery and 
grows inwards to the core. There is only one reaction site at the focal point of the 
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growing dendron to couple to the monomer, producing the next generation. Defective 
partially substituted monomers are often easily separable from the pure product by 
chromatography. 
In principle, dendritic contrast agents may be devised either with the complex at the 
periphery or in the core of the macromolecule. Examples of each case will be 
considered. 
IV.2 Gd1" complexes at the periphery of a dendrimeric structure 
In a recent study, only a moderate increase o f the reorientational correlation time, TR, 
of Gd 1" complexes was obtained by conjugating them to the surface of 
polyamidoamine ( P A M A M ) dendrimers.8 7 The relaxivity gains display a "saturation 
effect" and a consequent "quench" of the relaxivity for Gd 1 1 1 complexes linked to the 
dendrimeric backbone upon increasing the size o f the complex-dendrimer adducts. 
This observation was explained in terms of the undesired mobility of the anchoring 
spacer and flexibility o f the skeleton. In order to understand more about this 
phenomenon, a new series of P A M A M conjugates with G d - D 0 3 A P A B n on the 
periphery o f the dendrimers was synthesised (Figure IV .2 ) . 8 8 The [Gd-D03AP] 
complex was selected, as it possesses a fast water exchange rate. Typically, the G2-
P A M A M conjugate had an empirical molecular mass in the region o f 13500 Da, with 
16 Gd complexes bound at its periphery. 
N \ W / > ^ N H W NH NH \*J 
H 2 N^ h^1 NH2 O Q—l O H N h</ N H Q 
^ / \ i N H 2 1) H 20/CCI 4, CSCI 2, pH2-3(HCI), 12h QHN^ / \ N H O 
H 2 N^ I f H N H 2 2) H 2 0 , pH 9-10 (KOH), 12 h HN^ I 
NH2 NH2 O QH O 
Figure IV.2: Simplified representation of the reaction sequence leading to G2-PAMAM 
dendrimeric conjugate. 
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An enhancement in the relaxivity was observed by rigidifying the internal frame of 
Gd-containing P A M A M dendrimers following protonation o f the dendrimer or the 
formation of supramolecular adducts with cationic polyaminoacids. From an initial 
relaxivity value of 20.4 mM" 1 s'1 (at 25 °C, 20 MHz ) at pH < 6, an increase to ca. 
24.8 mM" 1 s"1 was observed (25 °C, 20 MHz), and the relaxivity reached a plateau of 
ca. 34 mM" 1 s"1 (25 °C, 20 MHz ) during the titration of an aqueous solution of the 
paramagnetic dendrimer with poly(Arg) (degrees of polymerization, dp ~ 56 and 
320). 
IV.3 Gd1" complexes at the core of the dendrimeric structure 
A different synthetic approach to prepare dendritic contrast agents is to conjugate 
dendritic wedges to a Gd 1" complex core, placing the metal ion at the barycentre of 
the molecular complex and efficiently coupling the local motion o f the Gd-OH2 
vector with the rotational motion of the whole complex. 
A compound prepared by this synthetic strategy is P760-Gd (Figure IV.3), a 
hydrophilic derivative o f Gd M I DOTA with a molecular mass o f 5.6 kDa. 9 0 This 
conjugate has been characterized in various media: aqueous solution, protein-
containing solution, and Z n 2 + - containing solution. 
N(CH 2(CHOH) 4CH 2OH) 2 OBr 
r n 
N N E NH NH Br R 0 OH N / N 
\_ u N(CH 2(CHOH) 4CH 2OH) 2 Br 
O 
Figure IV.3: The structure of the Gd'"-centered dendrimer P760-Gd. 
Like its parent complex Gd-DOTA, P760-Gd does not undergo transmetallation by 
Zn" ions and, furthermore, analysis of the non-covalent binding o f P760-Gd to serum 
proteins by proton relaxometry showed that the complex does not interact with 
human serum albumin. The relaxivity of P760-Gd is one o f the highest reported in the 
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literature for a gadolinium complex not displaying protein binding; 9 1 its large 
longitudinal and transverse proton relaxivities (rip ~ 25.0 s 'rnM" 1 and rjp~ 29.5 s" 
' m M ' 1 at 310 K and 0.94 T) are a consequence of its increased rotational correlation 
time (TR ~ 2 ns at 310 K). Unfortunately, the proton N M R D data obtained show that 
the benefits from the increased xR are not completely achieved because of sub-optimal 
water-exchange rate, and the relatively high relaxivity is likely to be associated with a 
large second sphere contribution. 
New types of dendritic framework have been synthesised based on a central G d m 
complex. 9 2 These dendrimers, containing four or twelve (Figure IV.4) glucose 
moieties at their peripheries, were synthesized by conjugating 
diethylenetriaminepentaacetic (DTPA) to carbohydrate-containing dendritic wedges. 
This extended ligand was complexed to a gadolinium ion to afford a contrast agent 
containing a single bound water molecule. Despite its acetylated glycosides, which 
may reinforce its hydrophobicity, this dendrimer shows a good solubility in aqueous 
solutions. However, its diamides containing core possesses rather slow water 
exchange rates, quenching any relaxivity gains that might otherwise have been 
obtained. 
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Figure IV.4: Structure of Gdm-dendrimer chelate |Gd(D2)|(H 20). 
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Unfortunately, relaxivity studies were not reported on this dendrimer or its deacylated 
analogue. Nevertheless, gadolinium centred spherically dendritic macromolecules are 
interesting and stimulating subjects to be studied as new potential candidates for MRI 
contrast agents. The important role played by carbohydrates in many recognition 
processes on cell surfaces make them candidates for the site-specific delivery of the 
contrast agents at a molecular level. 
The design and synthesis of new carbohydrate-containing dendrons has been the aim 
of the research during the first year of this project, and it wi l l be discussed in 
Chapter I I of this thesis. 
IV.4 Gd1" complexes incorporating hydrophilic dendrons 
Significant enhancements in the relaxivity values were recently obtained in 
dendrimers constructed upon the (RRRR/SSSS)-[GdgDOT A(Y\20)]5' complex. The 
macromolecules are synthesized by conjugating dendritic wedges to the Q-related 
peripheral carboxylate groups of the (RRRR/SSSS)-[GdgDOT A(H20)f complex. An 
example o f such a dendrimer is illustrated in Figure IV.5: 
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Figure IV.5: Structure of a dendrimer based upon |GdgDOTA(H 20)| 5". 
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The Gd 1 1 1 ion resides at the focal point of this spherical complex, which possesses an 
overall maximum density at the centre surrounded by a hydrophilic dendritic 
structure. The observed relaxivity ( n P = 19.6 mM"'s"', at 25 °C, 20 MHz) is thought to 
be dominated by a large second sphere contribution, that increases linearly with the 
molecular volume, and a fast inner sphere water exchange rate is also maintained (r,„ 
= 85 ns). 8 9 
An attractive example o f dendrimeric chelate possessing optimal water residence time 
(r,„ = 10 ns), slow molecular tumbling (rR = 238 ps) and good water solubility (> 15 
mM), is the q = 2 system Gd-TREN-bisHOPO-TAM-Asp-Asp 2-120H, 9 3 illustrated in 
Figure IV.6. 
N 
NH HN h 0 NH O l-T-:;.pf HO OH N NO OH Me OH Me HN O HN 
H,0 
OH 
NH NH OH N 
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HO 
NH OH HO ft OH OH 
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Figure IV.6: Structure of [Gd-TREN-bisHOPO-TAiM-Asp-Asp 2-120H(H 20) 2|, 
MW 1576 gmol'. 
However, all these optimized parameters result in an observed efficacy measured at 
20 MHz, 25 °C, o f 14.3 mM 's"1, inferior to the value observed at the same magnetic 
field strenght for the previously described q = 1 Gd-gDOTA based dendrimer. An 
explanation o f this data can be found in the field dependent magnetic properties of the 
HOPO-based complexes, which wi l l be discussed in section V o f this introduction. 
IV.5 Glycodendritic Complexes: taking advantage of the sugar 
moiety? 
An interesting recent study reported the in vitro relaxivity of some G d m -
glycoconjugates (Figure I V . l ) based on the DOTA ligand. 9 4 DOTA like ligands form 
L n m chelates of high thermodynamic and kinetic stability, which is of crucial 
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importance for in vivo applications, and DOTA-monoamides are easy to prepare. 
However, they also usually possess a rather slow water exchange rate so the 
relaxivity gains in non-covalent adducts are sub-optimal. 
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Figure I V . 1: A tetravalent galactoside based upon a mono-amide derivative of DOTX.94 
A 'H N M R D profile study was undertaken and the interaction of these 
glycoconjugates with lectins (carbohydrate binding proteins) was examined. The 
flexibility o f the glycodendrimer moiety in solution was found to limit the relaxivity 
of the Gd" 1 complex to a value lower than expected from its molecular weight. 
Precise details o f the relaxivity o f this system have not been reported, but it is likely 
to be low because of the slow water exchange rate and the high degree of flexibility 
inherent to the structure. The lectin-glycoconjugate interaction was found to slow 
down the tumbling rate and increase the relaxivity o f the Gd 1 1 1 chelates, but this effect 
was modest and the increase in relaxivity was only 8% in the lectin conjugate. 
An increase in the relaxivity value of a gadolinium contrast agent can be registered 
upon slowing down its molecular tumbling (r«), insofar as its inner water molecule's 
exchange rate (r,„) is also close to an optimal value, which is of ~ 30 ns. 9 5 A q = 1, 
small gadolinium complex, based on 1,2-HOPO chelate, GdH(2,2)-l ,2-HOP0 9 6 has 
been recently synthesized (the ligand structure is shown in Figure IV.2), whose 
relaxivity value (r/p = 8.2 mlvl 's"1, 20 MHz, 37°C), is approximately double that of 
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both [Gd(DOTA)(H 2 0)]" and [Gd(DTPA)(H 2 0)] 2 ", and rises from the optimization of 
all the relevant parameters: long rotational correlation time (rR = 107 ps), A2 is small 
( l .OxlO 1 9 s"2) and zv is long (47 ps), allowing an estimation of a very favourable 
longitudinal electronic correlation time T\e (~ 70 ns at 60 MHz). 
sJH \ N  O HN 
a 
.OH HCL 
^ N N ^ 
i 
Figure IV.2: H(2,2)-l,2-HOPO structure 
Extra enhancement to the overall relaxivity can be achieved by further increasing the 
rotational correlation time, grafting the small gadolinium-HOPO-chelate to large and 
rigid macromolecules. The toxicity of the compound has been also examined, and the 
pM values obtained from competition batch titration versus DTPA have shown a very 
high stability of the Gd(l l l ) complex and excellent selectivity for Gd(III) binding over 
Zn(II) and Ca(II); the luminescence spectroscopy experiments on the analogues 
europium-HOPO-chelate revealed no affinity for the Zn(II) and Ca(II) ions either. 
The exceptionally good relaxometric properties for a q = 1, small gadolinium 
complex, and the very low affinity for endogenous anions, renders GdH(2,2)-l ,2-
HOPO a promising extracellular contrast agent for MRJ. 
V. Survey of D/'-aqua complexes 
V.1 General considerations 
The commercially available poly(amino-carboxylate)-based chelates of first 
generation possess only one coordinated water molecule in their inner sphere (q = l ) , 
which can exchange sufficiently slow with the bulk solvent to limit the image-
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enhancing efficacy of macromolecular derivatives (typical r/p value ~ 4 mlv r ' s 1 ) . 8 
According to the Solomon-Bloembergen-Morgan equation, a bigger number o f inner 
sphere water molecules, with fast exchange rate, should significantly increase the 
relaxivity of the system. A straightforward way of testing this theory is to decrease 
the ligand's denticity, although the use of heptadentate ligands can lead to a 
substantial drop in the thermodynamic stability and kinetic inertness that are essential 
to guarantee the non-toxicity of the complex, or to a change of the chelate's 
selectivity towards physiological anions, with consequent possible formation of 
ternary complexes. With regard to this, [Gd(D03A)] and several functionalized 
derivatives based upon it have been investigated in detail. The complex 
[Gd(aD03A)] 3", synthesized a few years ago in our laboratory 5 2 (its molecular 
structure is reported in Figure II.9), is an example o f D 0 3 A based q = 2 system 
whose efficacy (r/p = 12.5 mM" 1 s"1) has been proved not to be perturbed by the 
presence of endogenous cations (e.g. Zn" 1), or anions (e.g. HCO3/CO3 2"). 
[Gd(aD03A)] 3" showed a kinetical inertness ten times superior to the clinically used 
[GdDTPA] 2" (Magnevist): 
However, among other examined D03A-based systems,97 evidence has been found 
for the displacement o f one or both of the coordinated water molecules by 
endogenous anions (eg. carbonate, lactate, malonate, citrate). In addition the 
formation of ternary Gd i nL-human serum albumin (HSA) adducts has been defined 
with coordinating groups on the surface of the HSA displacing the inner sphere water 
molecules.6 7 
Studies have therefore been oriented towards other classes o f heptacoordinated Gd 1" 
chelates. 
V.2 HOPO derivatives 
Hydroxypyridinate (HOPO) monoanions have been employed as a base structure in 
the synthesis o f q = 2 Gd(Il l) complexes: they become effective multidentate 
chelating agents (especially for metal ions, such as Gd 1 1 1) when the ring carbon in a-
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position to the hydroxyl (or carbonyl) group is functionalized and attached to a 
suitable backbone through amide bond formation 9 8 (Figure V . l ) . 
OH 
C H 3 
Figure V . l : HOPO structure 
In 1995, the first HOPO derivative was synthesized: Gd(TREN-l-Me-3,2-
HOPO)(H 2 0) 2 = tris[(3-hydroxy-l-methy 1-2-oxo-1,2-didehydropyridine-4-
carboxyamido)ethyl]amine (1 in Table V . I ) . 9 9 The purely oxygen donor ligand 
allows two coordinated water molecules at the metal centre, without destroying the 
chelate stability or affecting the efficacy of the complex. The relaxivity is 10.5 mM" 
V (at 37 °C, 20 MHz), double that of the commercial CAs . 1 0 0 Since then, an entire 
"HOPO-based family" of MRI contrast agents has been created: it includes 
complexes with chelating HOPO moieties and various caps, in which the lanthanide 
ion is coordinated to six oxygen donors. The complex accommodates two water 
molecules, which exchange at a fast, near optimal speed with the bulk solvent 
(molecular structures are reported in Table V . l and a comparison o f the rm o f some 
HOPO-based complexes versus commercial agents is shown in FigureV.2). 
Gd-DTPA 
Od-DTPA-BMA 
Gd-DOTA 
G0-HP-DO3A 
Gd aqua ion I 
KM K„ 
FigureV.2: Water exchange rate of HOPO-based Gd" 1 complexes (grey) vs commercial 
agents(black)99 (reproduced with permission of the author). 
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Variations of the chelating moiety 
OH2 \Me 
Gd-TREN-1-Me-
3,2-HOPO(1) 
Gd-TREN-MOE-
3.2-HOPO (2) 
° Y N H O ^ . N H 
Gd-TREN-Me2-
5.4-HOPY (3) 
OH 2 W 
OH 2 
OH, 
Gd-TREN-6-Me-3,2 
3.2-HOPO (4) 
O . . N H 
OH2 
Gd-TREN-1,2-HOPO (5) 
Variations ot the cap 
H N ^ O 
i G d . 
O ^ - N H 
V ONH 
6cfe 
Me ; \ M B 
H 2 0 OH 2 
Gd-TREN-1.2.3-HOPO (6) 
Gd-Ser3-TREN-1-Me-
3.2-HOPO (7) 
Gd-Gly-TREN- 1-Me-
3.2-HOPO (8) 
Gd-TREN-1-Me-
3,2-HOPO (1) 
Heteropodal omplexes 
HN O NH 
NO ; \ i 
"NH Me ; \ M e 
i H20 OH2 
^ f~ ° " N O 
Me 
NH 
- ' . V ' . V O ^ N - 1 
Me 
R = C H 3 
Gd-TREN-bisHOPOTAM (10) 
R = ( C H 2 C H 2 0 ) 4 5 - C H 3 
Gd-TREN-bisHOPO-TAM-PEG2000(13) 
R = ( C H 2 C H 2 0 ) 1 1 4 - C H 3 
Gd-TREN-bisHOPO-TAM-PEG5000(14) 
R = CH 2 CH 2 OH 
Gd-TREN-bisHOPO-TAM-EA(16) 
H 2 0 OH 2 
Gd-TREN-bisHOPO-SAM (11) 
W
0 \ H ° t n h ° n h m r ° 
N 0 
Me 
N O 
Me 
H 2 0 OH 2 / M o 
Gd-TREN-bisHOPO-IAM (11) 
HjO OH 2 
Gd-TREN-bis(6-Me-HOPO)-
TAM-tri (15) 
• . NH 
. - G d 
NH H ' ° ° ^ 
Gd-TREN-HOPO-bisTAM-EA 
(17) 
NH 
Gd-TREN-TAM-EA (18) 
10I Table V . l . Structure of hydroxypyridinone-based Gd 1 1 1 complexes. 
Besides a significant improvement in the r,„ values, the HOPO-based Gd complexes 
show a substantial difference in the relaxivity dependency upon magnetic field 
strength. Thus, in their I/Ti N M R D profiles, a distinctive peak in the relaxivity value 
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is registered at high fields, between 20 and 100 MHz. This behaviour is opposite to 
that observed for the contrast agents commercially available, which usually present 
higher relaxivities at magnetic fields below 10 MHz. The recently synthesized Gd-
TREN-bisHOPO-TAM-Asp-Asp 2 -120H(H 2 0) 2 (Figure V.3 a, Gd-2) , 9 0 where the 
Gd 1" chelate is grafted onto a dendron consisting of four 
tris(hydroxymethyl)aminomethane (TR1S) groups linked by three aspartic acids, 
presents the best N M R D profile (in Figure V.3 b) for such a HOPO-derivative 
gadolinium complex. 
a) 
O NH 
y O NH 
i hi n • • w 
Me ; 
H,0 
H O . O H 
HN " O HN 
H O O H 
O H 
HO " O H 
b) 
A GdDOM 
0.01 0.1 1 10 100 
Proton Larmor Frequency (MHz) 
1000 
Figure V.3: a) Gd-TREN-bisHOPO-TAM-Me(H 20) 2 (Gd-1) and Gd-TREN-bisHOPO-TAM-
Asp-Asp 2-120H(H 20) 2 (Gd-2) and b) relative \IT, NMRD profiles (at 298 K) 9 0 
(reproduced with permission of the author). 
The relaxivity value o f 14.3 mM"'s"' (20 MHz, pH 7.2, 25 *C) exhibited by this 
dendrimer is three times greater than that of the comparative q = 2 commercial agent 
G d - D 0 3 A 1 0 2 and 1.6 times that o f the monomer Gd(TREN-l-Me-3,2-HOPO)(H 2 0) 2 
[ G d l ] . At 90 MHz, the relaxivity value reaches 18 mW's ' 1 . The enhancement is 
explained in terms of the increased rotational correlation time: the higher molecular 
weight (1576 g/mol) and compactness of the structure (guaranteed by the short linker 
between two branching points o f each aspartic moiety) ensure a slower tumbling, 
without affecting the fast water exchange rate (r„, = 10 ns) of the two inner sphere 
water molecules or the short electronic relaxation time. Furthermore, the alcohols on 
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the dendritic moieties offer a solution to a problem associated to the use o f HOPO-
derivatives in general as contrast agents: their poor solubility in water. Many 
structural changes have been investigated to circumvent this drawback, such as the 
insertion into the ligand's structure of methoxy derivatives (as shown in 2), or 
salicylamide (11), or isophthalamide (in 12). Noticeable water solubility enhancement 
has been found with complexes based on another class o f bidentate chelating groups: 
the 6-carboxamido-5,4-hydroxypyrimidinones. An example is Gd-TREN-Me2-5,4-
HOPY (3), which showed a very much improved solubility (up to 100 mM) and 
exceptionally short water residence time (r,„ ~ 2 ns); the absence of binding 
interactions towards endogenous anions has been confirmed by titration of a 1 mM L' 
1 solution of the complex with acetate, lactate and malonate, at 20 MHz, 25 °C and 
pH 7.2. The accessibility o f the anions towards the metal centre is hindered by the 
tight coordination of the ligand donor groups, which probably presents a high steric 
constraint at the water binding sites. 1 0 3 A comparison o f relaxivity measurements in 
water and in blood serum reveals that the relaxivity is approximately 35% higher in 
the latter, this suggesting the presence of a weak interaction between the complex and 
human serum albumin. 
However, the complexes currently claimed to be the most promising relaxometric and 
solubility properties rely on a heteropodal bis-HOPO-TAM ligand, incorporating a 
triazacyclononane (TACN) derivative as a "cap" (Figure V.4) . 9 8 
N N N N 
r r N N 
NH O NH O HN HN 
NH NH O , 0 . ^ " N 5^ o o N ^ 
St N o o 
ft 
O N 
Me Me 
N O O 
Me H 2 0 O H 2 
H 2 0 O H 2 
3 4 
Figure V.4: Gd"'-TACN-3,2-HOPO (3) and Gd"'-TACN-1,2-HOPO (4). 
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To determine i f the TACN capping scaffold has any influence on the number of 
coordinated water molecules, the europium analogue complex was synthesized and 
luminescence lifetime measurements confirmed what had previously been predicted 
by molecular mechanic techniques: the system is a q = 3 complex. The relaxivity 
values for 3 and 4 are respectively of 13.1 and 12.5 mM"'s"' (20 MHz, 298 K, pH 7), 
one of the highest registered so far for low molecular weight mononuclear 
gadolinium complexes. The r,„ value has been measured of ca. 2.0 ns and the l v a l u e 
obtained from the N M R D fits are the lowest yet determined for any HOPO-based 
gadolinium complex (i.e. longer electronic relaxation time is expected). 
Given the very high toxicity of the gadolinium ion, it becomes crucial to examine the 
stability o f the chelate structures in their environments. Studies o f the effect of the 
ligand basicity on the thermodynamic stability of the gadolinium HOPO-based 
complexes demonstrated that maximum stability is gained with the intermediate 
basicity displayed by the heteropodal ligand TREN-bis-HOPO-TAM, 1 0 4 (10, Table 
V. l ) . Acidic or negatively charged substituents drastically decrease the stability of the 
complex, which is enhanced i f the overall charge is maintained as close to zero as 
possible and the ligand's basicity is optimized (Figure V.5). 
HN " O 
S 
HN HN 
HO „A 
20.0 
HO 
o 1 2 1H \ 
 HN N 19.5 OH OH Me 
N  
O NH 
19.0 Gd'L3 Gd-L1 Gd-L2 Gd-L4 
I - 1 •:!-GA' 0 18.5 
A, NO 180 OH IN ^ O HN HN HN HN 
M«H S S S » M A 
H
Me 
H,0 NH 17.5 I . I <2 i i 2 i . i 
H , 0 
Me 
OH NH 
Gd-L5 Gd-LS Gd-L7 Gd-L8 Gd-L9 
Figure V.5: (a) Functionalized Gd'"-TREN bisHOPO-TAM complexes and (ft) effect or the 
charge of the Gd" 1 complex on their stability 1 0 3 (reproduced with permission of the author). 
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The stability o f HOPO-based gadolinium complexes in the presence of Cu", Ca" and 
Zn" is important, as these metal cations, present in the human serum in non-negligible 
concentrations, potentially could displace toxic gadolinium from the complex. 
Titration studies on a representative complex, G d - L 5 , 1 0 5 indicate that the compound 
is of comparable stability and toxicity to commercial MRI contrast agents. 
Endogenous anions (e.g. carbonate, phosphate, citrate, malonate), present in serum 
and other biological fluids, can also decrease the contrast enhancing effectiveness by 
displacing the water molecules coordinated to the metal. Only hydrogenphosphate 
and oxalate exhibit a significant effect on the relaxivity of both the complexes Gd-L5 
and Gd-L9: in each case, phosphate replaces one o f the two bound water molecules, 
while the bidentate oxalate anion seems to replace both waters in Gd-L5 but only one 
in Gd-L9. It should be noted that the equilibrium stability studies reported by 
Raymond (e.g. pM/anion affinity) are perhaps not as important as kinetic stability 
profiles, examining the pH or pM dependence of the rate o f complex dissociation. It 
is these experiments that predict more accurately whether a complex is suitable for in 
vivo use. 
Macromolecules with higher number of coordinated water molecules 
Upon the principle o f the supramolecular self-assembly is based the recent work 
which led Raymond and collaborators to obtain the macromolecules in Figure V.6: 
self-assembled supramolecular clusters of G d m hydroxypyridinone (HOPO) 
complexes, templated by a Fe"1 terephthalamide ( T A M ) centre. 1 0 6 The peripheral 
Gd"1 ions coordinate two water molecules which exchange rapidly with the bulk 
solvent; the cylindrical architecture of the self-assemblies and the high rigidity of the 
supramolecules, contribute to efficiently increase the rR o f the cluster, resulting in 
elevated relaxivities at high magnetic fields, with a maximum centred around 60 -
100 MHz. The relaxivity of the trinuclear assembly Fe, 2 G d - 3 L c at 90 MHz is r t p = 
42 m M ' V (i.e. 14 mM"'s"' per Gd 1 1 1), a value maintained also at physiological pH 
and when dissolved in human serum. 
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III Figure V.6: Self-assembled supramolecular clusters of Gd hydroxypyridinone (HOPO) 
complexes. 
An alternative q = 2 system based on the DTPA structure has been developed by 
Ruloff et a l . , 1 0 7 shown in Figure V.7. 
o 
VS. 
e. 
H N ! ' 3 ; : ^ - - - O H 2 
o .-' A : 
o 
Figure V .7: Suggested structure for the Gd"1 complex of TTAHA 6" in aqueous solution pH 7. 
A fast water exchange rate was found for this system ( * e X 2 9 8 = (8.6 ± 0.6) x 106 s"1), 
which has been recently revisited for its incorporation into a novel heterotritopic 
ligand, LHs, or metallostar, which comprises two poly(aminocarboxylate) groups (the 
yV-tris-(2-aminoethyl)amine-// ,,JV ,,yV",//",jV"',A^"'-hexaacetate ligand or TTAHA) 
for binding to G d m ions and a 2,2'-bipyridine moiety for specific binding to Fe" ions. 
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By following a convergent approach, the complex { F e f C ^ L ^ O ) ^ } 4 " was 
obtained, and its molecular model is reported in Figure V . 8 . 1 0 8 The heterometallic, 
self-assembled metallostar possesses six efficiently relaxing paramagnetic centers 
confined into a small space, and the concurrent chelation o f the ligand to Fe" and 
Gd" 1 ions forces the rotational correlation time of the Gd"'-water proton vector to be 
close to that o f the entire assembly, minimizing the internal flexibility. Each of these 
feature lead to particularly high relaxivity values (27.0 and 33.2 mM" 1 s"1 at 20 and 60 
MHz, respectively, at 25 °C), and the 1/T/ N M R D profile shows the high field peak, 
typical o f a slowly rotating complex (similar to HOPO-based systems). The negative 
charge o f { F e [ G d 2 L ( H 2 0 ) 4 ] 3 } 4 " ensures its high water solubility, but at the same time 
implies a higher osmotic load, not viable for gadolinium complexes for medical 
applications.1 
a) b) 
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Figure V .8: a) 1/7", NMRD profiles of | G d 2 L ( H 2 0 ) 4 | 2 (A ) a n d {Fe |Gd 2 L(H 2 0 ) 4 | 3 } 4 (n )pH 6, 25 
C ; b) Framework molecular model of {Fe |Gd 2 L(H 2 0) 4 | 3 }* 1 0 6 
(reproduced with permission of the author). 
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VI. General remarks and outline of the presented work 
Some theoretical principles fundamental to the application o f contrast agents to MRI 
have been examined in this chapter, to understand better how the gadolinium chelate 
structure can be modified in order to improve the M R I contrast agent performances. 
A difficult balance between different parameters has to be respected in the design o f 
any new structure that seeks to replace the commercially available contrast agents. 
Despite many attempts, some of which have been reported earlier in this introduction, 
it is a big challenge to prepare a new system where all the parameters (eg. fast r m , 
slow tr, q > 1, kinetic / thermodynamic stability) act synergically to increase the 
overall relaxivity value. 
Indeed, even in the promising and largely examined HOPO based structures, where 
nearly optimal water(s) exchange rate (r,„), slow molecular tumbling (r«) and 
reasonably high water solubility (eg. Gd-2 9 0 and the heteropodal bis-HOPO-TAM 
ligand incorporating a triazacyclononane (TACN) as a "cap" 9 8 ) gave rise to 
reasonably good relaxivity values (~ 14 m M ' V , at 20 MHz, 25 °C), kinetic stability 
measurements need to be performed before any in vivo experiments. The non-trivial 
synthetic procedures needed for the preparation o f these compounds require the 
patient work of expert chemists and quite high costs. 
In the highly engineered work o f the self-assembled supramolecular clusters o f 
Gd i n HOPO complexes, containing an Fe111 terephthalamide (TAM) centre, 1 0 4 
questions about the post-injection toxicity (i.e. thermodynamic / kinetic stability) of 
the compound still need to be answered. 
The concerns about the heterometallic, self-assembled metallostars 1 0 5 are identical: 
wil l the water molecules stay bound to the metal ions, even in the body? Will the 
negative charges confer to the compound, apart from good water solubility, a higher 
osmotic load? 
The technique o f non-covalently binding q = I systems (the displacement of the inner 
sphere water molecule(s) in q = 2 systems to macromolecules has exhibited good 
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results, especially in the case o f a GdEGTA complex linked to HSA. 7 ' In this case, 
the replacement of the coordinated water molecules or displacement o f the complex 
itself from the protein adduct have to be carefully investigated, to test the stability of 
the supramolecular assembly. As for q = 2 systems conjugates to macromolecules, 
the displacement of the inner sphere water molecule(s) by endogenous anions or by 
donor groups o f the protein has been demonstrated to be very likely to happen. 6 8 6 9 
Based upon the discovery that high molecular weight dendrimeric structures, 
Rf\ HQ 01 
synthesized by attaching hydrophilic moieties (i.e. sugars ' ) to a paramagnetic 
centre (eg. GdDTPA, GdgDOTA, GdDOTA), can lead to slowly tumbling, highly 
water soluble macromolecular structures, it was considered worthwhile to explore the 
design of new dendrimeric structures. 
The collaboration between Bracco Imaging S.p.A. and Durham University allowed 
the herein described work of design and synthesis of new contrast agents for MR.I. 
Two different approaches have been followed: at first, efforts were focused on the 
synthesis of a new, medium molecular weight (~ 2080 gmol"1) dendritic structure, 
bearing sugar moieties at the periphery of a GdgDOTA core. The gadolinium-water 
vector should be placed at the centre of any tumbling motion, thus allowing a 
coherent tumbling of the macromolecule and an optimization o f its rotational 
correlation time. The carbohydrate wedges should also guarantee high water 
solubility and favour a large second sphere of hydration. 
Thereafter, we focused on the development o f q = 2 systems based on the alternative 
heptadentate core structure 6-amino-6-methyl-perhydro-l,4-diazepin ( A M P E D ) . " 0 
This core structure possesses three reactive amino positions available for further 
functionalization. Different diastereisomers can be obtained by alkylating the amino 
groups, and different water exchange rates can be found, as already shown in the 
GdgDOTA system.6' Once synthesized, the thermodynamic and kinetic stability of 
these new q = 2 gadolinium chelates needs to be proved, also at variable pH and in 
the presence of endogenous salts. 
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11.1 Design of new Gd dendrimer chelates 
The design and synthesis o f a new, medium molecular weight gadolinium 
dendrimer chelate w i l l be described in this chapter. Field dependent relaxivities 
have been monitored and compared to the behaviour o f structurally similar 
dendrimers, thereby exploring the potential application o f such compounds as 
novel contrast agents for diagnostic M R I . 
A tetra(carboxyethyl) D O T A derivative, the (RRRR/SSSS) diastereoisomer o f the 
[Gd(gDOTA)] 5 " complex, was chosen to be the core o f the molecular structures. It 
is a mono-aqua complex (q = 1) with a fast water exchange rate ( r m = 68 ns at 
298K, the fastest among the GdgDOTA diastereoisomers)1 and possesses a high 
thermodynamic stability (log/?//o = 24.03) 2 comparable to that o f [Gd(DOTA)]" 
(log/?//o= 25.58, 0.1M Me4NCl, 25 °C). Moreover, it is kinetically inert with 
respect to Gd 1" dissociation, consistent wi th a low in vivo toxicity. Structurally, 
the complex possesses four pendant carboxyl groups on the glutarate arms which 
allow further functionalisation via amide bond-forming reactions. Inspired by the 
work o f Stoddart et al.6 describing the convergent synthesis o f carbohydrate 
dendrimers, the carbohydrate-containing dendrons illustrated in Figure I I . l . l 
were chosen as substituents to be attached to the [Gd(gDOTA)] 5 " core. 
Figure 11.1.1: Molecular structure of IGd(gDOTA)!5" and dendrons. The reactive sites are 
depicted in yellow and red, respectively. 
HO 
HO H0 2 C 0 HO 
tr - J r , HO HO,C 
, ' auater 
HO N N 
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Symmetrical tetra-substitution is desirable, since i t is considered important to 
maximise the electronic relaxation time and to ensure that the gadolinium ion lies 
at the barycentre o f the macromolecular structure, allowing the gadolinium-water 
vector to be at the centre o f any tumbling motion. The numerous hydroxyl groups 
o f the dendrons should guarantee the water solubility o f the complex (an idea 
already considered in the pas t ) 4 ' 5 and favour the formation o f a well defined 
second sphere o f hydration. The quaternary carbon within the carbohydrate 
dendrons also provides a high degree o f structural rigidity, which should keep the 
motion o f the gadolinium-core efficiently coupled to the rest o f the 
macromolecule, as presented schematically in Figure II.1.2. The high molecular 
weight o f the structure should be translated into a decrease o f the molecular 
tumbling rate (i.e. an increase o f the rotational correlation time, TR), wi th a 
consequent elevation o f the overall relaxivity. 
/ 
Effective Motional 
Coupling 
II 
Carbohydrate containing dendrons 
Figure I I . 1.2: Effective motional coupling of GdgDOTA-core to the all system. 
Furthermore, as carbohydrates are involved in many biological recognition 
processes, they could also promote the site-specific delivery o f the contrast agent 
at a molecular level, for example targeting cell-surface lectins e.g. the 
asialoglycoprotein receptor found on the surface o f mammalian hepatocytes.7 
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11.2 Convergent synthesis of carbohydrate containing dendrons 
The target Gd -dendrimer chelates were assembled fol lowing a convergent 
growth approach: the triglucosylated dendrons o f TRIS were synthesized rapidly 
and in reasonable quantities, and then conjugated to the [Gd(gDOTA)] 5 " core in 
the final step. Initial work focused on the carbohydrate dendron 6, 8 which was 
envisioned as a useful intermediate in the synthesis not only o f Gd'"-centered 
carbohydrate dendrimers, but also for other synthetic projects within our 
laboratory. In order to achieve a stereo-selective glycosylation o f the hydroxyl 
groups o f TRIS, its amino group was first protected as its benzyloxycarbonyl 
derivative (Scheme II .2 .1 ) under Schotten-Baumann conditions. 
o 
A 
CI Ph HO HO H 
H , 0 NH O Ph N 
Y HO HO |23%| HO HO 
TRIS 
Scheme II.2.1: The preparation of an N-protected derivative of TRIS. 
This protection was achieved by reacting TRIS with benzyloxycarbonyl chloride 
in water, where a slightly basic pH was maintained by addition o f Na2C03; 
although only a moderate yield was obtained under these conditions ample 
quantities o f product could still be easily obtained. The product (1) was then 
glycosylated with 2,3,4,6-tetrabenzoyl-a-D-glucopyranosyl bromide (3), prepared 
in two steps f rom D-glucose (Scheme I I . 2 . 2 ) . 9 
H C K n f l B z C K HBr / AcOH B z O — H 
H Q - V ^ O C s H s N » B z O - v ^ O C H 2 C I 2 > R T n - A f t o u 
r T O ^ - v \ [67%] & Z 0 A O r \ [79%] B z O A / U u - H , 
HO OH BzO OBz L^~Jm BzO^ 
D-Glucose 2 3 
Scheme II.2.2: Synthesis of 2,3,4,6 -tetrabenzoyl-a D-glucopyranosyl bromide.3 
The initial step involves the protection o f the hydroxyl groups o f D-glucose as 
their benzoate esters by addition o f benzoyl chloride to a suspension o f the sugar 
in pyridine, to afford the ful ly protected product as a mixture o f a- and 
^-anomers. The pentabenzoate product was then dissolved in freshly distilled 
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CH2CI2, and displacement of the benzoyl group in the a-position was performed 
by treatment with 33 % hydrogen bromide in acetic acid. Recrystallisation f rom 
diethyl ether and petroleum ether afforded 3 as a crystalline compound in good 
yield. ' H N M R analysis (Figure II.2.3) showed a single anomeric signal at 8 = 
6.88 ppm with a coupling constant of 4 Hz. The magnitude o f this coupling 
constant is consistent the presence of the or-anomer, an observation which can be 
rationalized by examination o f the Newman projections o f both the a- and /?-
anomers (Figure II.2.4). The equatorial position o f H I in the or-anomer makes 
possible only a partial overlap o f its cr-orbital wi th the synclinal H2 (as shown in 
Figure II.2.4a). Consequently the corresponding signal in the *H N M R is a 
doublet with a small coupling constant J ~ 4 Hz, as predicted by the Karplus 
equation. The /?-anomer displays an antiperiplanar relationship o f H I to H2 
(Figure II.2.4b), resulting in greater overlap with the orbitals o f H2, and a 
consequent increased J value o f 12 Hz. 
P h T H 
P h T H 
HT1 HT3 H-4 
H t 6 
HT2 HT5 
A tit 
T 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 J 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 » ' 1 ' 1 ' ' 1 1 I 1 ' 1 ' 
8.5 8. a 7.3 7.0 6.5 6.0 S.S S.D 4.5 ppm 
Figure II.2.3: 'HNMR (300 MHz, CDC1 3) of 2,3,4,6-tetrabenzoyl-a D-glucopyranosyl 
bromide. 
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fl> BzO 
BzO 
B V O 
H I Br 
a-anomer /^anomer 
Figure II.2.4: Newman projections for a- and /2-anomers of 2,3,4,6 -tetrabenzoyl-a D-
glucopyranosyl bromide. 
Glycosylation o f 1 wi th 2,3,4,6-tetrabenzoyl-a-D-glucopyranosyl bromide 3 was 
accomplished in C t k C b / M e N O i , using A g O T f as the promoter and 2,4,6-
collidine as the base to afford the triglycosylated product 4 (Scheme II.2.3). 
BzO 
D i n 
BzO 
BzO 
BzO AgOTf Br 
2,4.6-coKdine B z O - B z O 
MeN0 2 / C H j C b 
X BzO BzO !49 %l N Ph 
BzO H 
HO 
o^/^oi 
BzO 
H Ph OBz BzO T HO 
HO 
NaOMe 
198% MeOH 
HO HO 
HO HO 
HO HO 
H 2 
Pd(OH) 2 / C HO HO HO HO 
EtOH / THF H So HO NH ? HO 100% Ph 
HO HO • 
HO HO 
HO OH HO VPo HO 
6 5 
Scheme 11.2.3: Synthesis of tris(j9-D-glucopyranosyloxymethyl)-methylamine (6). 
After purification o f the crude product (4) by column chromatography, the initial 
yield was not very high, and the experimental conditions were modified carefully 
in order to optimize the overall reaction yield. Perfectly anhydrous conditions and 
an atmosphere o f dry argon are strictly necessary for the synthesis o f 4, wi th the 
solution o f 2,3 ,4 ,6-tetrabenzoyl-«-D-glucopyranosyl-bromide added over a period 
of 20 min. The temperature o f the reaction mixture was required to be kept at 
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approximately -30°C, in order to avoid the formation of undesired side products 
such as hemiacetals or mixtures containing oc-anomers. Evidence for the excellent 
anomeric selectivity o f the reaction was obtained by ' H N M R analysis of the 
product: each of the three simultaneous glycosylations afford /?-glycosidic 
linkages only. A single anomeric signal integrating to three protons was observed 
as a doublet (J = 10.5 Hz) at 5 = 4.3 ppm, indicating that each hydroxyl in 1 was 
glycosylated to form a /^-linkage. 
The deprotection of the hydroxyl groups was carried out using sodium methoxide 
in methanol, under Zemplen conditions. The reaction's progress was monitored by 
TLC (SiC>2) and, along with the desired product (5), methylbenzoate was detected 
as the side-product. Once completed, quenching o f the reaction with Amberlite 
resin and subsequent filtration gave the pure glucopyranosyloxymethyl Cbz-
protected amine. Hydrogenolysis over Pd(OH)2/C led to the final amine (6) in 
quantitative yield. 
Other work within our laboratory, however, led to concerns about the low 
reactivity o f this dendron's amino group. With the amino group at a quaternary 
centre, the nitrogen is a relatively poor nucleophile as a consequence o f both steric 
hindrance and the unfavourable a-polarization effect o f the three /^-oxygens. 
Therefore, the coupling reaction between the carbohydrate wedges and the 
[Gd(gDOTA)] 5 " carboxylic acids (Scheme II.2.4) proved to be troublesome, with 
large amounts o f the coupling agent H B T U and an excess of 6 needing to be 
added. 8 
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Scheme II.2.4. Synthesis of a tetra-amide |Gd(gDOTA)| 5" complex,1 0 prepared within our 
group. 
The crude product obtained was identified by ES-MS as a mixture of the fully 
substituted tetraamide (major product), the under-substituted tri-amide and di-
amide (minor products), and a lactone derived from the undesired competitive 
lactonization of a sugar hydroxyl by the fourth carboxyl group of the Gd1" 
complex. The most probable structure of this lactone sub-product is illustrated in 
Figure I I . 2 .5 . 
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1 9 - 2 5 atom 
lactone r - N J N - i o 
OH,0 
0 l O H (X° 
H 
Figure II.2.5: Proposed structure of undesired lactone product. 
It was therefore decided to prepare a modified carbohydrate wedge, containing a 
more reactive amino function. The incorporation of a glycine spacer onto the 
amino group of TRIS should result in a new wedge containing a more 
nucleophilic amino group, even though it probably enhances the local flexibility 
of the resulting dendritic structure. This idea had already been explored,6 but the 
adopted synthetic strategy to obtain the glycine extended dendrons is different to 
that used in the Stoddart laboratories, where the glycine spacer was introduced 
directly on the primary amine of the derivative of 4 where the TV-protecting group 
had been removed. The strategy adopted (Scheme II.2.5) was to form initially the 
amide bond between TRIS and carbobenzyloxyglycine to yield 7, undertaken 
using the amide bond coupling reagents 1,3-dicyclohexylcarbodiimide (DCC) and 
1-hydroxybenzotriazole (HOBT). 
- ,A^N O ^ P h 
H O _ / T N H 2 D C C / H O B T *" H C v \ / N v ^ N ^ ^ V ^ l 
HO in DMF ~J « H 
TRIS "° 7 
Scheme II.2.5: The synthesis of a glycine-extended derivative of TRIS. 
Purification of the crude reaction mixture was performed by column 
chromatography, where polar solvent mixtures were needed for the elution of the 
pure fm-glycinamide compound 7, which was obtained in 28% yield. 
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The procedure followed for the synthesis of the branched dendron (10), in 
Scheme II.2.6, was identical to that described for the synthesis of (6). It involved 
the stereoselective glycosylation of (7) with 2,3,4,6-tetrabenzoyl-a-D-
glucopyranosyl bromide (3), deprotection of the hydroxyl groups using sodium 
methoxide in methanol and followed by hydrogenolysis over Pd(OH)2/C in order 
to remove the benzyloxycarbonyl protecting group to afford the product, 10. 
zO BzO 
- ^ V - 0 
D-rn 
Bz 
BzO £6 BzO AgOTf BzO Br 2.4,6-collidine B z O - B z O ^-0 H 
9- A MeNO, / CH-.CI N BzO 0 o H 1$ |67 %| HO H BzO ,4 9- A 0 " > / " O B z N HO 0 H BzO BzO BzO 8 HO 
NaOMe 
87% MeOH 
HO HO 
HO HO 
HO HO 
H 
Pd(OH), / C HO HO HO HO H H 
9 -9 -
A EtOH / THF N N H 
O H 
n ^ N H 
o 
5^ |96% I 
HO HO 
HO HO 
HO HO OH HO 
HO HO 
10 
Scheme 11.2.6: Synthesis of N-[tris(y3-D-glucopyranosyloxymethyl)methyl)glycinamidel0. 
The glycosylation of the three primary hydroxyl groups of TRIS has already been 
investigated by other groups 6 ' " ' l 2 ' 1 3 in the preparation of cluster glycosides and 
other glycoconjugates. The success of the reaction can be easily confirmed by 'H 
NMR spectroscopy. In the spectrum of compound 8 (Figure II.2.6) the signal 
corresponding to the three equivalent CHa a- to the quaternary carbon appears as 
a doublet (J = 10.2 Hz) at 3.50 ppm, equal to the coupling constant of the doublet 
at 4.24 ppm (J = 10.2), representing the three equivalent CHt,. Further evidence 
that the glycosylation leads selectively to /^-substitution on the anomeric carbons, 
comes once again from the ! H NMR spectrum, which displays a doublet (3J|,2 = 
9.0 Hz) at 4.16 ppm corresponding to the three anomeric protons. The symmetry 
of this molecular structure is demonstrated by the fact that only 7 signals are 
present for the three carbohydrate units. 
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Figure II.2.6: 'H NMR spectrum of the product of glycosylation, 8. 
The following two deprotection steps were performed in the particular order 
illustrated in Scheme II.2.6 because this sequence proved the most effective way 
to obtain the final triglycosylated amine product 10, whose 'H NMR spectrum is 
shown in Figure II.2.7. 
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Figure II.2.7: *H NMR spectrum (300 MHz, D 2 0 ) of the ligand structure. 
The coupling reaction between the complex [Gd(gDOTA)]5" and the trisaccharide 
wedge (10) to obtain the final dendrimer (Scheme II.2.7) was performed in the 
polar aprotic solvent DMF, using N-methylmorpholine as the base and HBTU-
BF4 as the coupling agent. The solution was allowed to stir overnight under an 
atmosphere of dry argon and the crude product was identified by ES-MS as a 
mixture of the fully substituted tetraamide (major product), the under-substituted 
tri-amide and some di-amide (minor product). The lactonization observed in the 
previously described coupling of 6 to the [GdgDOTA]5" core did not occur to a 
significant extent, in this case. The mixture was purified by gel permeation 
chromatography (GPC) to afford the pure dendrimer, 11. 
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Scheme II.2.7: Preparation of the tetra-amide dendrimer. 
Although this purification technique did not allow a complete separation of the 
desired tetra-substituted product from the lower mass under-substituted products, 
analysis of the GPC fractions by MALDI-TOF or electrospray mass spectrometry 
(ES-MS) ensured that only those fractions containing the desired tetra-substituted 
product were combined to afford the final sample. The exact molecular mass of 
the compound (MW 3448) was confirmed by ES-MS (the full spectrum is shown 
in the Appendix) and an expansion highlighting the isotopic pattern of the 
molecular ion [M] 3 " is shown in Figure II.2.8. 
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Figure II.2.8: Expansion of the electrospray mass-spectrum of the tetra-amide dendrimer, 
11, highlighting the isotopic pattern of the molecular ion [M]3~. 
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11.3 NMR studies 
11.3.1 Determining rm: VT 1 7 0 NMR R2p analysis 
The water exchange rate at the Gd'" centre of the [GdgDOTAGlui 2Gly 4(H 20)]" 
dendrimer 11 was determined by a variable temperature (VT) l 7 0 NMR R2p study. 
The profile obtained, showing the variation of T2 with temperature at 2.1 T, is 
displayed in Figure II.3.1. The concentration of Gd"1 in the sample, 3 mM, was 
determined by mineralization with 37% HC1 at 120 °C overnight. 
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Figure II.3.1: V T n O NMR R2p profile for tetra-amide dendrimer (11), lGd'"| = 3.0 mM. 
The concave shape of this profile suggests a reasonably fast water exchange, 
which after curve fitting gave a value for r„, = 221 ns. This value is close to that 
measured for the analogous complex without glycine spacer arms 
[GdgDOTAGlu, 2(H 20)]" (r,„ = 198 ns)4 but it is twice as slow as in [GdgDOTA-
TRIS4(H20)]" (rm = 93 ns), 4 the structurally analogous complex, which lacks 
peripheral pyranose groups. The molecular structure and VT l 7 0 NMR R2p profile 
of [GdgDOTA-TRIS 4(H 20)]" is shown in Figure II.3.2, for purposes of 
comparison. 
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Figure II.3.2: a) Molecular structure and b) VT n O NMR R2p profile of |GdgDOTA-
TRIS4(H 20)|", showing the fitted curve to the experimental data. 
It is possible that in the case of the complexes [GdgDOTAGlu^Gly^F^O)]", 11, 
and [GdgDOTAGlui2(H20)]" the introduction of the trisaccharide wedges allows 
greater interactions of the second sphere water molecules localized between the 
glucose groups and the metal centre. Although an overall relaxivity enhancement 
is in this way generated, the rate of exchange of the inner sphere water molecule 
with the bulk of the solvent can be limited. 
Stronger evidence for a well defined second sphere network is given by the shape 
and analysis of the 1/7/ NMRD profiles of the complexes 
[GdgDOTAGlu,2Gly4(H20)]" (11) and [GdgDOTAGlui 2(H 20)]" over the 
frequency range 0.1 to 70 MHz (shown in Figure II.3.3, II.3.4 and in the 
comparative Figure II.3.5). 
11.3.2 MTi NMRD studies 
The proton relaxivities for the G d m glycoconjugate 11 were measured over the 
proton Larmor frequency range 0.01 to 70 MHz. In Figure II.3.3 the nuclear 
magnetic relaxation dispersion profile of the tetra-amide dendrimer (11) at 25 °C 
is reported. The concentration of G d m in the sample was determined by ICP-mass 
spectrometry and also by mineralization with 37% HC1 at 120 °C overnight; the 
relaxivity has been corrected for the diamagnetic contribution. 
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Figure II.3.3: l/T, NMRD pronie for tetra-amide dendrimer, 11. |Gd 3 + ] = 3 mM. 
The relaxivity value for this Gd" 1 complex at the temperature of 25 °C, pH 7, 20 
MHz, is 19.6 mM" 1 s"1. The value increases in the higher field region of the 1/7// 
NMRD profile (from approximately 5 to 70 MHz), a feature which suggests that 
the compound does possess a relatively slow rotational correlation time. B y fitting 
the observed profile using standard methods, 1 4 ' l 5 ' l 6 ' l 7 ' 1 8 the tr value was 
estimated to be 318 ns. From a comparison of the 1/7/NMRD profiles of complex 
11 and the structural analogue without glycine spacer arms (shown in Figure 
II.3.4), it can be deduced that both curves possess a similar overall form. 
However, the lower relaxivity exhibited by [GdgDOTAGlui2Gly4(H20)]" 
compared to [ G d g D O T A G l u , 2 ( H 2 0 ) ] " (23.5 m M 's"1, at 25 °C, pH 7, 20 MHz), 
notwithstanding its higher molecular weight (3448 g/mol and 3220 g/mol, 
respectively), suggests that the extra flexibility imparted to the complex by the 
glycine spacers reduces the efficiency of motional coupling, with a consequent 
detrimental effect on the overall relaxivity. 
HO OH I 
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Figure 11.3.4: a) Molecular structure and b) \IT, NMRD profile for the complex 
|GdgDOTAGIu l 2 (H 2 0) | ' (298 K). 
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Fitting of the NMRD profiles was undertaken by Prof. Mauro Botta (University of 
the Oriental Piedmont "Amedeo Avogadro" -Italy-) to define the contributions 
given to the overall relaxivity separately by the inner, second and outer sphere 
water molecules. The predominant second sphere contribution is evident in the 
systems where the carbohydrate wedges have been attached, as shown in Figure 
II .3 .5 
25.0—1 
_ 2 0 . 0 -
T 15.0-
§ 10.0-
C L 
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G l u 1 2 G l u 1 2 G l y 4 T R I S 4 
Figure II.3.5: Relative contributions to the relaxivity for |GdgDOTAGIu l 2 (H 2 0) | , (Glu 1 2), 
|GdgDOTAGIu 1 2 Gly 4 (H 2 0)] , (Glu 1 2 Gly 4 ), |GdgDOTA-TRIS 4 (H 2 0) l , (TRIS 4 ) . 
In Table I I . 3 .1 , some of the relaxation parameters assessed from l 7 0 NMR and by 
the iterative fitting of the 'H NMRD profiles are reported. The values relative to 
complex 11, [GdgDOTAGlui2Gly4(H20)]~, are compared to those found for other 
GdgDOTA based dendrimers and for the core structure itself. 
Chemical Name 
MW 
(g mol"1) 
r l p *V 
(mM 'V 1 , 20 MHz, 25 °C) (ps) (ps) (ns) 
[GdgDOTA(H 2 0 ) ] 5 ~ 860 7.1 10.0 94 68 
[ G d g D O T A G I u 1 2 ( H 2 0 ) ] ~ 3220 23.5 20.0 390 198 
[ G d g D O T A G I u 1 2 G l y 4 ( H 2 0 ) ] " 3448 19.6 20.1 318 221 
[GdgDOTA-TRIS 4 (H 2 0) ]~ 1267 11.3 13.0 173 93 
Table II.3.1: Relaxation parameters for [GdgDOTAGlu 1 2 Gly 4 (H 2 0) | , GdgDOTA and other 
DOTA based dendrimers synthesiszed in our laboratoty. 
It is very clear that there is an enhancement of tr following the increase of the 
structures molecular weight and hence molecular volume. The slow molecular 
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tumbling obtained with the [GdgDOTAGlu^FbO)]" complex is the result of the 
structural rigidity and compactness of this system, where the local motion of the 
Gd'"-water vector resides close to any axis of reorientational motion and is 
effectively coupled to the overall tumbling motion of the whole complex. 
In the case of [GdgDOTAGlu^Gly^fbO)]", the glycine spacers have been 
introduced to increase the reactivity of the carbohydrate-containing dendrons 
reactive amine, making their conjugation to [GdgDOTA(H20)]5" easier. They 
have also enhanced the conformational freedom of the system, to such an extent 
that the compact molecular tumbling is limited. 
11.4 Relaxivity dependence on pH variation and enzyme 
activity 
Before exploring the in vivo behaviour of the gl ycoconjugates of gadolinium 
complexes, the stability of their O-glycoside bonds under physiological conditions 
was investigated since there is evidence that glycopyranosides can be susceptible 
to acid- or enzymatically catalyzed hydrolysis. 1 9 ' 2 0 
A simple NMR procedure has been used to estimate the kinetic stability of the 
gadolinium chelates under acidic conditions. The variation in the relaxivities of 
the gadolinium conjugates, at various pH values, were estimated over a period of 
at least 72 h. The measurement of the T\ values was undertaken at 60 MHz, 25 °C 
for the following solutions at known Gd111 concentrations (measured by 
inductively coupled plasma mass spectrometry): 
• aqueous [GdgDOTAGlui2(H20)]" solution in the pH range from 10 to 2; 
• aqueous [GdgDOTAGlu^Gly^F^O)]" solution in the pH range from 10 to 
2; 
• [GdgDOTAGlui2(H20)]" in ammonium acetate buffer (pH 5.08) / human 
serum albumin solution (1:1). 
No changes in the Ti value were registered in any of the reported solutions either 
at neutral or slightly acidic pH, even over a period of 96 h; only at pH ~ 3.5 did 
the Ti value drop slightly (from 230 ms at pH 4 to 215 ms at pH 3.5), suggesting 
some decomposition of the complex, such as cleavage of the glycosidic bonds. 
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Also, the presence in solution of components found in blood plasma could result 
in a significant change in the gadolinium chelate efficacy: enzymes, such as the 
glycoside hydrolases (or glycosidases) can, for example, break the glycosidic 
bonds (i.e. catalyze their hydrolysis). These enzymes are located in the lysosomes, 
where most glycoconjugates are degraded, and present their maximum activity in 
acidic environment (between pH 4.0 and 5.5). 2 1 ' 2 2 
Based upon these considerations, it seemed appropriate to test the stability of the 
dendrimers in the presence of selected enzyme. No changes in the Ti observed 
were registered upon titration of the [GdgDOTAGlui2(H20)]\ 
[GdgDOTAGlui 2Gly 4(H 20)]" and [GdgDOTAGal 1 2Gly 4(H 20)]- ammonium 
acetate buffer (pH 5.08) solutions with /?-glucosidase (from almonds) and 
/?-galactosidase, respectively, even when the concentration of the added enzyme 
was half that of the paramagnetic chelate (Figure 11.4.1). 
30- , i 
H GdoDOTA(Ghj) 1 2 ^ u c o a h * » e 
tmNT * ) 15 
• GdgDOTAGM(Ga)12 .ga l3cto6«tase 
1 
1 17 24 48 72 
T i m . (haws) 
Figure II.4.1: Variation of Ti relaxivity (60 MHz, 37 °C) with time for: 
[GdgDOTAGlu l 2(H 20)f: [Gd 3 +] 0.105 mM + 3.5 mM y9-glucosidase solution 
[GdgDOTAGlui 2Gly 4(H 20)]-: [Gd 3 +] 0.12 mM + 4 mM /?-glucosidase solution 
[GdgDOTAGal| 2GIy 4(H 20)]": [Gd 3 +] 0.12 mM + 3 mM /?-galactosidase solution 
As a control, the previously described tests to verify the stability of the 
compounds upon pH variation and enzyme activity, were repeated for the 
individual trisaccaride wedges. The experiments were monitored by ES-MS and 
'H-NMR, and once again only under very acidic (< pH 3.5) environmental 
conditions was any cleavage of the glycosidic bonds evident. Summarizing, the 
glycoconjugates appear to be stable in dilute acid solutions and to glucosidase 
enzymes. 
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11.5 In vivo studies 
The in vivo behaviour of [GdgDOTAGlui2Gly4(H20)]" and of 
[GdgDOTAGlunffbO)]" was examined by our collaborators in Italy (Bracco 
Imaging S.p.A and University of Torino), and their performance compared to the 
clinically used complex Pro-Hance. [GdgDOTAGlui2(H20)]" was administered in 
a dose equal to 0.1 umol/g to a female mouse over-expressing the transforming 
activated rat HER-2/neu oncogene under the control of the mouse mammary 
tumour virus promoter. The contrast agent induced a 50 - 60% enhancement in the 
MRI signal, and the signal enhancement was maintained over a post-injection 
period of time between 5 and 45 minutes. The [GdgDOTAGlunClHbO)]" caused a 
signal intensity enhancement that lasted longer than that created by Prohance, 
whose efficiency had decayed below 20%, 35 minutes after the injection. A 
similar profile was exhibited by the glycine spacer analogue complex 
[GdgDOTAGlu1 2Gly4(H20)]". Both Gd111 dendrimer chelates were excreted 
mainly via the renal system, with little or no evidence for clearance or retention in 
the liver. 
The first row of Figure II.5.1 shows five scans of mouse kidneys without contrast 
agents, over 12 minute intervals up to lh . In the second row, the excretion of 
Prohance through the kidneys is monitored over the same period of time and 
compared with the glucose dendrimer [GdgDOTAGlu^CfbO)]", in the third row. 
MRI Imaging with Contrast Agents 
Figure 11.5.1: MRI images (12,24,36,48,60 minutes) of mouse kidneys without CA (upper), 
with Prohance (centre) and with |GdgDOTAGlu,2(H 20)l (lower). 
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11.6 Conc lus ions 
A new medium molecular weight contrast agent with carbohydrate-containing 
dendrons attached to a [Gd(gDOTA)]5" core has been synthesized and its magnetic 
properties carefully evaluated and compared to the behaviour of similar 
gadolinium dendrimer chelates, also synthesized in Durham. The second sphere 
contribution has once again 2 3 ' 2 4 played a critical role in deteniiining the overall 
relaxivity enhancement. In the design of new dendritic systems, the carbohydrate 
containing dendrons should be conserved, while the glycine spacers need to be 
replaced with more rigid moieties. Dendrons containing more reactive hydrazide 
functions, for example, could be prepared (Figure II.6.1). They should contain 
suitably reactive amino functions without increasing significantly the overall 
flexibility of the target dendrimers. 
HO, 
HO-
HO, 0 
H O ~ H O ^ - X 
o x 
H O < ^ O H 
Figure 11.6.1: example of a more rigid spacer arm. 
With this aim in mind, a new carbazate derivative has been synthesized and the 
reactivity of its two carboxylic groups towards amide coupling tested in an 
attempt reaction coupling to TRIS, as shown in Scheme I I . 6 . 1 . 
o o 
Me 0 B r ^ l M e 0 „ Me O M e - J II k ,u ^ ^ > M e Me^l n I OMe NaOH/MeOH M e ^ II J, OH 
Me>V-N-NH2 K a C C D M F " Me^V"^ — M/VV"^  
12 13 
DMF 
O ^ . N H OH 
M e ^ O 
M e Me 
Scheme II.6.1: Synthesis of dicarboxycarbazate 13. 
83 
Chapter 2 
While the synthesis of the diacid 13 proceeded well, problems were encountered 
in the final coupling reaction, and the target molecule was not obtained. However, 
this idea is further developed in a parallel project in Durham. 
Furthermore, instead of [Gd(gDOTA)]5", alternative Gd'"-complexes, possessing 
even faster water exchange rate could be placed as a core element for the Gd"1-
dendritic complexes. A suitable example could be the 6-amino-6-methylperhydro-
1,4-diazepine (AMPED) structure, which has already been studied as the core 
structure for the lanthanide chelates discussed in Chapter I I I of this thesis. 
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New Ligands for q = 2 systems 
Chapter 3 
111.1 New ligands for q = 2 sys tems 
At the outset o f this project, the synthesis o f diaqua Gd complexes was already 
being pursued in our laboratory. As already mentioned above (Introduction Section 
II.2 and Section V) , an increase in the hydration around the metal centre can 
significantly enhance the contrast agent efficacy. Diaqua systems can be prepared by 
reducing the denticity of the core ligand structure, although the complex stability can 
in this way be compromised. Indeed, the use of heptadentate ligands can reduce the 
kinetic and thermodynamic stability of the gadolinium chelate with respect to cation 
mediated or acid catalyzed dissociation, or favour the interaction with endogenous 
anions or protein coordinating groups present in human serum' resulting in a 
displacement o f inner sphere water molecule(s). 2 ' 3 Based upon the same principle 
that inspired the previous work realized in our laboratory with [GdaD03A] 3 ", 4 where 
the anionic side chains electrostatically inhibit encounter of the complex with 
negatively charged species (such as protein and endogenous anions), are the two ideas 
3 3 
of synthesising a [GdaD03AP] " phosphonate, analogous to the [GdaD03A]" 
complex (Figure I I I . l , a),5 and [Gd(aD03Aasp)(H 20) 2] 3", given by the incorporation 
onto the D 0 3 A core of amino acid side arms, based on jV-Boc-aspartic acid-benzyl 
ester (Figure I I I . l , b). Both compounds were designed to bind non-covalently to 
serum albumin proteins: the overall relaxivity o f the system should be enhanced by 
its slower tumbling motion. 
o n 3 O , 0 H 2 O H 2 
l / N -
r RCONH H H 
N N 
O H 2 Gd Gd J H O - P J N N N N 
NHCOR VJ 
o 
o RCONH 
o HO 
F i g u r e I I I . l : a) Molecular structure of [Gd(aD03AP)(H 2 0) 2 | 3 ' and b) of 
| G d ( a D 0 3 A a s p ) ( H 2 0 ) 2 | 3 . 
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Further work focused on the synthesis of new q = 2 systems built upon a different 
core ligand structure: the triamino 6-amino-6-methyl-perhydro-l,4-diazepin 
(AMPED). This compound is readily prepared from low-cost starting materials in a 
synthesis that proceeds in two steps in near quantitative yield. 6 The synthesis o f 
AMPED, illustrated in Scheme I I I . l , was performed starting f rom the reaction o f 
AyV'-dibenzyl-ethylenediamine with /?ara-formaldehyde, and successive reaction o f 
the intermediate Schiff base with deprotonated nitroethane. The deprotection of the 
amino groups and the reduction of the nitro group was achieved by hydrogenolysis. 
This seven ring heterocycle possesses two differently reactive amino groups (primary 
and secondary), which can be used for further functionalisation e.g. introduction o f 
pendant arms by alkylation. The alkylation o f each of the nitrogen atoms was 
undertaken with ter/-butylbromoacetate in the presence of potassium carbonate, 
followed by treatment with trifluoroacetic acid, yielding 6-amino-6-methylperhydro-
1,4-diazepinetetraacetic acid, A A Z T A . This ligand was complexed in the presence of 
stoichiometric amounts o f L n ( l l l ) trichlorides (EuCb or GdCh). 
Ph r 
H H 
N .2AcOH 
J Ph 
NO, 
C 0 2 H 
H 0 2 C N 
AAZTA < 
• C 0 2 H 
C 0 2 H 
2 C H 2 0 
EtOH 
i) B r C H 2 C 0 2 f B u / K 2 C 0 3 
MeCN 
ii) C F 3 C 0 2 H 
N 0 2 
^ 27 
Ph 
H 2 
Pd/C 
MeOH/H 2 0 
NH 2 
H 28 
Scheme I I I . 1: Preparation of the core of the complex ( A M P E D ) . 
The [Gd-AAZTA]" complex is reported 7 to show promising relaxometric properties, 
a favourable kinetic inertness profile (the r t p value 7.1 mM''s"' at 20 MHz, 298 K was 
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maintained over the pH range 2 - 1 1 ) and a thermodynamic stability comparable to 
that of [Gd-DTPA] 2". It exhibits a remarkable inertness towards endogenous anion 
binding: 7 no changes in the relaxivity values (i.e. no replacement o f the coordinated 
water molecules) were registered during titration in the presence o f lactate or 
phosphate at concentrations even 200 times higher than the gadolinium chelate. 
Furthermore, the fitting o f the data 8 obtained by measuring n O N M R R2P as function 
of temperature allowed the estimation o f a Xm value of 90 ns. The exceptionally 
good magnetic properties and the stability shown by this new AMPED-based 
gadolinium chelate encouraged further studies. In association with Bracco Imaging 
S.p.A. (Italy), the design and synthesis o f new systems was planned. 
Phosphine and phosphonate based structures were envisaged as new pendant arms for 
the core ring strucure AMPED, to explore the different reactivity o f phosphinate (eg. 
a) and b) in Figure III.2) analogues of the previously mentioned carboxylate 
A A Z T A complexes. 
: i H 2 0 N H 2 H 2 0 
o 'i Me Me 
O H 2 OH H 2 N 
oKl oKl 
N 
T b) a) 
Figure I I I . 2 : Target Phosphinate (a) and (b) A M P E D based strutures. 
However, the original structure bearing carboxylate pendant arms was not abandoned: 
suitable 1,5-dicarboxylate pendant arms (Scheme III .2) were also synthesized and 
attached to the core ring (this work wi l l be discussed in detail in Chapter 4). 
Different diastereomeric structures were considered and their magnetic properties 
determined separately. It was surmised, at the outset, that as in the case o f 
GdgDOTA, 9 an isomer possessing faster water exchange rate ( r m ) may be isolated. 
Furthermore, the complexes obtained were adorned with glycosidic wedges, with the 
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aim of increasing the molecular volume of the system, and hence increasing the 
relaxivity by slowing down the overall molecular tumbling motion (i.e. larger TR). 
R _ R _ H 0 2 C ^ ^ ^ C 0 2 H 
Ri 
H 0 2 C ^ ^ ^ X 0 2 H 
- R 2 -C 0 2 H 
H 0 2 C N 0 
1 ^ R , - H 0 2 C ^ C 0 2 H R z = h 
R l = H R 2 = H 0 2 C ^ ^ C 0 2 H 
H 0 2 C ^ ^ 5 C 0 2 H R 2 = H 0 2 C ^ ^ C 0 2 H 
R 1 -
Scheme I I I . 2 : Target ligand structures based on A M P E D inorporating 1,5-dicarboxylates 
pendant arms. 
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III.2 Synthesis of ligands based on the core ring structure D03A 
III.2.1 Phosphonate based macrocyclic compounds 
The synthetic pathway to the target triphosphonate complex [Gd(aD03AP)(H20)2]3" 
(Figure III .3) began with the synthesis o f the appropriate "pendant arms" to be 
reacted with an N-Boc protected cyclen. 
The first step in the preparation o f the phosphonate moieties involved the protection 
of 5-bromopentanoic acid as its /-butyl ester, following the method of Schmidt et 
al.:]0 stirring o f the acid in oxalyl chloride gave the acid chloride, which was then 
esterified to 14 by treatment with /-butanol in the presence of pyridine, as shown in 
Scheme III .3 . The pyridine acts as a nucleophilic promoter o f reaction and as a base, 
preventing the generation o f a high acid concentration. Removal o f the white 
pyridinium salts by column chromatography gave the ester 14, whose bromo-
functionality was converted into the phosphonate ester 15 using excess 
triethylphosphite, according to the Michaelis - Arbusov reaction mechanism." 
n O P"2 
\i r H N P-OH OH 2 Gd HO-P 
N 
HO 
Figure I I I . 3 : The structure of I G d C a D O J A P K H j O ) ! ! 3 . 
O o 
HO Br 
1. (COCI)j 
'BuO' Br 
2. r-BuOH 
C 5H 5N 
14 
85% 
89% 
OEt 
EtO P T)Et 
O 
OEt 
P - O E t BuO 
Scheme I I I . 3 : Synthesis of terf-butyl-5-(diethoxy-phosphonyl)-pentanoate (15). 
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Deprotection of the /-butyl group with trifluoroacetic acid afforded the carboxylic 
compound (16) in quantitative yield, which was used directly in the following Hell-
Volhardt-Zelinski reaction, performed by carefully adding molecular bromine to the 
acid chloride derived from 17. The reaction was quenched by pouring the crude 
mixture into cold ethanol and the final bromoester (18) was obtained as a yellow, oily 
product (Scheme III.4) . 
(BuO P - O E t P - O E t 
P - O E t 
EtO' 
Br 
1 7 
/ 0 B EtOH 
P - O E t -
65% 
CI 
Br 2 
Br 
OEt 
P - O E t 
ii 
O 
Scheme I I I . 4 : Synthesis of (±) Ethyl-2-bromo-5-(diethoxy-phosphonyl)-pentanoate (17). 
Among the many strategies attempted,5 the best results in the alkylation of the 
1,4,7,10-tetraazacyclododecane with the a-bromo-phosphonate ester were achieved 
with the sequence of reactions reported in Scheme IH.5. The trisubstituted cyclen 
was prepared by a slightly modified method of Yang et al.n f rom reaction of 
1,4,7,10-tetraazacyclododecane with ethyl trifluoroacetate in the presence of 
triethylamine. The product l,4,7-tris-trifluoromethylcarbonyl-12-N-4 (18) was 
isolated in good yield, by purification through a short silica gel column. 
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MeOH 
CF, 0 
CF 
C F , 0 
CF 
19 18 
KOH 
MeOH/H,0 
0 0 , 
/ ~ ~ \ A-OJBU E t o ^ r ^ ^ ^ P ^ 
I N^, I ll 
l Br O 
0 OEI 
P - O E I OIBu 
N N N 
C 3 C J ~N N; -N N -MeCN. C s , C 0 3 R \ J R H \ _ / H 
21 20 
OEt 
P-OEI EtO 
Scheme I I I . 5 : Synthesis of tri-substituted phosphonate derivative of the a D 0 3 A ligand. 
The next steps involved the BOC-protection o f the free amino group of 18 a nd 
deprotection of the trifluoroacetamide 19 with aqueous potassium hydroxide, to 
afford the monocarbamate 20 as a clear oil . The alkylation o f the macrocyclic 
secondary amine groups was performed with an excess of (±) ethyl-2-bromo-5-
(diethoxy-phosphonyl)-pentanoate (17) in the presence of caesium carbonate as base. 
The final product (21) was isolated in low yield after purification by column 
chromatography. The completion of the synthesis was then, performed in our 
laboratory 5 and data were obtained from spectroscopic analysis and from 
experiments in solution and also in the presence o f HSA. The final steps of the Gd 1"-
complex synthesis are briefly illustrated in Scheme III.6. The BOC protecting group 
was removed by the use o f trifluoroacetic acid in the presence of dichloromethane 
and the hydrolysis o f the ethyl ester groups was achieved using hydrogen bromide 
solution in acetic acid. 1 9 
The complexation with gadolinium and europium were accomplished in aqueous 
solution at pH 6 as shown in Scheme III.6. 
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N N 
P - O E t 
Ho-r 
HO 
C N . N 5 
^"NH N 
HBrtAcOH \ NH N 
• ^ X E t O ' V - / H O - V H O ' V 
° - P - O H 
U C I j H 2 0 
pH6 
N • N 
HO \ 
° » P - O H 
Scheme I I I . 6 : Final steps in the synthesis of | G d ( a D 0 3 A P ) ( H 2 0 ) 2 | 3 . 
The relaxivity observed for [Gd(aD03AP)(H 2 0) 2 ] 3 ' was 7.3 mlvl 's"1 at 60 MHz, 37 
°C, pH 6.8. This relaxivity is in the range expected for similarly sized complexes with 
two bound water molecules.1 3' 1 4 It is higher than the values found in diaqua 
complexes containing macrocyclic heptadentate ligands such as [Gd(D03A)(H 2 0)2] 
(6.1 mM- 1 s_l at 60 MHz, 25 °C) and [Gd(PCTA[12])(H 2 0) 2 ] (6.9 mM ] s"1 at 60 
MHz, 25 °C) . 1 5 ' 1 6 
In vitro experiments involving binding to proteins were also performed. 5 It was 
found that the relaxivity o f this complex increased from 7.3 m M ' 1 s"1 to ~ 30 m M ' 1 s'1 
when the gadolinium chelate is in the presence o f human serum albumin at a 
concentration of 0.6 m M , similar to the in vivo concentration. However, when 
phosphate anions were added to the complex-protein solution, it was found that these 
anions were able to displace the inner sphere water molecules, resulting in a 
significant reduction o f the observed relaxivity. 
The failure to develop suitable diaqua species as contrast agents is often due to their 
intrinsic kinetic and thermodynamic stabilities with respect to premature 
decomplexation or to their tendencies to react with anionic species in solution (i.e. 
HCOy, lactate or phosphate in biofluids) with displacement o f one or both o f the 
bound water molecules. Evidently, this phosphonate complex suffers from these 
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anion-binding problems, precluding its usage in vivo. Work on this system was 
therefore curtailed. 
III.2.2 A new kind of pendant arm for Gd111 complexes 
In order to circumvent the problems of anion binding encountered with the previously 
described [Gd(aD03AP)(H20)2]3" complex, a new type o f pendant arm was designed 
to be incorporated into the D 0 3 A based core structure. It was resolved that the 
resulting q = 2 target complex (shown in Figure III .4) should possess three pendant 
amino acid moieties. The systematic variation of the substituent group should allow 
the protein binding affinity o f the complex to be modulated, and the presence of the 
carboxylate anionic groups was proposed to inhibit the anion binding problems which 
had afflicted the phosphonate system discussed above. 
OH O 
r RCONH H N 
o OH Gd 
N N 
UJ NHCOR 
RCONH 
Figure I I I . 4 : Target |Gd(aD03A)(H 2 0) 2 | 3 complex . 
The synthetic pathway to the amino-acid based pendant arm is outlined in Scheme 
III.7. 
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Scheme I I I . 7 : Synthesis of a new pendant arm to incorporate to the | G d ( a D 0 3 A ) ( H 2 0 ) 2 ) 3 . 
The N-Boc-aspartic acid-benzyl ester was reduced to the corresponding homoserine 
derivative (22) following the p rocedure o f Johns et al.n The /-butyl ester of y~ 
hydroxy amino acids is reported to be stable toward lactonization. However, side 
products such as the lactone (a) or the methyl ester (b) reported in Figure III.5 were 
isolated during the preparation o f alcohol 22, but were obtained in fairly low yields. 
ry1 
N MeO N 
H ~Y 
0 
7 ^ b 
Figure I I I . 5 : Side products generated in the synthesis of 22. 
It was observed that this reduction is very sensitive to moisture and consequently has 
to be performed under anhydrous conditions, using an argon atmosphere. Indeed, the 
addition of the reaction mixture to the reducing agent has to be performed as quickly 
as possible. After chromatographic purification, 22 was oxidised via Swern 
oxidation ' • to the corresponding aldehyde 23, which was subsequently reacted 
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with the Wittig reagent 2 1 to give a mixture of the Z- and £-vinyl bromide in 40 % 
yield. The last synthetic step, involving the reduction o f alkene 24, proved to be very 
troublesome. A mild method was at first attempted involving the use of fermenting 
baker's yeast and glucose in warm aqueous solution. Unfortunately no product was 
obtained with this approach. Hydrogenation over Pd(OH)2/C was then attempted, but 
this approach proved too reactive: after only lh a mixture was obtained of the 
dechlorinated diester and the debenzylated acid. 
The synthesis o f the target molecule was therefore not accomplished, but the idea of 
incorporating amino-acid based moieties onto an heptadentate core ring structure has 
been preserved and applied in further work with the new core ring structure 6-amino-
6-methyl-perhydro-l,4-diazepin (AMPED), discussed in the next section of this 
chapter. 
III.3 Synthesis of ligands based on the core ring structure 
AMPED 
III.3.1 Phosphinate complexes based on AMPED 
Phosphinate analogues o f the carboxylate A A Z T A complexes were prepared with the 
main aim of obtaining lanthanide complexes possessing suitable physico-chemical 
and biochemical characteristics for use as contrast agents. Our attention focused on 
these systems because it was considered that they retain similar stability profiles to 
the parent A A Z T A complexes. However, a different steric demand around the Ln 1 " 
ion is likely because of the longer C-P (1.8 A vs 1.5 A for C-C) and P-0 bonds (1.5 A 
vs 1.25 A for C-O). It was thought that these differing steric demands might favour 
the enhancement o f the second sphere contribution to the overall relaxivity observed 
and, perhaps, modify the affinity of the complex towards anion chelation. The 
introduction of the phosphinate groups should allow the fast water exchange rate to 
be retained and favour the formation o f stronger hydrogen bonds compared to 
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carboxylates, perhaps keeping more water molecules close to the coordination sphere 
of the complex. 
III.3.2 Synthesis of AAZTA based complexes possessing simple 
phosphinate pendant arms 
Phosphinate groups are attractive alternative ligating systems to carboxylates. Two 
different synthetic routes were investigated for the synthesis o f ligand 31 (or L I ) . In 
the first route, shown in Scheme III . 8 , (O-mesylmethylene)methylphosphinic ethyl 
ester (26) was prepared in two steps by reacting methyldiethoxyphosphine with para-
formaldehyde in THF to afford the alcohol 25, which was subsequently converted 
into the mesylate by treatment with mesylchloride and triethylamine in THF. 
OEt 
Me-R 
OEt 
p(CH20) 
molecular sieves 
THF / 50 °C 
65% 
O 
Me-P 
i 
"OH 
OEt 
2 5 
CH 3 S0 2 CI / NEt3 
THF/0°C 
70% 
NH, P C O E I 
Me 
V 
EtO' Me 
Me 
O 
11 
-P 
OEt O 
O 
O-S-Me 
2 6 
K 2 C0 3 , 
CH 3CN 
NH 3 
2 8 
-H 
Scheme I I I . 8 : First synthetic approach for the A M P E D dialkylation. 
Dialkylation o f AMPED was attempted with two equivalents o f mesylate 26 and the 
progress o f reaction was monitored by TLC, HPLC and ES-MS. Unfortunately the 
desired product was not observed and an alternative route, shown in Scheme III .9 , 
was then investigated. 
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Scheme I I I . 9 : Synthesis of the A A Z T A P ligand ( L I ) . 
Two equivalents o f methyldiethoxyphosphine were dissolved in few millilitres of 
acetonitrile and this solution added directly to a suspension o f AMPED and para-
formaldehyde in acetonitrile. The desired dialkylated AMPED was obtained as the 
main product of reaction and was separated by column chromatography from the 
monoalkylated, traces o f the trialkylated and the alcohol generated from the direct 
reaction o f MeP(OEt)2 with /wra-formaldehyde. Alkylation o f the primary amine was 
performed by addition of /-butylbromoacetate to a solution of the dialkylated 
AMPED in C H 3 C N at 0 °C in the presence of K2CO3 as base. The subsequent 
deprotection o f the carboxy and phosphinate groups proved to be more difficult than 
anticipated. Initial attempts to perform this hydrolysis used 6 M HCl at both room 
temperature and reflux for varying times (30 min to several days) but each attempt 
was unsuccessful in affording pure product, as monitored by 3 l P and ' H N M R 
analysis o f the crude product. However, a sample of approximately 80% purity was 
obtained by refluxing 30 overnight in 6 M HCl followed by removal of solvent. The 
3 I P N M R spectrum o f this sample displayed singlets at 48 ppm (ester) and 36 ppm 
(acid), consistent with incomplete hydrolysis. Acidic hydrolysis in HBr/MeCC^H was 
also attempted, but the ' H N M R spectrum of the crude showed no signals 
corresponding to the AMPED ring protons, suggesting that the core structure might 
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have been destroyed. An improved method for this deprotection step was sought. 
Surprisingly, treatment o f 30 with TMSI in MeCN proceeded smoothly and gave the 
target ligand L I . 3 I P N M R analysis o f this sample displayed only a singlet at 36 ppm 
indicating that the product contained no other phosphorus-containing impurities. 
The complexation o f ligand L I with lanthanide salts (Eu(OAc)3 • 6H2O and GdCb • 
6H2O, respectively) was performed in water (pH 5.5) at 60 °C. The excess lanthanide 
salt was removed as the corresponding hydroxide by raising the pH to 10, filtering o f f 
the Ln(OH)3 and restoring to neutral pH. 
II1.3.3 Studies of the complexes magnetic properties and stability 
The emission spectrum o f [Eu U I AAZTAP(H 2 0) 2 ]~ , here called [ E u I U L l ] " , was 
measured in H 2 0 and in D 2 0 at pH 7.4 (pD = pH + 0.4), 298 K exciting into the 
charge-transfer band at 255 nm (the emission spectrum of the complex in D 2 0 is 
shown in Figure 111.6). 
8 35E.05 
7 36E*05 
6.36E*OS 
J[ 5 35E«K 
i 
I 4 35E.05 
S 3 35EWS 
2 35E405 
1 35E«05 
3.50EXM 
570 590 610 630 650 670 690 710 
wavelenght (X / nm) 
F i g u r e I I I . 6 : Emission Spectrum of ( E u u l L l ] ~ (1 m M solution in D 2 0 , p H 7.4). 
Measurement of the luminescence lifetimes in H 2 0 and D 2 0 allowed an estimation of 
the hydration state o f the complex. The number o f bound water molecules was 
calculated according to the following (Equation III .4.1): 2 3 
i. = 255 nm 
— D20 
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? A „ = 1 2-(kfl2O-kmo-0.25) (Eq. III.4.1) 
In this equation, £ (H20) and *<D20) are the radiative decay rate constants in H 2 0 and 
D2O, respectively; the term 0.25 for E u m refers to quenching due to second sphere 
water molecules. 
Measurements o f the excited state lifetime (&H20 = 2.63 ms"1, £020 = 0.8 ms' 1) 
established that [ E u l u L l ] " is a diaqua system [qEu= (Ak- 0.25) • 1.2 = 1.90]. 
In further work, lifetime measurements o f an aqueous solution of the E u m chelate (0.5 
mM) in the presence o f carbonate anions (20 m M aqueous Na2COj) showed little 
change, strongly suggesting that the system remains q = 2. However, significant 
changes were noted in the form of the europium emission spectrum (Figure III .7 ) . In 
particular, the ratio o f the AJ = 2 / AJ = 1 band intensities at 620/590 nm increased 
from ~ 3:2 to 5:1, consistent with the chelation o f a carbonate group, observed in 
several earlier studies on anion chelation.2' 2 4 This observation suggests a change in 
the coordination sphere o f the metal and is consistent with displacement o f the 
carboxylate or the phosphinate pendant arms by the carbonate group. 
2 02EKJ6 
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§• 1.42E*06 
i? 1-22E+C6 
I 1 02E*06 
§ 8.20E+O5 
I 6.20E»O5 
420E*O5 
2.20E*05 
H2O 
= 25S nm 
— D20 
630 650 670 
wavetenght (>. / nm) 
,.nii F i g u r e I I I . 7 : Emission spectrum pH 7.4 of [Eu I.I | (1 m M solution in D 2 0 ) + 40 mM aqueous 
N a 2 C O a . 
A comparison o f the *H N M R spectrum of [ E u i n L l ] " in the absence (Figure III.8) 
and in the presence o f 40 m M aqueous Na2CC>3 solution (Figure III.9) was done. The 
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spectra observed were notably different and suggested that a large change had 
occurred in the coordination environment about the europium centre. 
A 
I ' ' — 1 1 I 1 1 1 1 I 1 1 1 ' I ' 1 1 ' I I 
25 20 15 10 S 0 -5 -10 
F i g u r e I I I . 8 : *H N M R spectrum of |Eu'"L11 (200 MHz, D j O , 24 °C). 
Vn, 
25 20 15 10 10 
I I I I F i g u r e I H . 9 : ' H N M R spectrum of | E u " ' L l | in D 2 0 + 40 mM N a 2 C O j (200 MHz, 24 °C). 
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6.5 to 2.2 mM"'s"' (60 MHz, 37 °C) when aqueous carbonate (14 mM) solution was 
added to the gadolinium chelate solution (0.678 mM). Once again, the displacement 
of the phosphinate arms (or o f the carboxylate ones) with carbonate was suggested. 
The occurrence o f such a displacement is a severe drawback for the 
[Ln I I IAAZTAP(H20)2]" system, and compromises its in vivo use as a contrast agent. 
III.3.4 A more functionalized phosphinate pendant arm 
Other routes for adorning the AMPED periphery were considered. A more 
functionalized phosphinate pendant arm was synthesized (Scheme I I I . 10), according 
to a procedure previously developed in our laboratory. 2 5 
^ ^ . N H C O P h 
32 
1. (f-BuO)2/H3P02 
dioxane, reflux 18h 
2. (CH2Oydioxane 
reflux, 48h 
NHCOPh 
HO^ „P^ 
I I OH 
O 
33 
CH(OEt) 3 
reflux, 4d HCL 
NHCOPh 
» OCH(OEt)2 
EtOH, reflux,36b 
NHCOPh NHCOPh 
MsO^ 
II OEt 
O 
MsCI/Et3N / THF HO 
« • I I OEt 
r.t O 
34 
Scheme I I I . 10: Synthesis of a more functionalized phosphinate pendant arm. 
Upon completion o f its synthesis, the phosphinate wedge could be incorporated onto 
an AMPED core, affording a ligand suitable for a target complex such as that shown 
in Figure 111.12. 
H 2 0 , N H 2 <7T 
0 H 2 H 2 N-
L n 3 t = Eu 3*,Tb a*, G d 3 + 
F i g u r e 111.12: The target complex | L n I , , A A Z T A P N ( H 2 0 ) 2 r , 
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On the basis of the results previously obtained with the [Ln AAZTAP(H20)2]" 
complexes, the synthesis of [LnM IAAZTAPN(H20)2]~ was not pursued. It was 
expected that the coordination sphere of the metal ion would have not been 
significantly changed, therefore the system could have exhibited similar affinity 
towards anion binding. 
111.4 Conclusions 
The design and synthesis of di-aqua gadolinium complexes based on the heptadentate 
structures D03A and AMPED has been described in this chapter. None of the chelate 
structures developed has exhibited the thermodynamic stability and inertness towards 
anion chelation necessary for the possible future use of the complexes as probes in 
MRI. The high relaxivity value of ~30 mM''s'' observed for the 
[Gd(aD03AP)(H20)2)37HSA system dropped when phosphate anions were added to 
the complex / protein solution, at a concentration similar to that found in vivo. The 
anions are able to displace the inner sphere water molecules, thereby precluding the 
usage of the system in vivo. Similar results were obtained for the 
[GdAAZTAP(H20)]" system. Carbonate anions were found to displace the ligating 
groups of the complex, leading to a drop of the relaxivity value. The radical change in 
the coordination sphere of the metal ion was apparent from the ' H NMR and emission 
spectrum of the analogue E u m complex. Given the behaviour with the phosphinate 
groups, research was directed towards di-aqua systems based on the novel AMPED 
core, adorned with carboxylic acid side arms. This work is described in Chapter 4 of 
this thesis. 
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Carboxylated AAZTA complexes as 
relaxation agents 
Chapter 4 
IV.1 AMPED based complexes with carboxylic acid side arms 
The initial idea' o f an AMPED core bearing carboxylic acid side arms was revisited. 
Inspired by observations from the GdaD03A system,2 it was thought that an AMPED 
based complex bearing carboxylate anionic groups could also inhibit anion binding. 
A simple racemic a-bromo diester (Figure I V . 1, a) and an enantiopure amino-acid 
ester (Figure I V . 1, b) were considered at the outset as precursors to 1,5-carboxylates 
prepared for incorporation into the AMPED core structure. Introduction of a metal 
ion ( E u m , G d m , Yb" 1 ) into the ligand structures led to A A Z T A lanthanide chelates, 
whose different magnetic and physico-chemical properties were determined and 
studied. 
The work in this chapter focuses on the enhancement o f the carboxylated A A Z T A 
complexes efficacy as relaxation agents. Their molecular volumes were increased by 
attachment to dendrimeric wedges, in an attempt to enhance the contribution of the 
second coordination sphere to their relaxivities and to slow down the overall 
molecular tumbling rate (\/rR).3 Carbohydrate containing dendrons were envisaged as 
suitable candidates to be attached to the gadolinium AMPED based chelates by an 
amide coupling reaction on the carboxylic side arm. 
MeOOC 
a) 
COOMe BnOOC 
b) 
40 
{S),COOH 
NH2 
Figure I V . 1: Precursors to 1,5-carboxylate pendant arms: a) Simple racemic a-bromo ester; b) 
enantiopure amino-acid ester. 
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IV.2 Simple racemic or-bromo diester as AMPED side arm 
IV.2.1 Preparation of [LnIM(Glu)2racem/c-AAZTA]3 
The racemic dimethyl a-bromoglutarate, 35, was prepared via a Hell-Volhardt-
Zelinski reaction, where molecular bromine was carefully added to a solution o f the 
acid chloride derived from the monomethylglutaric acid (Scheme I V . l ) . 4 The 
reaction was quenched by adding methanol to the mixture cooled at 0 °C. Sequential 
extraction gave the crude product, together with significant amounts of 2,4-
dibromodimethylglutarate. The product was obtained as a clear oil and was separated 
from the dibromide by disti llation under reduced pressure using a long Vigreux 
column. 
M e O O C ^ ^ - ^ C O O H 1 . S 0 C I 2 2 . Br 2 M e O O C ^ ^ ^ C O O M e 
3. MeOH R 
35% 3 S B r 
Scheme I V . 1: Synthesis of (±)dimethyl-2-bromo-pentanedioate. 
The second step in the preparation o f the ligand structure 39 (Scheme IV.2) involved 
the Af-alkylation o f the AMPED secondary amines with the racemic bromide 35. This 
reaction proceeded selectively at the less hindered secondary amine sites, and the 
product (36) was obtained in good yield and used directly for the next step. 
^ C O O M e fBuOOC^ ^ C O O M e 
COOMe / MeOOC 
35 Br NH; ^ C O O M e BrCH2COOrBu
 ffluOOC^Ijl N > - C O O M e 
' V ^ l O K 2 C 0 3 , Na 2 S0 4 / N ^ N O K 2 C 0 3 , CH 3CN 
84% _ 1 CHjCN 
M e O O C — X O O M e 35% MeOOC COOMe 
90% TFA/CH 2CI 2 
HOOC^ ^ - C O O H HOOC /—COOMe 
H O O C ^ N VcOOH m K . H H O O C ^ J i V-COOMe 
I 96% 
H O O C ^ ^ C O O H MeOOC' 
39 (L2) 
mixture or the 4 possible diastereoisomers 
Scheme I V . 2 : Synthesis of the diglutarate A A Z T A ligand, L 2 , as a racemic mixture. 
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Dialkylation o f the primary amine with tert-buiy\ bromoacetate gave the fully 
functionalized ligand structure, 39. This may exist as four different stereoisomers 
(RR/SS/two meso stereoisomers RS+SR), determined by the configuration at each of 
the labelled stereogenic centres. However, neither in TLC nor from the 'H N M R 
spectrum, shown in Figure IV.2, could these diastereoisomers be distinguished. 
C(CH 3) 3 
4 X OCH 3 -COOMe {BuOOC^ 
ffluOOC^N \ -COOMe 
MeOOC "COOMe 
2 X CH2COO(Bu 
2 X CH 2 C0 2 CH 3 
CH2&CH2CO2CH;} 
1 CH23CH2C02CH3 
4 X CH 2 ring 
CH.N ' 
CHyN 
CH 3 
I 
1111111 n 11111111111111 m i 111 | 1111111111111111 i i i | 1111111111 n i l l 1111111111111 i | i n I 1111111111 I I I 111111 n 1111111111111111 n 111111 | i 11 M 11 M | i 111111 
3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 1.6 1.4 1.2 ppn 
F i g u r e I V . 2 : ' H N M R spectrum of the ester 37 (400 MHz, in CDC1 3 ) . 
Removal of the /er/-butyl esters in trifluoroacetic acid/dichloromethane (1:1) 
solution (Scheme IV.2) gave 38, which was precipitated from diethyl ether as a white 
crystalline solid. The subsequent deprotection o f the methyl esters was found to be a 
very slow reaction: hydrolysis in aqueous KOH solution (1M, 20 °C) reached 
completion onl y after 7 days. Complexes o f Gd" 1, E u m and Y b m with 39 were 
prepared by reaction of stoichiometric quantities of the L n m trichloride salt with the 
ligand in water. The pH dropped when the metal salt was added to the ligand 
solution, and a white solid precipitated. The pH was maintained at ~ 5.5 by addition 
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o f aqueous K O H solution (1M), and the reaction progress was followed by ES-MS 
(for the G d m chelate) and by ' H N M R (for E u n i and Y b m ) . The liquid supernatant 
was separated from the precipitate by centrifugation. The resultant white solid was 
soluble only in aqueous HC1 (2% solution), thus allowing its characterization only by 
ES-MS: lanthanide complex, salts and a 2:1 metahligand species ( L M 2 ) were 
identified as the constituents o f this precipitate. The separation o f the small quantity 
of complex from the other constituents present in the precipitate was never 
accomplished, therefore further details cannot be provided about the nature o f this 
isomeric structure. The lanthanide complex was also dissolved in the supernatant. The 
excess lanthanide was removed as its corresponding hydroxide, by raising the pH o f 
the solution to ~ 10 with an aqueous potassium hydroxide solution. A mixture o f the 
lanthanide complex and KC1 salts was finally isolated as a white crystalline solid. The 
properties o f the lanthanide ( Y b n i , E u r a , Gd 1 1 1) complexes prepared from ligand L 2 
(Figure IV.3) were examined in the presence o f the potassium salts. 
Figure IV.3: Stereoisomeric mixture of complexes synthesized from simple racemic a-bromide. 
Information about the number o f stereoisomers present in solution could be gathered 
by analysis o f the *H N M R spectrum. Two diastereoisomeric species o f 
[Yb n i(Glu)2race/m'c-AAZTA] 3"were apparent in solution, in approximately a 9:4 ratio 
(Figure IV.4). These two isomers are characterized by different dipolar shifts, 
exemplified by the signals o f their methyl groups, resonating at 10 and 14 ppm, 
respectively. 
The *H N M R spectra o f the analogous [Eu n i(Glu)2race/«/c-AAZTA] 3" complex 
confirms the presence in solution o f two main species in approximately the same ratio 
H3 O- . q O H 2 4v O H h ' -9 coo ooc 
L n ' ^ Y b 1 " (Eu 1 1 1, Gd"1) 
1 13 
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(9:4), with dipolar shifts o f lower magnitude, but in the same sense as the Yb 
system. 
CH 3 
n 3 osss> r coo 
1 - ^ f f - X O 
o C H l 
• 
A 
i i i i i — i — i — i — i — | — i — i i • | i i i — i | i—i—i—i | i — i — i i | i i i i | i — i i i — [ — n — i — i — | i i i i — | i i i i | i i i i | 
50 40 JO 20 10 0 -10 -20 -30 -40 -SO POP 
Figure I V . 4 : ' H N M R spectrum of [ Y b m ( G l u ) 2 r a « ? m / c - A A Z T A f (200 MHz, D j O , pH 5.5). 
Based upon previous studies on lanthanide complexes o f DTPA, 5 it has been 
hypothesized that in solution these A A Z T A complexes can be 9-coordinated, with the 
ligand affording seven donor atoms and two water molecules bound to the metal ion 
on one face o f a square antiprismatic structure. Looking at [Ybm(G\u)2racemic-
A A Z T A ] 3 " up its N3 basal plane, two enantiomeric conformations can be 
distinguished, defined by three NC-CO torsion-angles (A: positive and A : negative). 
Different right or left handed orientations o f three o f the acetate arms can in this way 
be visualized, associated with the different A or A helicities about the metal centre 
(Figure IV.5). It is assumed that each o f the NC-CO torsion angles is the same sign, 
in each case. 
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O H H O 
N N ay N N 
/ ^ - 7 N V 
o o r H O O H 
H O O H 
o-V N :/ r-mc'V-—•>? 
N 
o: 
O H H O 
A 
F i g u r e I V . 5 : Possible stereoisomeric conformations adopted by | Y b (Glu)t(J7X>- and (SS)-
A A Z T A ] ' in solution, acidic p H . The two structures on the right are the enantiomers of the pair 
on the left 
Measurements o f the radiative decay constants for deactivation o f the E u m excited 
state in H 2 0 and in D 2 0 (£(H20) = 4.86 ms"', VfcO)= 2.85 ms"1) allowed an estimation 
of the hydration state o f the complex. The number o f bound water molecules was 
calculated according to Equation III .4 .1, 6 already discussed in Section III .4 o f this 
chapter: [qEu = (Ak - 0.25) • 1.2]. It was in this way established that 
[Eu i n (Glu) 2 racem/c-AAZTA] 3 " is a diaqua system (q = 2.06). 
The 1/Ti N M R D profile o f the [Gd m (Glu) 2 race/wc-AAZTA] 3 " complex was 
measured and the relaxivity ( r / p ) at 20 MHz, 25 °C was determined to be 8.0 mW's ' 1 , 
a value in the range o f magnitude expected for a q = 2 system of similar volume ( M W 
= 659) . 7 ' 8 The water exchange rate at the Gd 1 1 1 centre was determined by variable 
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temperature (VT) l 7 0 N M R R2p measurements (at 600 MHz, neutral pH, 25 °C), and 
the r,„ value obtained was 414 ns. As demonstrated by N M R and luminescence 
studies on DOTA based systems,9' 1 0 ' " ' l 2 ' 1 3 the rate o f water exchange at the 
lanthanide ion can be markedly different for two isomers of the same complex. Is this 
theory applicable to AMPED based systems also? This question was addressed by 
attempting the separation (or at least an increase o f the ratio) o f [Ybn i(Glu)2race/w'c-
A A Z T A ] 3 ' isomers in solution. Attempts to epimerise the statistical 
[Ybm(Glu)2race/w/c-AAZTA] 3 ' isomeric mixture in the Yb 1 " or Eu 1" complexes were 
undertaken, but unfortunately this strategy did not work: over the pH range 2.5 to 6 
no change was registered in the observed isomeric ratio, even after heating for a 
week. 
IV.3 Enantiopure amino-acid a-bromo diester as AMPED side arm 
Since the product (36) obtained from the alkylation of AMPED (28) secondary 
amines with racemic dimethyl ar-bromoglutarate (35) was a mixture of 
diastereoisomers, it was decided to synthesise an enantiopure amino acid ester, 
wherein stereoselective alkylation o f the AMPED secondary amines leads to a 
simplified diastereomeric mixture in the lanthanide complex. 
The enantiopure 2-bromo amino acid diester 41 was prepared in two steps from L -
glutamic acid 5-benzyl ester (Scheme IV.3). 
BnOOC N ^~4S | .COOH ^ N g B n O O C ^ - ^ C O O H B U Q A C BnOOC^^(S),COO<Bu 
NH, Naii^  - Br HCIO„ (70%)" Br 
58% 40 88% 41 
Scheme I V . 3 : Synthesis of (25)-2-Bromo pentanedioic acid l-(l,l-dimethylethyl) 5-
(phenylmethyl) diester, 41. 
The first step involved the diazotization o f the amino group o f L-glutamic acid-5-
benzyl ester by treatment with hydrobromic acid and sodium nitrite, in the presence 
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of sodium bromide at -5 °C. It is hypothesized14 that the diazonium salt immediately 
undergoes an intramolecular SN2 reaction, involving nucleophilic attack of the 
oxygen of the carboxylic acid onto the electrophilic carbon, followed by loss of the 
dinitrogen leaving group (Scheme IV.4). 
o o o o o o 
PrT " O " ^S-QH P h ^ ^ 0 " ' rO®H ^ P h ^ O ' v "OH 
^N© 1 Br 
in J 
N Jq 
Br^ 
Scheme IV.4: Double inversion mechanism in the synthesis of 40. 
The resulting cyclic oxonium ion is then opened by nucleophilic attack of bromide, 
resulting in the formation of the or-bromide (40) where the or-carbon possesses the 
same configuration as in the starting glutamic acid. The /-butyl ester 41 was prepared 
by transesterification of 40 with /-BuOAc in the presence of a catalytic amount of 
HC104 (70 % ) , affording the ester product (41) in 88% yield. 
Alkylation of the AMPED secondary amines with the enantiomerically pure diester 
41 (Scheme IV.5) led to the disubstituted AMPED derivative 44 and to the mono-
substituted diastereoisomers 42 and 43. 
B n O O C . ^J?lCQOffiu ^ C O O B n ^ C O O B n 
, - K , . Br
 1 ^ S T > C 7 NH2(RK.„cOO/eu N H 2 < R > " C C _ 
V ^ N ^ / K 2 C 0 3 , C H 3 C N 8 n O O C ^ ^ W C O O / B u 
42 43 B n O O C " ^ — ( R ) * C O O ( B u 
44 
Scheme IV.5: Alkylation of AMPED secondary amines with the enantiomerically pure 
amino-acid diester. 
The mixture of alkylated AMPED products was separated by extraction in EtOAc / 
aqueous HBr (1M). The disubstituted product remained dissolved in the oganic 
solvent, probably because of its higher lipophilicity and the decreased basicity of the 
alkylated secondary amines. The monoalkylated derivatives remained in the aqueous 
phase and were subsequently extracted into an organic layer after the pH was adjusted 
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to ~ 9 with ammonia solution. The mixture of the two diastereoisomers of the mono-
alkylated AMPED was separated (or, at least, it was largely enriched in one of the 
two diastereoisomers) via crystallization from EtOH, one isomer being found to be 
soluble in the solvent and the other precipitating as a white crystalline solid. The 
purity of these two compounds was determined by 'H NMR analysis. In Figure IV.6 
is shown the spectrum of the diastereomeric mixture and in Figure IV.7 the spectrum 
of diastereoisomer 42 (soluble in ethanol) after crystallization. Evidence of the 
successful diastereomeric separation was given by observing the signal at 8 ~ 5.10 
ppm, which corresponds to the two benzylic protons: two resonances were observed 
when both the diastereoisomers were in solution (&SH = 0.008 ppm) and the signal 
became a > 90% one singlet when they had been separated. 
-COOBn 
CH 2Ph I 
- - i 
' 11 
NH2 V"COO/Bu + 
" V ^ J O BnOOC 
NH, H 
Ph 
CH 2Ph 
COO/Bu 
C(CH 3 ) 3 
CH 2 COOBn 
CtfzCHN 
CWN ^ r i n 9 
C H a 
LjLJL 
Figure IV.6: 'H NMR spctrum of the mono-alky la ted AMPED isomeric mixture (42 + 43) 
(700 MHz, CDCI3). 
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CH2Pb 
Ph 
CHjPh 
COOffii 
CHpCOOBn 
CHfiHN 
C ( C H 3 ) 3 
C H 3 
Figure 1V.7: *H NMR spectrum of the mono-alkylated AMPED isomer soluble in EtOH, 42 
(700 MHz, CDCIj). 
Unfortunately crystal structures of these compounds have not so far been obtained, 
and the relative / absolute configuration of the two diastereoisomers has thus not been 
assigned. However, ligands have been prepared either from the dialkylated and the 
two monoalkylated AMPED derivatives. 
IV.3.1 Preparation of [Lnl"(Glu)2('f?r?;-AAZTA]3-
In Scheme IV.6 is reported the synthesis of the disubstituted AMPED based ligand 
structure L5, which involved the alkylation of the primary amine of 44 with ter/-butyl 
bromoacetate and two subsequent deprotection steps, where the ter/-butyl and the 
benzyl protecting groups were removed by treatment with trifluoroacetic acid and 
hydrogenation over Pd / C, respectively. 
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C O O B n 
N H 2 (R)> . . c O O ( B u 
. A ^ j ^ B r C H 2 C O O f B u 
/ B u O O C 
(Bu O O C 
B n O O C ( R f C O O f B u 
K 2 C 0 3 , N a 2 S 0 4 
C H 3 C N 
65% 
" I 
/ — C O O B n 
(R)V"C 
T F A / D C M 
B n O O C (R) C O O I B u 
50 
88% 
H O O C 
B n O O C (RrcooH 
C O O B n 
P d / C 
98% 
H O O C ^ ^ - C O O H 
H O O C ^ N ( R V - C O O H 
H O O C ^ ( R T C O O H 
59 (L5) 
Scheme IV.6: Synthesis of the (Glu)2(7?K)-AAZTA ligand LS. 
The dialkylation of the AMPED secondary amines, which led to L5, proceeded 
stereoselectively, with clean inversion at the stereogenic centre of the alkylating 
glutamic acid derivatives. Apart from the defined chiral centres of the carbon atoms 
on the pendant arms (R - configuration), the triply substituted nitrogen atoms of the 
ring structure can give rise to other possible stereoisomers. However, the 
configurational instability of these isomers, as a consequence of the rapid nitrogen 
inversion, leads to fast interconversion of these limiting structures. Hence, only a 
single set of signals is observed in the 'H NMR spectrum (Figure IV.8), which can 
either be the average of the rapidly interconverting isomers or the more 
thermodynamically stable structure. 
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P h - H 4 X C ( C H 3 ) 3 
2 X C H 2 P h 
( B u O O C ^ ^ - C O O B n 
BnOOC ^~^tfi?CO01Bu 
2 X C H 2 C O O / S u 
Coring 
C H j C O O B n I 2 X C H j C H N 
CHN \Y "\ ' ' 
J 
C H , 
Figure IV.8: 'H NMR spectrum of 50 (700 MHz, CDCI 3 ) . 
Gd1", Eu1" and Yb1" complexes were prepared from the (Glu)2(^/?^-AAZTA ligand. 
Both the 'H NMR spectra of [Yb l " (Glu) 2 W-AAZTA] 3 - (Figure IV.9) and 
[Eulll(Glu)2(7?/?y)-AAZTA]3" (Figure IV.10) suggested the presence in solution of one 
dominant species and a second minor one, in ratio > 9:1. Two dimensional *H - 'H 
COSY NMR experiments (the one relative to the europium complex is shown in the 
Appendix) confirmed the coexistence of two species and allowed the separation of 
some of the related resonances. 
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C H 3 
COO r o o Yb 
o o c ^ V 0 
o 
CH 
• 
i 
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50 40 30 » 10 0 -10 -X -30 —A -50 Mil 
Figure IV.9: 'H NMR spectrum of |Yb n i(Glu)j(W?)-AAZTA|^ showing the major (red) and the 
minor species (blue) (D 2 0, 700 MHz, pD 5.4,24 °C). 
It appears that in the 'H NMR of the Eu"1 complex the methyl group resonates at 
about 6.6 ppm in the major species, but is not obviously assigned in the minor 
species. 
Me 
l 
COO 
o ooc-^V 
o 
~l—I—«—I—*—I—'—'—I—I—I—'—I—'—'—I—'—I—•—»—I—1—•—•—•—I—•—~r 
10 3 0 -:> - 1 0 - 1 5 
Figure IV.10: *H NMR spectrum of |Eu n i(Glu)i0HI>-AAZTA| 3 (700 MHz, DjO, pD 5.4,24 °C). 
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The emission spectrum for [Eun'(Glu)2(#/?>AAZTA]3" was recorded following direct 
excitation of the Eu1" ion at 397 nm (Figure IV. l l ) . 
o 6 OOE+07 
I E 
630 650 
wavetenght (i. / nm) 
Figure I V . l l : Emission spectrum of [Eu'"(Glu) 2 ^/y-AAZTA| 3 in D 20,397 nm, pH 6. 
The spectral form of the europium emission in the range 570 - 720 nm is consistent 
with the presence of only one species in solution. The number of chemically distinct 
environments of the Eu111 ion can be estimated from the number of bands in the AJ = 0 
and AJ = 1 transitions between 579 nm and 595 nm. In the spectrum considered here, 
only one band is distinguished at 580 nm and three bands in the AJ = 1 manifold, 
indicating the presence of only one species. Furthermore, the symmetry of the system 
can be examined by comparing the intensity ratio of the AJ = 1 and AJ = 2 bands. The 
dominance of the AJ = 2 transition is consistent with the lack of symmetry around the 
metal ion, which is further supported by the presence of three bands in the AJ = 1 
manifold, as compared to the only two bands expected for a C4 symmetric system 
such as Eu m DOTA, 1 3 ' 6 for example. 
Rate constants for the depopulation of the excited states of [Euin(Glu)2fJ?i?,)-
AAZTA] 3" were measured in H 2 0 and D 2 0 at 20 °C. This allowed an estimation of 
the degree of hydration of the complex which, according to the values measured of 
* H 2 0 = 3.6 ms"1 and £020= 1.15 ms"1 (Equation IIL4.1) 6 is consistent with a diaqua 
system (calculated q value of 2.4). 
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The 1/T, NMRD profile of the [Gd1"(Glu)2(7?^-AAZTA]3" complex was measured 
and the relaxivity (r!p) at 20 MHz, 25 °C was determined to be 8.65 mM"'s"'. Such a 
relaxivity value corresponds to that expected for such a small molecular volume (MW 
659) q = 2 complex. The measured water exchange rate at the Gd1" centre was rather 
slow: VT l 7 0 NMR R2p measurements allowed an estimation of tm = 720 ns (at 600 
MHz, neutral pH, 25 °C). This value of rm is much larger than is desirable: lifetimes 
of the order of 20 - 30 ns are required in order to get relaxivity gains as TR increases. 
Accordingly, the monoalkylated analogue was examined, for purposes of comparison. 
IV.3.2 Preparation of [LnMIGlu AAZTA]2 complexes 
Ligands derived from the mono-alkylated AMPED diastereoisomers 42 and 43 were 
prepared by following an analogous experimental procedure to that employed in the 
preparation of the dialkylated AMPED ligand L5 (Scheme IV.6). As already 
mentioned, the relative / absolute configuration of the two diastereoisomers 42 and 43 
has not been determined, so it will be assumed that structure 42 corresponds to the 
isomer soluble in ethanol and structure 43 to the crystalline solid precipitated from 
ethanol (the molecular structures of the two compounds are shown in Scheme IV.5). 
The alkylation of the remaining secondary and primary amines of 42 (Scheme IV.7) 
and 43 (Scheme IV.8) with /er/-butyl bromo acetate proceeded slowly, over 48 
hours, and heating at reflux of the reaction mixture was required to ensure the 
alkylation of all the three amino positions. 
Ligand L3 (Scheme IV.7), derived from diastereoisomer (42), soluble in ethanol, was 
easily obtained in good yield after the deprotection steps. 
1 1 C O O f B u C O O H r r NH l i n o M 
^ 6 
fBu O O C N H O O C N (S) H BrCHoCOOfBu T F A / DCM 
Pd/ K 2 C 0 3 , N a , S O 93°/ 
C H 3 C N 96 B n O O C 
B n O O C B n O O C 60°/ 
fBu O O C H O O C 
/ C 
% 
42 (soluble in EtOH) 48 52 
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HOOC. 
^| X O O H 
H O O C ^ N f 
HOOC ^ ( R f C O O H 
54 (L3) 
Scheme IV.7: Preparation of ligand L3 from the soluble in ethanol diastereoisomer 42. 
Gd1", Eu i n and Y b m complexes were prepared from the GluAAZTA ligand L3, and 
the 'H NMR analysis of the ytterbium adduct (Figure IV.12) indicates the presence 
of only one major complex isomer species in solution (9:1 ratio with a second, minor 
species) with a chemical shift of 9 ppm for the methyl group. Higher resolution 'H 
NMR (500 MHz) and correspondent *H - ! H COSY NMR spectra which helped in the 
identification of the two species in solution are shown in the Appendix. 
CH >'3 
o .o 
o Yb; o 
N 
0 tsF^ N 
O ooc 
n 
•40 -20 -30 10 10 30 20 ppm 
Figure IV.12: 'H NMR spectrum of |Yb u l GluAAZTA] 2 " showing the major species (red) and 
the minor one (blue) (200 MHz, D 2 0 , pD 5.4,24 *C). 
125 
Chapter 4 
The related europium complex was also formed as one main species, as confirmed by 
'HNMR (Figure IV.13) and two dimensional "H - *H COSY NMR analysis (which is 
shown in the Appendix). However, the dipolar shifts observed here do not 
correspond to those of the Yb" 1 complex, suggesting that there might have been a 
reduction in the coordination number from 9 (q = 2) to 8 (q = 1). This would lead to a 
change in^- the second order crystal field coefficient that determines the dipolar 
shift- as well as geometric changes around the Ln" 1 ion. 
9 = ^ 
Eu 
N Me 
o ooc 
i 
1 • J 
1 I 
15 10 5 0 -5 -10 -15 ppm 
Figure IV.13: 'H NMR spectrum of (Eu'"GluAAZTA] J (500 MHz, D 2 0, pD 5.4,24 °C). 
The emission spectrum of [Eu n iGluAAZTA] 2" was recorded following direct 
excitation of the Eu"1 ion at 397 nm (Figure IV.14). 
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4 70E+05 
o 3.70E*05 
2 70E*05 
630 650 
wavelenght {XI nm) 
Figure IV. 14: Emission spectrum of |Eu l u GluAAZTA| 2 (1 mM solution in D 2 0 , pD 5.4, 24 °C). 
The form of the emission spectrum of the monoglutarate complex [EumGluAAZTA] 2" 
in the range 570 - 720 nm was very similar to that of the diglutarate [Eum(G\\i)2(RR)-
AAZTA] 3", 43. The presence of only one band in the AJ = 0 region at 580 nm 
suggested that only one species was in solution. The three bands in the AJ = 1 
manifold and the dominance of the AJ = 2 band were evidence of a lack of symmetry 
in the coordination of the metal ion. 1 3 ' 6 
Rate constants for the population of the Eu"1 excited state were measured as ^ H 2 O ) = 
3.0 ms"1 and A(D20) = 1.16 ms'1 indicating that the europium complex possessed a 
value of q = 1.9.6 
The relaxivity value (r,p) at 20 MHz, 25 °C of [GdmGluAAZTA] 2" was determined to 
be 7.3 mM 's"1, and a water exchange rate (r m ) at the Gd111 centre of 115 ns was found 
by VT 1 7 0 NMR R2p measurements (600 MHz, neutral pH, 25 °C). This zm value is 
lower than those recorded for the related diglutaric AAZTA complexes 
[GdU I(Glu) 2 W - A A Z T A ] 3 ' and [Gdn ,(Glu)2racem/c-AAZTA]3-, but is still relatively 
long, implying that the rate of water exchange may still quench relaxivity gains in 
more slowly tumbling analogues. 
As for the ligand prepared from diastereoisomer 43, problems were unexpectedly 
encountered during the final deprotecting step (Scheme IV.8). Various attempts at 
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removing the benzyl protecting group by hydrogenation over Pd/C and also on 
Pd(OH)2/C failed and the lanthanide complex had to be prepared from ligand L4, still 
bearing the benzyl on the remote carboxy group. 
^ C O O B n ( B U O O C ^ ^ C O O B n H O O C ^ ^ C O O B n 
( R N M R ) ' 'COOfBu B r C H 2 C O O f f i u O O C v ^ ^ < R » •' 'COOfBu T F A H O O C ^ ^ < R ^ • ' C O O H \ H 2 / 
" CH3CN N. N. / 
4 3 40% C O O f f i u C O O H 
(crystallized from EtOH) 4 9 5 3 * L 4 ' 
Scheme IV.8: Preparation of ligand L4 from diastereoisomer 43 (crystallized from ethanol). 
The Eu111 complex was prepared from ligand L4, and rate constants for depopulation 
of the excited states were measured in H2O and D2O at 20 °C: ko^o)= 4.7 ms'1 and 
k(DiO) =3.11 ms"1. Consequently, the degree of hydration, q, of the complex was 
estimated6 to be 1.6. 
IV.3.3 Preparation of the [LnMI(Glu)2(7?Sj-AAZTA]3" complexes 
To conclude the work on the amide derivatives of AAZTA-diglutarates, to investigate 
i f the nature of the isomers can play a determinant role in the water exchange rate 
dynamics, it was decided to prepare the (TfS^-diglutarate AAZTA isomer (Figure 
IV. 15) and examine the properties of the Eu m/Yb I U/Gd U I complexes derived from it. 
X ^ - C O O R " 
- N ^ ( s O — C O O R 
R'OOC ^ f R r C O O R 
Figure IV.15: The (Glu),(RS>AAZTA isomer. 
The enantiopure (R)-2-\>xomo amino acid diester 46 was prepared in two steps from 
the D-glutamic acid 5-benzyl ester (Scheme IV.9) following the same experimental 
procedure already used for the synthesis of the corresponding (S^-enantiomer 41 
(synthesis reported in Scheme IV.3). 
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BnOOC-^MRJ-COOH H B r N a N 0 2 BnOOC ^ ^ R ) , C O O H , B u 0 A c B n O O C ^ / v ^ C O O f B u 
tiH2 NaBr | r H C I 0 4 (70%) B r 
58% 45 88% 46 
Scheme IV.9: Synthesis of (2/?)-2-Bromo pentanedioic acid l-(l,l-dimethylethyl) 5-
(phenylmethyl) diester, 46. 
Stereoselective alkylation of the secondary amine of the monoalkylated AMPED 
diastereoisomer soluble in ethanol (42), as shown in Scheme IV.10, led to the 
disubstituted AMPED derivative 47, whose primary amine was then dialkylated using 
tert-bu\y\ bromo acetate (Figure rV.16). Further deprotection of the /er/-butyl and 
benzyl groups led to ligand L6. 
f B u O O C . ^ C O O B n 
B n O O C ^ ~ m C O O f B u ^ C O O B n ^ / 
NH u ; ,A B u O O C N <^V-COO(Bu 
( S J J L ^ w d Br ( S ) > - C O O h 3 u B r C H 2 C O Q f B u ^ A T T N O 
^ \ ^ - N ~ J K 2 C 0 3 . C H 3 C N - " V ^ N O K 2 C 0 3 , N a 2 S 0 4 i 7 n o / ^ JL C H 3 C N B n O O C ^ 7 R ) * C O O r B u 
BnOOC ^ - t R 5 * C O O ( B u ' 0 / o B n O O C ^ ( R f C O O f B u d 0 o / 
42 47 5 1 
I H2 
9 4 % Pd /C 
H O O C ^ ^ C O O H f B u O O C 
H O O C ^ , N <s>V-COOH / B u O O C 
J F A / D C M 
X 93% 
H O O C ^ ^ R ) * C O O H H O O C ' ^ ( R j * C O O h 3 u 
61(L6) 60 
Scheme IV. 10: Preparation of ligand (Glu)2(/?5>-AAZTA, L6, from the ethanol soluble 
diastereoisomer 42. 
C O O H 
COOfBu 
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Ph CH2Ph 4 X C(CH 3) 3 
J 
CH2COO/Bu 
Coring 
CH2COOBn C H ^ H N 
VJAJ 
: H 3 
Figure IV.16: HNMR spectrum of the fully functionalized ligand structure 51 
(700 MHz, CDCI 3 ) . 
The lanthanide (Yb m , Eu"1, Gd1") complexes were prepared following the classical 
procedure of slowly adding an aqueous solution of the hexahydrate lanthanide salt 
(LnCb • 6H2O) to the ligand, also dissolved into water. The pH value was kept 
constant at ~ 5.5 by adding aqueous potassium hydroxide solution, and stirring of the 
reaction mixture at 50 °C overnight led to formation of the lanthanide complex. As 
already observed with [Ln"'(Glu)2race/M/c-AAZTA]3", the precipitation of a white 
solid straight after the addition of the metal ion solution was observed. The resulting 
solid was, once again, soluble only in acidic water and from ES-MS it was 
determined to be a mixture of lanthanide complex (which it was not possible to 
separate from the other components of the precipitate), salts and a 2:1 metahligand 
species (LM 2 ) . The lanthanide complex was dissolved in the supernatant, and the 
excess lanthanide was removed as the corresponding hydroxide by raising the pH of 
the solution to ~ 10 with aqueous potassium hydroxide solution. 
130 
Chapter 4 
'H NMR analysis of the Y b m and EuU I complexes (shown in Figure IV.17 and IV.18, 
respectively) showed that two species were in solution, in approximately a 1:4 ratio 
(Yb , n complex) and 1:3 (Eu m complex). The chemical shifts observed for the isomers 
of the Yb I H (if5)-complex correspond to those found for the (it/?)-diastereoisomer. 
Noticeably, the diastereomeric mixture of the [Ybm(Glu)2f/?$-AAZTA] 3" complexes 
was enriched in the same isomer as the racemic mixture [Yb,n(Glu)2race/w'c-
AAZTA] 3", just the isomeric abundance in solution was different ([Ybni(Glu)2(&S>)-
AAZTA] 3 " 1:4 / [Yb in(Glu)2race/w/c-AAZTA]3" 9:4). 
C H 3 
n 3 -6i COO r Yb 
5 L " i t i CH • 
o 
I 
I 
{ 11J J J 1 • • 
i—i—i—i—i—i—i—i—i—t—i—i—i—i—i—i—i—i—i—i—i—i—i—i—i—i—i—i—i—i—I—I—i—I—i—i—I—i—i—i—i—I—i—i—i—i—I—i—I—i—i—I—i—r-
50 *»0 30 20 10 0 - 1 0 -20 -30 - 4 0 p p » 
Figure IV.17: *H NMR spectrum of |Ybm(Glu>i(HS)-AAZTAl 3 (700 MHz, D,0, pD 5.4,24 °C). 
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Figure IV.18: *H NMR spectrum of |Eu m (Glu)2(7f5;-AAZTA| 3 (700 MHz, D,0, pD 5.4,24 °C). 
Magnetic and luminescence measurements were performed on the Gd111 and Eu"1 
complexes, respectively. Rate constants for the depopulation of the excited states of 
[EuHI(Glu)2(7tS;-AAZTA]3" (kH20 = 3.34 ms"1 and k^o = 1.27 ms"1) allowed an 
estimation of the degree of hydration of the complex,6 giving a q - 2.18. 
An rip value of 7.5 mM's" 1 was measured for the [ G d i n ( G l u ) 2 ^ - A A Z T A ] 3 " 
complex at 20 MHz, 25 °C. Variable temperature 1 7 0 NMR R2p measurements (600 
MHz, neutral pH, 25 °C) gave a water exchange rate at the Gd1" centre of 243 ns. 
This T„ value is the lowest of those measured for the other AAZTA-diglutarates, i.e. 
[Gd"'(Glu) 2W-AAZTA] 3" and [Gd I I1(Glu)2race/M/c-AAZTA]3". 
IV.4 Summary and analysis of the results obtained for the 
glutarated AAZTA derivatives 
In Table I V . l the best fitting parameters determined by analysis of the 1/Ti NMRD 
and VT 1 7 0 NMR R2p profiles are reported and compared to the Gd"1 chelates based 
132 
Chapter 4 
on the A A Z T A core structure (molecular structures in Figure IV.19) discussed in this 
chapter. 
? !/° 7 
H,0 
0-----,-'Gd 
ooc 
r \ P H i "~|3-
V / N ^ / 
o 
o 
o 
[GcT'GluAAZTAr 
[Gd , ML3] 2 
OOC 
(Gd'u(Glu)2rRR;-AAZTA]3 
IGd"'L5]s" 
Q 2 | OH 2 H 2 0 
/ q l , O H * 
o 
Q :--Gd 
"OOC 
[Gdm(Glu)2RacemioWAZTA]J 
[GdD,L2]3" 
"OOC 
O 
[Gd l"(Glu) 2<^AAZTA] 3" 
[Gd'^e] 1" 
Figure IV.19: The four synthesized Gd"'chelates based on the AAZTA core structure. 
Gd ' " che la te r 1 p (mM" 1 s 1 ) 
-20 MHz, 298K-
tm (ns) A 2 ( s 2 ) x v (s) 
[Gd"'Glu AAZTA]2" 7.3 115 3.4x10 1 B 2.1x10"13 
[Gd'^GIukfR/^AAZTA]3" 8.6 720 2.2x10 1 9 6.3x10"13 
[Gd^Glu^racJAAZTA] 3" 8.0 414 2.7x10 1 9 2.8x10"13 
[Gd'^GIuMRSJAAZTA]3" 7.5 243 1.57x1019 2.8x10"13 
[Gd3*] have been determined by mineralization with HCI 37% at 120°C overnight 
Table I V . 1: Best fitting parameters determined by analysis of NMRD profiles and VT "O NMR 
R2p experiments. 
IV.4.1 Diglutarate A A Z T A adducts: summary of observations 
The diglutarate ligand exists as (RR)- and (RS)- isomers. Both structures were 
prepared by alkylation o f the AMPED secondary amines with the enantiopure a-
bromo diester 41 (in the case of the (RR)-\somer) and 46 (used only in the second 
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alkylation step for the preparation o f the (RS)-\somzx). A mixture of stereoisomers 
(RR/SS-RS=SR) was also prepared from the racemic a-bromo diester 35 (Figure 
IV.20). 
Figure IV.20: Diglutarate derivatives based on AMPED: a) (RR)-isomer, b) (RS)-isomer and c) 
racemic isomeric mixture. 
The ligands used to prepare the complexes were shown to be one isomeric species, as 
deduced by TLC and NMR analysis. Yb 1 " complexes based on the (RR)-\'\%md 
system gave rise to a > 9:1 mixture of complex stereoisomers, while the (RS)-sysXcm 
afforded a 1 : 4 mixture of the same isomeric types. In the ' H N M R spectra o f the 
corresponding Eu" 1 complexes, these two isomeric complexes could also be 
identified, present in ratio 8:1 ((RR)-\somev) and 1:3 ((TfSj-isomer), displaying 
identical chemical shifts. With Yb" 1 complexes prepared from the racemic ligand 
(mixture of the RR/SS-RS=SR isomers), a 9:4 ratio is obtained, in perfect agreement 
with the 9+1 : 1+4 ratios mentioned for the (RR)- and (RS)- systems (this comparison 
between relative isomeric abundances is shown in Figure IV.21). Attempts to 
epimerise the statistical complex isomeric mixture in the Yb" 1 or Eu 1" complexes did 
not seem to work: over the pH range 2.5 to 6 no change in the complex isomer ratio 
was observed on prolonged heating. Each o f the exam ined Yb" 1 complexes ((RR)-, 
(RS)- and racemic- mixture) appears in the N M R analysis as a mixture o f two 
complex stereoisomers, in slightly different ratio to the correspondent Eu" 1 
complexes. The two stereoisomeric species show similar chemical shift behaviour. 
However, the small differences in the chemical shifts of their resonances allow the 
distinction of the two species. In the Yb" 1 complexes 'H-NMR spectra, for example, 
the C-Me group resonates at about 10 ppm for one species and at 14 ppm for the 
other one. 
COOH HOOC 
(R) \ . , , 
COOH COOH HOOC HOOC 
HOOC COOH HOOC HOOC COOH COOH 
HOOC HOOC RfCOOH HOOC COOH b) c L5 L6 L2 
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ft 2 l p H 2 
• o o c ^ ^ Y 0 
o 
'H NMR spectrum (200 MHz, 20 °C, pH 5.5) of 
the [Yb3 +(GIu)2race/M/c-AAZTA]3" complex (9 : 4 
ratio). 
O O H 2 — ] 3 _ 
"OOC 
.0 
o 
'H NMR spectrum (700 MHz, 20 °C, pH 5.5) of 
the [Yb 3 +(Glu) 2C/?5>AAZTA] 3" complex ( 1 : 4 
ratio). 
Q H 2 ( ? O H : 
O 
o-
' I I 
Yb.\ 
'2 |3-
coo" 1 
- - 0 
"OOC 
o 
'H NMR spectrum (700 MHz, 20 °C, pH 5.5) of 
the [Yb 3 +(Glu) 2(7?/f)-AAZTA] 3" complex (> 9 : 
1 ratio). 
Figure IV.21: Sections of 'H NMR spectra (700 and 200 MHz, D 2 0,20 °C) showing the most 
shifted resonances for the Yb 1" diglutarated AAZTA complexes a), b) and c). 
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In the Gd" 1 complexes, the measured relaxivities at 20 MHz, 25 °C were about 8.0 
mM''s ' ' , typical values for a diaqua complex o f this molecular volume. 
From the VT l 7 0 N M R R2p measurements, undertaken at 600 MHz and neutral pH, 
the water exchange rates associated with each Gd" 1 complex were obtained. The 
(RR)-sys\&m (8:1 isomeric mixture from *H N M R of the Eu" 1 complex) possesses a 
slow rate o f water exchange (kex) o f 1.4 • 106 s \ The (RS)-system (1:3 isomeric 
mixture, from ' H N M R of the Eu"1 complex) showed a kex of 4.1 • 106 s"1 and for the 
Gd 1 1 1 complex derived from the statistical mixture of isomers, a kex of 2.4 • 106 s"1 was 
measured. 
Solving the simultaneous equations (1) and (2) related to the (RR)- and (7?5^-systems 
and using mole fractions to weight the contributions of the individual isomers (x and 
y)-
(RR) 1.4 • 106 = 0.88 x + 0.11 y (1) 
(RS) 4.1 • 106 = 0.25 x + 0.75 y (2) 
allows the identification o f the rate of water exchange of the individual complex 
stereoisomers. Thus, one isomer exchanges water more slowly than the other, as in 
gDOTA 9 and analogues:2 a factor o f six separates the two water exchange rates, 
which correspond to (x) kex = 9.2 • 105 s'1 and (y) kex = 5.4 • 106 s"1. These results lead 
to the conclusion that in the (/^-system, the more abundant stereoisomer (in the 8:1 
mixture) is also the one possessing the faster water exchange rate, while in the (RR)-
system the major isomer in the 1:3 mixture is the one possessing the slower exchange 
rate. The analysis is consistent (± 10%) also using mole fractions derived from the 
ratios determined by 'H N M R of the Yb 1 " analogue mixture o f isomers. 
A comparison between the l 7 0 N M R R2p vs temperature profiles of the three 
synthesized di-glutarate Gd 1" A A Z T A derivatives is shown in Figure IV.22 and in 
Figure IV.23. It highlights the higher transverse relaxation time values (at different 
temperatures) shown by the enantiomerically pure (RS)- isomer [G<^n{G\\x)i(RS)-
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A A Z T A ] 3 " compared to the racemic isomeric mixture [Gd i n (Glu)2racew/c-AAZTA] 3 
600- . 
550- -[Gdlll<Glu)2(RR)AAZTAl3- , 
• [Gdm(Glu)2(racemic)-AAZTAf" 
5 0 0 • •[Gd'"(Glu)2ff?S)AAZTA]3-
450-
400 
350 
300 
250 
200 
150 
5 0 -
1 • 1 ' 1 • 1 • 1 • 1 ' 1 ' 1 ' 
280 290 300 310 320 330 340 350 
7-<K) 
Figure IV.22: Comparison of the "O NMR R2p/T profiles (600 MHz, pH 7) for 
|Gdm(Glu) 2r«5'>-AAZTAl 3 , |Gd , I I (Glu) 2 racemic.-AAZTA]3 and [Gd I , l (Glu) 2 r/f^-AAZTA|^. 
Q-
CM 
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Figure IV.23: Comparison between 1 7 0 NMR R2p IT profiles (600 MHz, pH 7) of 
|Gd"'(GluK/W;-AAZTA| 3 and |Gdul(Glu)2(racCTrt/£-MAZTA|3-. 
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IV.4.2 Monoglutarate A A Z T A adducts: summary of observations 
In the monosubstituted series, the (RR)- and (SR)- stereoisomers (Figure IV.24) were 
separated after monoalkylation of the AMPED core. 
The absolute configurations have still not been assigned, since no crystals of suitable 
quality for X-ray diffusion have been isolated. One diastereoisomer was taken 
forward (42, soluble in ethanol) and synthetically elaborated. The carboxymethyl 
groups were added, to obtain the ligand as one stereoisomer (as confirmed by *H 
N M R spectroscopy). Separately, the other isomer (43) was also brought forward. The 
Yb" 1 complex o f the monoglutarated ligand L 3 (derived from isomer 42) was initially 
promising, as one major complex isomer species (9:1) was observed, characterized by 
a chemical shift o f 9 ppm for its methyl group. 
The related Eu" 1 complex also formed one main complex species and the Gd" 1 
complex had a relaxivity of 7.3 mM"'s"' and a water exchange rate, kex = 8.7 • 106 s"1. 
In Figure IV.25 is shown a comparison between the l 7 0 N M R R2P I temperature 
profiles (600 MHz, pH 7) o f two of the disubstituted [Gd i nGlu2(7?/?,)-AAZTA]3" and 
[GdmGlu2racem/'c-AAZTA] 3" complexes and the mono-substituted 
[Gd'"GluAAZTA] 2 ". 
N H 2 ( R )>- ' iCOOfBu (R) 
H 
COOBn 
BnOOC 
NH 
(S) 
42 43 
Figure IV.24: (RR)- and (SR)- monoalkylated AMPED stereoisomers. 
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'(GlufefracemicJAAZTA]3' 
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Figure IV.25: Comparison between n O NMR R2p IT profiles (600 MHz, pH 7) of 
|Gd"' (GluK«SMAZTA| 3 . |Gd u l(Glu) 2racem/c-AAZTA| 3 _ and |Gd" ! GluAAZTA| 2 . 
The more concave shape shown by the V T 1 7 0 N M R ^ p r o f i l e o f the monoglutarate 
compared to the other diglutarated AMPED derivatives is consistent with its faster 
water exchange rate which, however, is not as fast as the target value o f r m ~ 20 ns. 
IV.5 Amide derivatives of Gd'"AAZTA glutarated complexes 
The main idea o f this final work on the lanthanide A A Z T A glutarate compounds is to 
adorn the periphery o f the mono- and di-glutarate Gd 1 1 1 chelates possessing faster 
water exchange rates (in Figure IV.26) with bulky, hydrophilic moieties. 
H 3 -jo \ 2 
o ^ v r . coo o 
1 o 
Gd' o N 
0 ®Z* o 
OOC R OOC (R) 
o 
T m = 243 ns 
o 
x m = 115 ns 
[Gd'"L3]2 [Gd'"L6]3-
Figure IV.26: The two glutarate Gd 1" chelates (pH 5.5) used for amide coupling with 
hydrophilic moieties. 
139 
Chapter 4 
It was thought that, in this way, the overall relaxivity would be enhanced, as a 
consequence of the increased molecular volume (i.e. slower molecular tumbling) and 
possibly o f a more pronounced second sphere contribution to the overall relaxivity. 
To test the reactivity of the free (i.e. not coordinated to the metal ion) carboxylated 
functions of the G d m chelates towards amide bond formation, a coupling reaction 
with the TRJS amino group was firstly attempted. Two different routes were 
explored: the first one is shown in Scheme I V . l l , and it involves the direct coupling 
of the amine free carboxylate groups o f the Yb" 1 chelate. 
°> —12 o H 2 O 1-
0 . - - Y b : H O ' > - N H 2 o V'Yb\- o 
0 HBTU BF4, NMM U N ° H ° 
Z \ J L £> DMF H°^\ N N 
O O C ^ ^ R ^ Y I E L D 1 0 % H O ^ V ' V 
O H O — o 
to F H O ^ - ™ jT~;o 
( R Ml 
o 
[Yb'"L3]" [YbM,L8]-
Figure I V . l l : Direct coupling of TRIS to the Y b m chelate free carboxylate pendant arm. 
This one step synthetic pathway led to the product, [Yb"'L8]", which was obtained in 
modest yield. The same synthetic strategy did not afford the desired product when 
applied to the diglutarated complex [Gd'"(Glu)2f./?$-AAZTA] 3", and the alternative 
pathway shown in Scheme IV.12 was therefore followed. This involved the 
functionalization o f the carboxylic function of the ligand structure still /er/-butyl 
protected, removal of the /er/-butyl groups and finally complexation o f the ligand L7 . 
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A ^ T N C ? H B T U B F 4 , N M M H 
/ \ A . D M F N ^ A . 
H O O C ^ i R r C O O / B u H O ^ V " Y ^ ^ R ^ C O O / B u 
H O ^ O 6 2 
TFA 
H O ™ ~ ~ I " H O ™ 
HO, I 1 HO 
H 2 ° v NH NH 
O — C A \ J ^ O H s GdCI3 H O O C . 
O- r G d " , V " " / ° inH 20, pH5 5 Ws) 
rf ^ H O O C ^ N J U C 0 O H 
H _ ° H ° H Q H 
H O ^ N ^ ^ V H O ^ V N Y ^ ( R T C O O H 
H O — o O H O ^ o 
[Gd'"L7]" S3 (L7) 
Scheme IV.12: The "long route" for functionalizing the glutamic carboxylate. 
Relaxometric measurements were performed on the TRIS dialkylated adduct 
[Gd"'L7]- and an r,p o f 7.7 mM"'s'' (T, = 158.1 ± 0.2 ms at 60 MHz, 37°C; [ G d 3 + ] I C p 
= 0.12 mg / mL) was observed, disappointingly similar to the value found for the 
parent complex [Gd l l l(Glu) 2(7?5:;-AAZTA] 3", with r,p was 7.5 m M 's"1 (20 MHz, 
25°C). 
Other amide derivatives o f L n M I A A Z T A glutarate complexes were prepared. 
Carbohydrate containing wedges were chosen as the bulky and hydrophilic 
substituents suitable to be attached to the lanthanide mono- and digluatarate A A Z T A 
chelate cores. In Scheme I V . 13 the carbohydrate wedge was coupled to the free 
carboxylic side arm function by amide bond formation, promoted by the coupling 
agent HBTU • BF 4 , using A^-methylmorpholine as base. 
141 
Chapter 4 
no HO 
Hfl V 
HO 
MO 
A O ^ HO 
2eq HO O HO 
NH 
HO HO O. .0 HO O H 20 
H O ^ H O 
HO 
HO HO 
0 HBTU BF„ r~H,0 
NMM 
HO 
DMSO H (S) 
N 0 
R 
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O 
Scheme IV.13: Coupling reaction of carbohydrate wedges to |Gd l u GIuAAZTA| . 
Both ytterbium and gadolinium adducts were prepared and purified by HPLC ( ' H 
N M R and ES-MS spectra are reported in the Appendix). Relaxometric measurements 
were performed on the analogue Gd 1 1 1 adduct, but a low relaxivity value of 3.36 mM" 
's'1 (at 20 MHz, 25 °C) was obtained. An r/p value o f 4.87 m M 's'1 was found for the 
compound at 60 MHz, 37 °C. 
An amide derivative o f [Gd H I(Glu)2(ftS^-AAZTA] 3" was also prepared, by using the 
same method previously described for [Yb'"(Gluco)GluAAZTA]": the primary amine 
was coupled to the glutaric carboxylate pendant arms of the Gd 1 1 1 complex (Scheme 
IV.14). 
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Scheme IV.14: Coupling reaction of carbohydrate wedges to IGd"'(Glu) Ir*5>AAZTA|. 
An ES-MS of [Gd U I L10] is shown in the Appendix. Fitting o f the VT l 7 0 N M R R2p 
profile shown in Figure IV.27 allowed an estimation o f the water exchange rate, and 
the value of rm was determined to be 205 ns. 
55 
45 
i • 
30 
2 5 H—•— i—•— i—•—i—•—i—•—i—•—i—•—i—•— i—• 
270 280 290 300 310 320 330 340 350 
Temp(K) 
Figure IV.27: n O NMR R2p IT profiles (600 MHz, pH 7) for |Gd'"(Gluco)2(Glu)2(WS>-
AAZTA)3". 
Relaxivity measurements on [Gd ! I IL10]~ gave an r i p value o f 15 mM"'s"' (at 60 MHz, 
37 °C). However, this value is in disagreement with the results obtained by our 
collaborators in University o f Torino, who measured a relaxivity o f 7.1 m M ' V 1 at 20 
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MHz, 25 °C. This last value is low with respect to the molecular weight o f the 
complex ( M W 1834), and making think o f a reduction in the hydration number from 
q = 2 to q = 1 after coupling o f the central diglutarate A A Z T A chelate to the bulky 
carbohydrate substituents. 7/7/ N M R D profiles were measured for the fGd u l L10]~ 
complex at 25 and 37 °C (Figure IV.28), and the fact that the relaxivity at 37 °C was 
lower than that at 25 °C indicates that there is not a kinetic limit to the relaxivity 
itself, and the rm is short enough not to limit this value. 
• 25 'C 
• 37 °C 
0.1 1 10 
Proton Larmor Frequency(MHz) 
Figure IV.28: 1/T, NMRD profiles for |Gd m L10T at 25 and 37 °C 
For purposes o f comparison, the 1/Ti N M R D profile o f [Gd L10J" at 25 °C is shown 
in Figure IV.29 with the 1/Tj N M R D profile o f a q = 2 system o f similar molecular 
weight prepared in the Bracco Imaging S.p.A. laboratories. 
The two amide derivatives o f Gd" 1 A A Z T A glutarated complexes present 7/7/ 
N M R D profiles of similar overall form. However, the lower relaxivity measured for 
[Gd m L10] - can only be explained by setting a value of q = 1 in the fitting. In Table 
IV.2 are reported the main parameters obtained from the fitting. 
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OH NMRD profile at 25 C 
20 OH 
H 18 
HO OH i h HO 
16- H N 
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•[Gd'"L10]~ 
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Figure IV.29: Comparison between ///', NMRD profile of |Gd l u L10r and that of a q = 2 Bracco 
Imaging S. p. A. compound (Bl) of similar molecular volume. 
r 1 p (20 MHz, 
298K) 
mM"V 
x m (ns) A V ) T V (S) XR(PS) q 
B1 13.3 1760 2.6x10 1 9 2.8x10"" 316 2 
[Gd'"L10r 7.1 205 7.05x10 1 9 2.12x10"11 167 1 
[Gd3*] have been determined by mneralization with HCI 37% at 120°C overnight. 
Table IV.2: Main parameters obtained from the fitting of 1/T, NMRD profile and VT ' 7 0 R2p 
profile of |Gd"'L10| and a q = 2 Bracco Imaging S. p. A. compound of similar molecular volume. 
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IV.6 Conclusions 
A series of lanthanide A A Z T A complexes with glutarate substituents has been 
prepared, and their magnetic properties have been defined. Measurement of the 
NMRD profiles has allowed an estimation of the relaxivity values at different 
magnetic field strengths and the fitting of the VT 1 7 0 R2p profiles afforded the water 
exchange rates at the paramagnetic centre o f each Gd" 1 complex. Gd 1" complexes o f 
the (RR), (RS) and the racemic- ligands were isolated and their Eu" 1 and Yb" 1 
analogues characterized by NMR. This allowed a measurement of the ratio of the 
individual complex (A / A) stereoisomers in solution. 
A difference exists between the water exchange rates measured for the different 
isomers: the fastest r,„ value is exhibited by the "diglutarated" A A Z T A derivative 
[Ln n i (Glu)2(7?5j-AAZTA] 3 "(r m = 243 ns, where r„,= \lkex). More precisely, this water 
exchange is given by the contribution of the r„, values o f the two complex 
stereoisomers constituent the [Ln'"(Glu)2(7?5^-AAZTA]3" system. Solving the 
simultaneous equations (as reported in section I V , X X ) related to the (i?5)-system 
allowed an evaluation of the contribution of the individual isomers to the observed 
water exchange rate. The more abundant isomer possesses a kex = 5.4 • 106 s"1, six 
times faster than the other, which shows a kex = 9.2 • 105 s"1. This noticeable 
difference among water exchange rates of complex stereoisomers suggested that 
further systems could be developed based upon this particular isomeric structure. 
However, the water exchange rate value found to be the fastest among these 
glutarated A A Z T A based systems does not seem so extraordinary when compared 
with other similar sized systems, for example the q = 1 (RRRR-SSSS) 
[Gd'"gDOTA)] 5", which exhibits a kex = 1.85- 107 s"1. 
The molecular volume of the faster water exchanging "diglutarated" [Ln'"(Glu)2(7?5y)-
A A Z T A ] 3 " and "monoglutarated" [Ln i n (Glu )AAZTA] 2 " complexes was increased by 
functionalization o f their free carboxylate pendant arms with carbohydrates 
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containing wedges. The relaxivity values measured for these amide derivatives were 
not as high as expected for systems o f such molecular volume ( M W 1834 and 1175 g 
/ mol, respectively). An explanation of this result is a decrease in the hydration 
number: the number of inner sphere water molecules decreases from q = 2 to q = 1 as 
the steric demand increases at the Ln" 1 centre. This increases from Eu 1" to Yb 1 ", and 
has been observed, very recently, in the analysis of the X-ray structures o f Eu"1 (q -
2) and Yb 1 " (q = 1) complexes of related A A Z T A complexes.1 5 Thus, the 
functionalization of the A A Z T A system with sterically demanding substituents may 
cause a change in the coordination sphere around the metal ion, hindering the access 
of a second water molecule to the lanthanide ion. 
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IV.7 Final Conclusions and Future Work 
The aim o f this research project has been the development o f new gadolinium chelates 
exhibiting good solubility, stability (thermodynamic and kinetic) and paramagnetic 
properties (i.e. relaxivity) which can make them possible candidates for future 
applications in diagnostic medicine as CAs for M R I . 
The challenge was to design innovative systems with superior performance compared 
to those already on the market. A t the outset, a gadolinium chelate possessing 
carbohydrate containing dendrons coupled to a GdgDOTA core was synthesized. The 
effective motional coupling obtained with this system, together wi th its relatively high 
molecular weight (-3400 gmol" 1) translated into a slower molecular tumbling (i.e. 
lower TR values) and therefore enhanced efficacy of the contrast agent at the magnetic 
fields typically used for M R I applications. An alternative strategy was investigated 
using a series o f new heptadentate ligands based on a 1,4-diazepine core structure. 
Phosphinate groups were attached to the endocyclic nitrogens, but the resultant di-
aqua complexes o f L n m ions were not sufficiently stable with respect to competitive 
anion coordination. Alternative structures using appended glutarate groups were 
synthesized in a stereocontrolled manner. However, although these systems were 
stable to added anions, the water exchange rate o f the Gd" 1 complexes was not 
sufficiently fast to allow their exploitation in higher molecular weight derivatives. 
Significant differences in water exchange rate were identified for particular 
stereoisomeric complexes, suggesting that caution needs to be exercised to consider 
this issue in designing such systems. Future strategies to develop high relaxivity di-
aqua systems require a di-aqua binding site that is further away f rom the site o f ligand 
functionalization (to increase molecular volume), without compromising motional 
coupling. Such a system has been achieved, o f course, for a mono-aqua system, as 
described in Chapter 2. 
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Experimental 
Chapter 5 
Experimental Methods 
5.1 Experimental Details 
A l l reagents were used as supplied by commercial sources unless otherwise stated. 
Solvents were dried over the appropriate drying agents when required. Water and 
H 2 0 refer to high purity water with conductivity < 0.04 uScm"', obtained from the 
"PuritesTiLL Plus" purification system. 
Reactions requiring anhydrous conditions were carried out using Schlenk-line 
techniques under an atmosphere o f dry argon. Anhydrous solvents when required 
were freshly distilled over the appropriate drying agent as indicated below: 
dichloromethane and triethylamine were dried over calcium hydride; N,N-
dimethylformamide over molecular sieves; nitromethane was dried over calcium 
chloride and left to stand over molecular sieves; THF, methanol, acetonitrile were 
used as received from the solvent purification system "Pure Solv". 
A l l pH measurements were performed using a Jenway 3320 pH meter attached to an 
Aldrich Chemical Company micro-pH combination electrode, calibrated using pH 
4, 7 and 10 buffer solutions. 
Chromatography 
Thin-layer chromatography was carried out on silica plates (Merck 5554) and 
visualised under UV light (254 nm) or by washing in a bath o f ethanol/sulphuric acid 
5% or permanganate or by staining with iodine. Preparative column chromatography 
was performed using neutral aluminium oxide (Merck Aluminium Oxide 90, activity 
II—III, 70-230 mesh) washed in ethyl acetate, or silica (Merck Silica Gel 60, 230-
400 mesh). 
Gel filtration chromatography (GPC): used a P6 Biogel stationary phase, eluting 
with water, 0.7 mL/min. 
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The HPLC analysis and separation was carried out on a Perkin Elmer system 
comprising a Perkin Elmer Series 200 Pump, Perkin Elmer Series 200 Autosampler, 
Perkin Elmer Series 200 Fluorescence detector. GILSON-FC203B fraction collector 
was used in separation procedures. The stationary phase was a Phenomenex Synergi 
4[i Fusion-RP 80, and the size of the column used was 150x4.6 mm (f low rate 
lmL/min). The methods used are described below. 
Chromatographic method A1 (HPLC) 
Perkin Elmer Series 200 Pump 
Perkin Elmer Series 200 Autosampler 
Perkin Elmer Series 200 Diode array detector 
Column: Phenomenex Synergi 4u Fusion-RP 80 
Column dimensions: 150*4.6 mm 
Particle size: 4 (j,m 
Flow rate: 1 ml/min 
Detection (UV) : 210 nm, 254 nm. 
Injection volume: 100 uJ 
Mobile phase: 
A: H 2 0 
B: Acetonitrile 
Programme A 1 : 
Time (min) Solvent A (%) Solvent B (%) Gradient 
0 100 0 0 
10 100 0 0 
20 0 100 1 
22 0 100 0 
24 100 0 -3 
28 100 0 0 
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Chromatographic method A-2 (HPLC) 
Stationary phase: Lichrosorb 60 RP-Select B 5 \im 
75 x 4 mm column packed by Merck KGaA 
Temperature: 45 °C 
Mobile phase: gradient elution 
A = 0.01 M K H 2 P 0 4 and 0.017 M H3PO4 in water 
Gradient timetable: 
Flow rate: 
Detection (UV): 
Injection: 
Sample cone: 
Instrumentation 
B = CH 3 CN 
min % A % B 
0 95 5 
15 20 80 
20 20 80 
1 mL min"1 
210 run 
10 uL 
1 mg mL"1 
VWR Elite LaChrom- Hitachi high pressure gradient pump 
system (L-2100), V W R Elite LaChrom - Hitachi L-2200 
autosampler, VWR Elite LaChrom - Hitachi L 2300 column 
oven, VWR Elite LaChrom - Hitachi L 2400 UV detector 
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Spectroscopy 
'H and 1 3 C N M R spectra were recorded on a Varian Unity-300 spectrometer (*H at 
299.908 MHz, 1 3 C at 75.412 MHz), Varian V X R 400 ( ] H at 399.968 MHz, 1 3 C at 
100.572 MHz), Bruker A M X 500 spectrometer or Varian Unity-700 spectrometer 
( 'H at 699.73 MHz). Spectra were referenced internally to the residual proton-
solvent resonances and are reported in ppm relative to TMS, with coupling constants 
in Hz (typically ±0.4 Hz). 
Electrospray mass spectra were recorded on a VG Platform I I (Fisons Instruments), 
operating in positive or negative ion mode, with methanol as the carrier solvent. 
Accurate masses were recorded on a Thermo Finnigan LTQ instrument. 
Luminescence spectra of the Eu 1" complexes were recorded using a direct excitation 
of the Eu" 1 ion at 255 nm or 397 run. 
Lifetime measurements o f the Eu" 1 complex were recorded on a Perkin Elmer LS55 
luminescence spectrometer using FL Winlab software. The Eu 1 1 1 ion was excited 
directly at 255 nm or 397 nm, with an excitation slit width o f 10 nm. Lifetime values 
were measured following excitation o f the sample by a short pulse o f light, 
monitoring the integrated intensity o f light (613 nm for europium) emitted during a 
fixed gate time, t g , a delay time, td, later. A gate time of 0.1 ms was used. The data 
obtained fol low an exponential decay: 
I = A 0e' .(-kt) 
where 
A 0 
k 
= intensity at time t after the flash 
= a pre-exponential factor 
= rate constant for the decay of the excited state 
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A linear form of the relationship was obtained: 
In I = In Ao- kt 
The data were fitted with this equation in Microsoft Excel. The excited state 
lifetime, x, is the inverse o f the rate constant, k. 
'tn 
t 
Time 
Figure 1: Measured parameters for lifetime measurement. 
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Experimental Procedures 
N-(Benzyloxycarbonyl)tris(hydroxymethyl)methylamine (1) 
HO 
HO H 
N 
T 
HO 
1 
Ph 
Benzyloxycarbonyl chloride (12 mL, 0.084 mol) was added dropwise over 0.5 h to a 
stirred solution o f TRIS (6.7 g, 0.056 mol) in H 2 0 (30 mL) cooled at 0 °C. The pH 
of the medium was maintained at 8-10 by addition of Na2CC>3. After 1 h o f stirring at 
0°C, the reaction was allowed to warm to room temperature and left to stir overnight. 
The white slurry was filtered, washed with H 2 0 (2x30 mL) and dried for one day 
under high vacuum. The solid was ground up with a spatula, the water still present 
was removed by azeotropic evaporation with toluene (2 x 200 mL) and the white 
powder obtained was dried under high vacuum to afford the product (3.1g, 22%). Rf 
(CHC1 3 / MeOH 9:1, S i0 2 ) = 0.84 (UV) . M.p. - 102 - 104 °C (lit. 102-104 °C).' SH 
(CDCI3, 300 MHz) : 3.71 (6H, s, 3xCH 2 ) , 5.10 (2H, s, 0-C// 2-Ph), 5.77 (1H, br s, 
NH), 7.36 (5H, m, Ph-H). £ C ( C D C 1 3 , 75.41 MHz): 61.7 (C(quat)), 63.0 (CCH 2 ) , 67.0 
(CH 2Ph), 128.9, 129.0, 129.5, 138.2 (Ph ring carbons), 157.4 (CO). ES-MS: m/z 256 
[M+ H ] + . 
1,2,3,4,6-Penta-O-benzoyl-a-D-glucopyranose2 (2) 
Benzoyl chloride (18 mL, 0.15 mol) was added dropwise to a suspension of glucose 
(5.0 g, 0.027 mol) in pyridine (95 mL) at 0 °C. The reaction mixture was stirred 
overnight at room temperature and then washed with H 2 0 (400 mL) and left to stand 
- ^ \ - 0 0 BzO 
£ 5 
BzO 
BzO OBz 
2 
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for 1 h. The white precipitate was filtered, washed with HC1 (0.2 M , 500 mL) and 
recrystallized from a mixture of Me2CO (120 mL) and MeOH (350 mL). The solid 
obtained was filtered and washed with MeOH (2 x 20 mL) to afford a white solid 
(13.1 g, 67%). R f (EtOAc/ Hex 3:7, S i0 2 ) = 0.38 (UV). M.p. 180- 184 °C (lit. 184 -
186 °C). 2 c 5 H C D C l 3 , 300 MHz): 4.51 (1H, dd, J = 4.5, 12.6, H-5), 4.65 (2H, dd, J = 
1.8, 9.3, H-6), 5.71 (1H, dd, J = 3.7, 10.0, H-2), 5.89 (1H, t, J = 10.0, H-4), 6.35 (1H, 
t, J = 10.0, H-3), 6.9 (1H, d, J = 3.7, H - l ) , 7.28 - 7.75 (15H, m, Ph-H), 7.89 - 8.21 
(10H, m, Ph-H). <5b(CDCl3, 75.41 MHz): 62.6 (C-6), 67.1 (C-4), 69.0 (C-2), 70.7 
(C-5), 90.3 (C-3), 95.1 (C- l ) , 128.3 - 130.3 (Ph ring carbons), 133.4, 133.6, 133.8, 
134.2 (Ph ring carbons), 164.6, 165.4, 165.6, 166.1, 166.3 (COPh). ES-MS: m/z 724 
[ M + N a ] + . 
2,3,4,6-Tetra-O-benzoyl-a-D-glucopyranosyl bromide 2 (3) 
1,2,3,4,6-Penta-O-benzoyl-a-D-glucopyranose (13.1 g, 0.018 mol) was dissolved in 
freshly distilled CH 2 C1 2 (20 mL) and treated with 33% HBr in CH 3 COOH (20 mL). 
After standing for 1.5 h at room temperature, the reaction mixture was diluted with 
CH 2 C1 2 (100 mL) and washed successively with a saturated solution o f aqueous 
NaHC03 (3 x 100 mL) and with H 2 0 (100 mL). The organic phase was dried over 
Na2S04 and concentrated in vacuo to afford a light yellow solid (11.6 g, 0.017 mol). 
The product was recrystallized from a mixture o f E t 2 0 (30 mL) and petroleum ether 
(12 mL) and left to stand for 0.5 h. The white precipitate was filtered and washed 
with petroleum ether to afford a white crystalline solid (9.37 g, 79%). Rf (EtOAc / 
Hex 3:7, S i0 2 ) = 0.66 (UV). M.p. 127 - 130 °C (lit. 129-130 °C). 2 & ( C D C 1 3 , 300 
MHz): 4.54 (1H, dd, J = 4.5, 12.3, H-5), 4.66 - 4.78 (2H, m, H-6), 5.34 (1H, dd, J = 
4.0, 10.0, H-2), 5.84 (1H, t, J = 10.0, H4), 6.28 (1H, t, J = 10.0, H3), 6.88 (1H, d, J = 
4.0, H I ) , 7.27 - 7.62 (15H, m, Ph-H), 7.88 - 8.10 (10H, m, Ph-H). £ C ( C D C 1 3 , 75.41 
BzO 
BzO 
BzO Br 
BzO 
3 
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MHz): 62.2 (C-6), 68.2 (C-4), 70.8 (C-2), 71.7 (C-5), 72.9 (C-3), 87.1 (C- l ) , 128.6 -
130.3 (Ph ring carbons), 133.5, 133.6, 133.9, 134.1 (4 x Ph ring carbons), 165.3, 
165.6, 165.8, 166.3 (COPh). ES-MS: m/z 672 ( M + Na) + . 
A^-(Benzyloxycarbonyl)tris(2,3,4,6-tetra-0-benzoyl-/ff-D-
glucopyranosyloxymethyl)-methylamine (4) 
AgOTf (0.690 g, 2.654 mmol) was activated by dissolving in anhydrous toluene (10 
mL) and the solvent was removed under vacuum. This procedure was repeated a 
further two times. A mixture o f 1 (0.171 g, 0.67 mmol), AgOTf and 2,4,6-collidine 
(0.255 ml, 1.93 mmol) in CH 2 C1 2 (5 mL) and M e N 0 2 (5 mL) was stirred at -30 °C 
under an argon atmosphere. A solution o f 2,3,4,6-tetra-O-benzoyl-a-D-
glucopyranosyl bromide, 3, (1.4 g, 2.12 mmol) in CH2CI2 (5 mL) was added 
dropwise over 20 min to the reaction mixture, which was stirred for 30 min at the 
same temperature, then for 2 h at 0 °C and finally left stirring overnight at room 
temperature. After completion of the reaction (TLC), C5H5N (1.0 mL) was added to 
the reaction mixture, which was left to stir for 30 min and then diluted with CH2CI2 
(20 mL), before being filtered through Celite. The filtrate was washed successively 
with aqueous Na2S203 solution (1 M , 2 x 50 mL), aqueous HC1 solution (0.1 M , 2 x 
50 mL), saturated aqueous NaHC0 3 solution (2x50 mL) and H 2 0 (2x50 mL). The 
organic phase was dried over Na2S04 and the solvent was removed in vacuo, to 
BzO 
BzO O 
BzO-BzO ^ O 
OK - v \ - 0 BzO BzO N Ph 
BzO H 
D < ^ O E 
BzO 
OBz BzO 
BzO, 
BzO 
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afford crude product (2.20 g), the TLC of which showed a main product (R f 
(EtOAc/Hex 3:7) = 0.11; H2SO4), in addition to a few other minor components (Rf = 
0.28, 0.48; H 2 S 0 4 ) . The main product was separated by column chromatography 
(Si0 2 , EtOAc / Hex, 3:7) to yield the product (0.600 g, 45%) as a white foamy solid. 
R f (EtOAc / Hex 1:1, S i0 2 ) = 0.49 (UV, H 2 S0 4 ) . £ W ( C D C 1 3 , 500 MHz): 3.55-3.61 
(6H, m, C ( q u a t ) C / / a ) , 4.03 (3H, d, 2 J C H a , C H b = 8.0, C(qual)CHb), 4.31 (3H, d, 3J,, 2 = 10.5, 
H - l ) , 4.37 (3H, dd, 3 J 5 , 6 a = 6.0, 2 J 6 a > 6 b = 12.0, H-6a), 4.56 (3H, dd, 3 J 5 , 6 b = 2.5 2 J 6 a , 6 b = 
12.0, H-6b), 4.80 (1H, d, 2 J H a ,Hb = 12.0, CHbPh), 4.86 (1H, d, 2 J H a , H b = 12.0, C// aPh), 
5.36 (3H, dd, 3 J, , 2 = 8.0, 3 J 2 > 3 = 9.5, H-2), 5.50 (3H, app. t, 3 J 3 , 4 ~ 3 J 4 , 5 = 9.5, H-4), 
5.65 (3H, app. t, 3 J 2 , 3 ~ 3 J 3 , 4 = 9.5, H-3), 7.29 - 8.12 (65H, br.m., Ph-H). <5b(CDCl3, 
125.68 MHz): 59.15 ( C ( q u a l ) ) , 60.66 (C-6), 63.35 (CH 2Ph), 68.77 ( C ( q u a t ) C H 2 ) , 69.76 
(C-4), 72.08 (C-5), 72.18 (C-2), 72.79 (C-3), 101.79 (C- l ) , 128.45 - 130.34 (Ph ring 
carbons), 155.15 (urethane CO), 164.94, 165.53, 165.98, 166.40 (COPh). ES-MS: 
w/z2014 [M+Na] + . 
A/-(Benzyloxycarbonyl)tris(>3-D-glucopyranosyloxymethyI)methylamine (5) 
HO 
OhT-
HO 
HO O 
O X) 0 ^ HO H - - -v \ - - -0 O O N HO T HO 
OH O 
O HO O - ^ / p ^ 
5 
A solution of 4 (0.600 g, 0.301 mmol) in methanolic NaOMe (0.1 M , 20 mL) was 
stirred at room temperature for 6 h, then neutralized with Amberlite IR-120(H + 
form) ion-exchange resin and filtered. The solvents were removed in vacuo and the 
resulting white powder was partitioned between H 2 0 (20 mL) and E t 2 0 (15 mL). 
The aqueous layer was washed with further E t 2 0 (3 x 15 mL) and then freeze-dried 
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to obtain 5 as a colourless glass (0.22 g, 98%). R f (EtOAc / Hex 1:1, S i0 2 ) = 0.05 
(UV, H 2 S0 4 ) . <5w(D20, 300 MHz): 3.08 (3H, 3J,, 2 = 8.7, 3J 2 > 3 = 7.5, H-2), 3.18 - 3.22 
(6H, br. m, H-4 and H-5), 3.25 (3H, app.t, 3J 2, 3 = 9.3, H-3), 3.47 (3H, br.d, 2J 6 a,6b = 
12.3, H-6a), 3.70 (3H, br.d, 2 J 6 a , 6 b = 12.3, H-6b), 3.98 (3H, d, 2JHa,Hb = 10.5, 
C ( q uat)CH a / / 6 ) , 4.20 (3H, d, 3 J 1 > 2 = 7.5, H - l ) , 4.88 (2H, s, C/fcPh), 7.23 (5H, s, Ph). 8C 
( D 2 0 , 75.41 MHz): 58.79 ( C ( q u a t ) ) , 60.8 (C-6), 66.86 (CH 2Ph), 67.95 (C ( q u a t ) CH 2 ) , 
69.72 (C-4), 73.16 (C-2), 75.60 (C-3), 75.96 (C-5), 103.12 (C- l ) , 128.00, 128.58, 
128.93 (Ph ring carbons), 156.76 (urethane CO). ES-MS: m/z 742 [ M + H ] + . 
Tris-(/^D-glucopyranosyloxymethyl)-methylamine (6) 
A suspension of 5 (0.22 g. 0.296 mmol) in H 2 0 / EtOH (10 mL, 1:1) and 20% 
Pd(OH) 2/C (0.05 g) was hydrogenolysed overnight using a Parr hydrogenator (40 psi 
H 2 ) . The reaction mixture was filtered over Celite, the solvent was evaporated in 
vacuo and the residue was dissolved in H 2 0 (15 mL) and freeze-dried to afford a 
white powder (0.196 g, 100%). ^ / ( D 2 0 , 400 MHz): 3.14 (3H, dd, J = 8.0, 9.0, H-2), 
3.19 (3H, app. t, J = 9.0, H-4), 3.26 - 3.29 (3H, m, H-5), 3.32 (3H, app.t, J = 9.0, H-
3), 3.54 (3H, dd, J = 6, 12.5, H-6a), 3.58 (3H, d, J = 11.2, C / / 2 C ( q u a l ) ) , 3.74 (3H, dd, J 
= 2, 12.5, H-6b), 3.83 (3H, dd, J = 10.4, C ( q u a t ) C H a H b ) , 4.29 (3H, d, J = 8.0, H - l ) . 5C 
( D 2 0 , 100.57 MHz): 59.0 ( C ( q u a t ) ) , 60.75 (C-6), 69.75 (C 4 & C 7 ) , 73.17 (C-2), 75.57 
(C-3), 76.02 (C-5), 102.93 (C- l ) . ES-MS: m/z 608 [ M + H ] + . 
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Af-(Benzyloxycarbonyl)-Ar-[tris(hydroxymethyl)methyl]glycinamide (7) 
Hydroxybenzotriazole (1.35 g, 9.99 mmol) was added to a solution of 
carbobenzyloxyglycine (2.00 g, 9.56 mmol) and 1,3-dicyclohexylcarbodiimide (2.06 
g, 9.98 mmol) in D M F (20 mL). When all reagents were dissolved, TRIS (2.32 g, 
19.15 mmol) was added. The reaction mixture was stirred overnight at room 
temperature, under an atmosphere o f argon. After completion o f the reaction (TLC), 
DMF was removed under vacuum and the white solid obtained was dissolved in 
EtOH (20 mL). The white slurry was filtered and the filtrate evaporated to dryness. 
The product was purified by column chromatography (SiO"2, CH2CI2 / MeOH 1%—» 
CH2CI2 / MeOH 5%) to yield a white solid (0.86 g, 28%). R f (CH 2 C1 2 / MeOH 1%, 
Si0 2 ) = 0.4 (UV, H 2 S0 4 ) . J w (DMSO, 300 MHz): 3.51 (6H, d, J = 6, CH2OH ), 3.62 
(2H, d, J = 6, C / / 2 NH) , 4.69 (3H, t, J = 6, 3 * OH), 5.02 (2H, s, C/ftPh), 7.13 (5H, 
bs, Ph-H), 7.32 (1H, s, C(quat)N//), 7.44 (1H, m, CH 2 N/ / ) . <5b(DMSO, 75.41 MHz): 
44.19 ( C H 2 N H C O ) , 61.04 (CH 2 OH), 62.44 (CH2C(quat)), 66.81 (CH 2Ph), 127.74, 
127.96, 128.39 (Ph-C), 136.90 (Ph-C(quat)), 158.05 (COCH 2 NH), 171.63 
HO H 
9- X N T > 0 HO H O HO 
7 
(COOCH 2Ph). ES-MS: m/z 335 [M+ Na ] + , 647 [2*M+ Na] + . 
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A'a-(Benzyloxycarbonyl)-A^-[Tris(2,3,4,6-tetra-0-benzoyl-/?-D-
glucopyranosyloxymethyl)methyl]glycinamide (8) 
BzO 
BzO-
BzO 0 ^ 
-\ 
BzO—1 
BzO- \ ^ - \ ^ - 0 
BzO 
B z O " 
8 
AgOTf (0.50 g, 1.94 mmol) was activated by dissolving in anhydrous toluene (10 
mL) and the solvent was removed under vacuum. This procedure was repeated a 
further two times. A mixture of 7 (0.147 g, 0.471 mmol), AgOTf and 2,4,6-collidine 
(0.19 mL, 1.44 mmol) in CH 2 C1 2 (4.4 mL) and M e N 0 2 (4.4 mL) was stirred at -30 
°C. A solution of 2,3,4,6-tetra-O-benzoyl-a-D-glucopyranosyl bromide, 3, (1.10 g, 
1.67 mmol) in CH 2 C1 2 (4.4 mL) was added dropwise over 20 min to this suspension. 
Stirring was continued for 30 min at the same temperature and then the reaction 
mixture was stirred for 2 h at 0 C, the n overnight at room temperature. After 
completion o f the reaction (TLC), C5H5N (1.0 mL) was added to the reaction 
mixture, which was left to stir for 30 min and then diluted with CH 2 C1 2 (20 mL) 
before being filtered through Celite. The filtrate was washed successively with 
aqueous Na 2 S 2 03 solution (1 M , 2 x 50 mL), aqueous HC1 solution (0.1 M , 2 x 50 
mL), saturated aqueous NaHC03 solution (2 x 50 mL) and H 2 0 (2 x 50 mL). The 
organic phase was dried over Na 2S04 and the solvent was removed in vacuo to 
afford crude product, the TLC of which showed a main product (Rf (EtOAc / Hex 
3:7) = 0.2; H 2 S 0 4 ) and a few other minor components ( R f = 0.46, 0.51; H 2 S0 4 ) . The 
main product was separated by column chromatography (S i0 2 , EtOAc / Hex, 3:7) to 
afford the product as a white foamy solid (0.47 g, 49%). R f (EtOAc / Hex 4:6, S i0 2 ) 
= 0.30 (UV, H 2 S0 4 ) . SH (CDCI3 , 300 MHz): 3.50 (3H, d, 2 J C Ha,CHb = 10.2, 
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C(quat)C/4), 3.60 - 3.70 (5H, m, H-5), 4.16 (3H, d, 3 J 1 > 2 = 9.0, H - l ) , 4.24 (3H, d, 
2J CHa,CHb = 10.2, C ( q u a t ) C / / 6 ) , 4.38 (3H, dd, 3J 5,6a = 4.5, 2 J 6 a , 6 b = 12.0, H-6a), 4.54 (3H, 
app.d, 2 J 6 a , 6 b = 12.0, H-6b), 5.18 (2H, s, C// 2Ph), 5.35 (4H, app.t, 3J,, 2 ~ 3 J 2 , 3 = 8.5, H-
2 and C/ / 2 NH) , 5.55 (3H, app. t, 3 J 3 , 4 ~ 3 J 4 > 5 = 9.6, H-4), 5.69 (3H, app. t, 3 J 2 ; 3 ~ 3 J 3 , 4 
= 9.6, H-3), 6.01 (1H, s, N//carbamate), 7.28 - 8.06 (60H, m, Ph-//). Sc (CDC1 3, 
75.41 MHz) : 58.37 ( C ( q u a t ) ) , 59.26 (CH 2 NHCO), 61.91 (C-6), 65.89 (CH 2Ph), 66.86 
(C ( q u a l ) CH 2 ) , 68.54 (C-4), 70.92 (C-5), 70.97 (C-2), 71.50 (C-3), 100.29 (C- l ) , 127.26 
- 128.87 (Ph ring carbons), 132.13 (PhC ( ,„ a 0), 164.04 (COCH 2 NH), 165.01 
(COOCH 2Ph). ES-MS: m/z 2071 [ A / + N a ] + , 4119 [2><A/+Na] +; (Found: [ M + N a ] + , 
2070.6128. C , ,6H98N 2033 requires [ M + Na] + , 2070.5984). 
A^-(Benzyloxycarbonyl)-/V-[trisO0-D-glucopyranosyloxymethyl)-
methyl]glycinamide 
A solution o f 8 (0.47 g, 0.23 mmol) in 0.10 M methanolic NaOMe (20 mL) was 
stirred at room temperature overnight. It was then neutralized with Amberlite IR-
120(PLUS) ion-exchange resin, filtered and the solvents were removed in vacuo. 
The solvents were removed in vacuo and the resulting white powder was partitioned 
between H 2 0 (20 mL) and E t 2 0 (15 mL). The aqueous layer was washed with 
further E t 2 0 ( 3 * 1 5 mL) and then freeze-dried to obtain 9 (0.16 g, 87%). R f (CHCI 3 
/ MeOH / H 2 0 6:4:1, S i0 2 ) = 0.45 (UV, H 2 S0 4 ) . SH ( D 2 0 , 500 MHz): 3.11 (3H, app. 
t, H-2), 3.19 - 3.32 (9H, m, H-3, H-4, H-5), 3.55 (3H, dd, 3 J 5 i 6 a = 5.5 , 2 J 6 a.6b= 12.0, 
H-6a) 3.66 (2H, s, C/ / 2 NHCO), 3.74 (3H, dd, H-5, 3J 5,6b = 2, 2 J 6 a , 6 b = 12.0, H-6b), 
HO 
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3.78 (3H, d, 2 J C Ha,CHb = 10.5, C(quat)C// f l), 4.08 (3H, d, 2 J C Ha,CHb = 10.5, C(quat)Ctf 6), 
4.28 (3H, d, 3J,, 2 = 8.0, H - l ) , 5.00 (2H, s, CH 2Ph), 7.29 (5H, m, Ph-H). Sc ( D 2 0 , 
125.67 MHz) : 44.1 (Gly-CH 2 ) , 59.1 (C(quat)), 60.8 (C-6), 67.6 (CH 2Ph), 67.7 
(C(quat)CH2), 69.8 (C-4), 73.2 (C-2), 75.6 (C-3), 76.1 (C-5), 103.1 (C- l ) , 127.9 -
128.6 - 128.1 (Ph ring carbons), 157.8 (COCH 2 NH), 172.2 (Gly-CO). ES-MS: m/z 
821 [ M + N a ] + , 1619 [ 2 * M + N a ] + . (Found: [ M + N a ] + , 820.9684 C 3 2H5 0 N 2 O 2 , 2 3 Na, 
820.9682). 
A^-ITris^D-glucopyranosyloxymethyOmethyllglycinamide (10) 
A suspension o f 9 (0.47 g. 0.23 mmol) in 10 mL of H 2 0 / EtOH (1:1) and Pd(OH) 2/C 
(0.17 g) was hydrogenolysed overnight using a hydrogenator (40 psi H 2 ) . The 
reaction mixture was filtered over Celite, the solvent was evaporated under reduced 
pressure and the residue was dissolved in H 2 0 (15 mL) and freeze-dried, to afford a 
white powder (0.146 g, 96%). SH(D20, 500 MHz): 3.14 (3H, app. t, 3 J, , 2 = 8.0, H-2), 
3.22 (3H, app. t, 3 J 3 , 4 = 9.5, H-4), 3.28 - 3.34 (8H, m, H-3, H-5, C / / 2 N H 2 ) , 3.55 (3H, 
d , 2 J 6 a , 6 b = 12.5, H-6a), 3.76 (3H, d, 2 J 6 a , 6 b = 12.5, H-6b), 3.79 (3H, d, 2 W n b = 10.0, 
C(quat)C//a), 4.12 (3H, d, 2JCna,cnb = 10.0, C(quat)C//6), 4.31 (3H, d, 3 J , , 2 = 8.0, H - l ) . 
Sc ( D 2 0 , 125.67 MHz): 42.93 (Gly-CH 2 ) , 57.56 (C(quat)), 60.82 (C-6), 67.76 
(C(quat)CH2), 69.79 (C-4), 73.17 (C-2), 75.66 (C-3), 76.07 (C-5), 100.12 (C- l ) , 
172.30 (CONH). ES-MS: m/z 687 [M + Na] + , 1351 [2*Af + Na] + . (Found: [ M + H ] + , 
HO 
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665.2614. C 24H450 I 9N2 requires [ M + H ] + , 665.2611; [ M + Na] + , 687.2438. 
C 24H440| 9N2 2 3Na, requires [ M + Na] + , 687.2430). 
Tetraamide Dendrimer (11) 
To a suspension of GdgDOTA (15 mg, 0.017mmol) in TV-methylmorpholine (0.012 
mL, 0.11 |amol) and DMF (0.82 mL) was added O-benzotriazol-l-yl-N, N, N\ N'-
tetramethyluronium tetrafluoroborate (40 mg, 0.12 mmol) and the mixture allowed 
to stir for a few minutes. A solution o f the amine 10 (70 mg, 0.13 mmol) was added 
to the reaction and the mixture allowed to stir overnight at 40 °C, under an 
atmosphere of dry argon. The reaction was partitioned between water (10 mL) and 
CH 2 C1 2 (10 mL). The aqueous layer was washed with CH 2 C1 2 (10 mL) and freeze-
dried. The crude o f the reaction is a mixture of the ful ly substituted tetraamide 
(major product) and the under-substituted triamide and diamide (minor products). 
Purification by gel-filtration chromatography afforded the pure product (19 mg, 
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32%), as confirmed by electrospray analysis. ES-MS: [ M ] 2 " = 1715.07, [ M ] 3 " = 
1143.04 (tetraamide product). 
1/7 / NMRD and V T n O NMR Rip analysis 
A solution of the Gd'"-complex (0.016 g, 4.6 umol) in water (25 mL) was prepared. 
The concentration of Gd" 1 in the sample was assessed by ICP-optical emission 
spectroscopy, and was found to be: [Gd 1 1 1] = 0.15 mM. Relaxivity value found by 
MTi N M R D analysis: r , p = 19.6 m M 's"1 (298 K, pH 7, 20 MHz). Fitting o f the 1/7/ 
N M R D profile gave estimated TR = 318 ns. 
The concentration of Gd 1" in the sample prepared for the V T l 7 0 N M R R2p analysis, 
assessed by ICP-optical emission spectroscopy: [Gd 1 1 1] = 6.0 m M . Fitting of the 1 7 0 
NMR R2p data gave rM = 221 ns. 
(Af'-/e/-/-Butoxycarbonyl-A?-methoxycarbonylmethyl-hydrazino)-acetic acid 
methyl ester (12) 
To a stirred solution of /-butylcarbazate (0.50 g, 3.67 mmol) in DMF (10 mL), 
methylbromoacetate (1.40 mL, 14.80 mmol) and K 2 C 0 3 (2.04 g, 14.80 mmol) were 
added dropwise, and the reaction mixture was stirred at 40 °C, under an argon 
atmosphere. The progress o f the reaction was monitored by TLC, and after 48 h the 
solvent was removed under reduced pressure. Extraction o f the residue in H2O / 
CH2CI2 (2><10 mL) followed by purification of the crude of reaction by column 
chromatography (Si0 2 , Hex / EtOAc 5 % —> 20 % ) gave the product as a brown 
coloured gum (0.44 g, 43 % ) . R f (Hex / EtOAc 20%, S i0 2 ) = 0.35 (Permanganate). 
OMe MeO 
OHN' O 
>=° 
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12 
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SH(CDC\3, 300 MHz) : 1.34 (9H, s, C(Ctf , ) 3 ) , 3.63 (6H, s, 2 x OCH3), 3.72 (4H, br 
d, C/ / 2 N), 6.75 (1H, br s, N t f ) . 6c ( D 2 0 , 100.61 MHz): 28.36 (C(CH 3 ) 3 ) , 51.87 
(OCH 3 ), 52.67 (CH 2 CO), 57.09 (C(CH 3 ) 3 , 156.49, 171.66 (C=0). ES-MS: m/z 276 
[ M ] + , 299 [M+Na] + . (Found: [ M ] + , 275.9975. C , , H 2 0 N 2 O 6 requires [ M ] + , 275.9985). 
(A^'-fcr/rButoxycarbonyl-N-methoxycarbonylmethyl-hydrazino)-acetic acid (13) 
The ester, 12 (0.44 g, 1.59 mmol), was dissolved in MeOH (5 mL), and 5 mL of 1 M 
aq KOH was slowly added. After 7 h stirring at room temperature, the solution was 
acidified to pH 4.5 with 1M HC1 and extracted with EtOAc ( 2 x 5 m L ) . The solvent 
was removed under reduced pressure and a white powder was obtained as the 
product o f reaction (0.38 g, 97%). SH (CDC1 3, 400 MHz): 1.43 (9H, s, C(CH3)3), 
3.71 (4H, s, 2 x C / / 2 C O O H ) , 5.42 (1H, br s, N # ) . <5c(CD3CN, 100.61 MHz): 27.12 
(C(CH 3 ) 3 , 29.59 (C(CH 3 ) 3 ) , 58.37 (2 x CH 2 COOH), 170.59 ( C O ) , 206.27 (C=0). 
ES-MS: m/z 271 [M+Na] + . 
terf-Butoxycarbonyl-5-bromo-pentanoate3 (14) 
5-Bromovaleric acid (18.32 g, 0.10 mol) was dissolved in CH 2 C1 2 (50 mL) and 
oxalyl chloride (25 ml, 0.286 mol) was added. The resulting yellow solution was 
HO 
O HN o 
O 
OH 
13 
0 
/BuO Br 
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stirred at room temperature for 3 h. Excess acid chloride was removed by 
distillation, the reaction mixture was washed with CH2CI2 (4 x 50 mL) and a mixture 
consisting of pyridine (4.6 mL, 0.057 mol), /-butyl alcohol (6.4 ml, 0.069 mol) in (5 
mL) was slowly added, at -78°C. The reaction mixture was allowed to warm to room 
temperature whilst stirring overnight under an argon atmosphere. The crude product 
was purified by column chromatography to remove any pyridinium salts (S i0 2 , 10% 
ethyl acetate in hexane —» 50% EtOAc in Hex), to yield a yellow oi l , 14 (20.0 g, 85 
% ) . £/y(CDCl 3 , 400 MHz): 1.31 (9H, s, C ( C t f j ) 3 ) , 1.66 (2H, m, CH2), 1.82 (2H, m, 
CH2), 2.18 (2H, t, CH2CO, J = 7.7), 3.34 (2H, t, C// 2 Br, J = 6.8). <5b(CDCl3, 100.61 
MHz): 23.74 (CH 2 ) , 28.19 (CH 3 ) , 32.11 (CH 2 ) , 33.25 (CH 2 Br), 34.56 (CH 2CO), 
80.23 ( ( Q q u a t ) ) , 172.40 (C=0). ES-MS: m/z 259.0 [ 7 9 Br M + N a ] + , 261.1 [ 8 l B r M + 
Na] + . (Found: [M+Na] + , 258.0213, C 9 H 1 6 0 2 BrNarequires [M+Na] + , 258.0231). 
7e/7-butyl-5-(diethoxy-phosphonyl)-pentanoate (15) 
14 (8.10 g, 0.027 mol) was dissolved in triethylphosphite (25 mL) and heated at 
reflux for 18 h under an argon atmosphere. The crude product was distilled under 
reduced pressure (78 °C, 1.0 mmHg) to yield 15 as a clear oil (7.0 g, 89 % ) . SH 
(CDC1 3, 400 MHz): 1.22 (6H, t, O C H 2 C / / j , J = 7.2), 1.33 (9H, s, C(C/ / j ) 3 ) , 1.53 
(6H, m, CH2), 2.12 (2H, t, CH2CO, J = 7.6), 3.98 (4H, m, CH20?). <5b(CDCl3, 125.6 
MHz): 16.61 (POCH 2 CH 3 ) , 24.14 (CH 2 ) , 25.86 (CH 2 ) , 26.29 (CH 2 ) , 27.97 
(C(CH 3 ) 3 ) , 35.06 (CH 2 CO), 61.53 (POCH 2 , JCp = 6.5), 80.21 (C(quat)), 176.6 
(C=0). 3 1 P N M R (CDC1 3, 80.9 MHz,) Sp: 32.91. ES-MS: m/z 295.2 [M+ H ] + , 317.2 
[M + Na ] + , 611.4 [2M + Na] + . (Found: [M+Na] + , 317.1525. C, 3H270 5PNa requires 
[M+Na] + , 317.1494). 
li^OEt 
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5-(Diethoxy-phosphonyl)-pentanoic acid (16) 
O 
HO li .OEt 
i OEt 
16 
15 (4.04 g, 0.014 mmol) was suspended in CF 3 COOH (2.0 mL) and C H 2 C I 2 (2.0 
mL). The resulting solution was stirred under argon at room temperature overnight. 
The reaction mixture was concentrated under reduced pressure and the residue 
washed using CH 2 C1 2 ( 3 x 1 0 mL), to give 16 in near quantitative yield (3.20 g, 96 
% ) . <SW(CDC13, 400 MHz): 1.28 (6H, t, CH2CH3, J = 7.0), 1.71 (6H, m, CH2), 2.42 
(2H, t, CH2CO, J = 7.0), 4.16 (4H, m, CH2PO), 12.56 (1H, s, OH). £ C ( C D C 1 3 , 100.6 
MHz): 16.41 (CH 3 ) , 21.75 (CH 2 ) , 24.72 (CH 2 ) , 25.46 (CH 2 ) , 35.55 (CH 2 CO), 63.01 
(POCH 2 CH 3 ) , 179.77 (C=0). 3 , P N M R (CDC1 3, 80.9 MHz,) 5P: 33.53 CP=0). ES-
MS: m/z 237.1 [M]~. (Found: [M]", 237.0905. C 9 H 1 9 0 5 P requires [M]", 237.0907). 
(±) Ethyl-2-bromo-5-(diethoxy-phosphonyl)-pentanoate (17) 
16 (5.29 g, 0.022 mmol) was dissolved in SOCl 2 (10 mL) and heated under reflux 
for approximately 1 h. Liquid bromine (3.53g, 0.021 mmol) was carefully added and 
the resulting brown solution was heated under reflux, under an argon atmosphere 
overnight. The reaction mixture was cooled in an ice bath and slowly added to a 
cooled solution o f anhydrous EtOH (~ 20 mL). The resulting yellow solution was 
stirred under argon for 30 min and then poured onto crushed ice (100 g) and stirred 
until ful ly melted. The product was extracted using E t 2 0 (3 x 50 mL) and the 
organic phase was dried over MgSCv The solvent was filtered and then removed 
O 
li^OEt 
EtO 
Br OEt 
17 
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under reduced pressure to yield 17 as a yellow oily product (4.9 g, 65%). £ W (CDC1 3 , 
500 MHz): 1.04 (6H, t, J = 8.5, POCH 2 C//j) , 1.13 (3H, m, C H 2 C / / j ) , 1.79 (4H, m, 2 
CH2), 2.12 (2H, C// 2 CO), 3.90 (4H, m, POC// 2 CH 3 ) , 4.04 (3H, m, COOC// 2 CH 3 & 
CtfBr) . £ C ( C D C 1 3 , 125.6 MHz): 13.90 (CH 3 ) , 16.33 (CH 3 , J C . P = 5.7), 20.34 (CH 2 ) , 
23.88-25.01 (CH 2 , J C P = 141 ), 35.10 (CH 2 CHBr), 45.32 (CHBr), 62.20 
(CH 3 CH 2 OCO), 62.22 (CH 3 CH 2 OP), 169.60 (C=0). 3 1 P N M R (CDC1 3, 80.9 MHz,) 
8 P: 32.50. ES-MS: m/z 345.1 [ 7 9 Br, M\+, 347.2 [ 8 1 Br, M ] + , 367.2 [ M + Na] + . (Found: 
[ M f , 345.0461, CnH 2 3 0 5 PBrrequires [ M ] + , 345.0466). 
1,4,7-Tris-trifluoromethyI carbonyl-l,4,7,10-tetraazacyclododecane4 (18) 
1,4,7,10-Tetraazacyclododecane (3.68 g, 21.39 mmoll.01 g, 5.87 mmol) and NEt 3 
(0.8 ml, 6.98 mmol) was dissolved into anhydrous MeOH (100 mL) and cooled to 0 
°C. Ethyl trifluoroacetate (12.17 g, 0.086 mmol) was added dropwise over a 30 min 
and the mixture was left stirring for 4 h under an argon atmosphere, at room 
temperature. Removal o f the solvent under reduced pressure gave the crude of 
reaction. Purification by flash column chromatography (S i0 2 , 1% MeOH in DCM 
-> 3% MeOH in DCM) gave 18 (4.74 g, 45 % ) . R f (EtOAc, S i0 2 ) = 0.30 (UV) . 5H 
(CDCI 3 , 400 MHz): 1.49 (1H, br s, NH) , 2.87 (4H, m, NCH 2 ) , 3.52-3.65 (8H, m, 
NC/ / 2 ) , 3.85 (4H, m, N C / / 2 ) . Sc (CDC13,100.6 MHz): 20.93 (CH 2 ) , 46.91-52.81 (m, 
NCH 2 ) , 116.44 (q, CF 3 , J C . F ~ 278, further split due to conformers), 156.78-158.22 
(m, C=0, existence o f conformers and long range C-F coupling). ES-MS: m/z 483.3 
[ M + N a ] + , 943.1 [ 2 M + N a ] + . 
O O 
N N 
N 
H 
C F 
18 
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l-/ert-Butoxycarbonyl-4,7,10-tris-trifluoromethylcarbonyl-l,4,7,10 
tetraazacyclododecane (19) 
O O 
X r ~ \ A 
F 3 C N ^ C F 3 
 
F 3  N N 
C. J 
0 C F 3 
fBuO 
19 
To a stirred solution o f 18 (2.0 g, 4.44 mmol) in dry MeOH (20 mL) di-tert-butyl-
dicarbonate (1.11 g, 5.28 mmol) was added. The resulting mixture was left stirring 
for 5 h at room temperature under an argon atmosphere. The solvent was removed 
under reduced pressure to yield the crude mixture, which was then purified by flash 
column chromatography (S i0 2 , CH2CI2 —> 2% EtOAc in CH 2C1 2) to give the product 
as a colourless oil (1.60 g, 65%). R f (EtOAc / CH 2 C1 2 1:9, S i0 2 ) = 0.54 (UV). dH 
(CDC) 3 , 400 MHz) : 1.33 (9H, s, C(C / /j) 3 ), 3.34-3.73 (16H, m, N C t f 2 ) . Sc 
(CDCI3,100.6 MHz): 20.62 (CH 2 ) , 27.98 (C(CH 3 ) 3 ) , 48.54-50.70 (m, NCH 2 ) , 81.04 
(C(CH 3 ) 3 ) , 116.03 (q, CF 3 , J C . F ~ 287 Hz, further split due to conformers), 156.67-
158.70 (m, C = 0 , existence of conformers and long range C-F coupling). ES-MS: 
m/z 583.3 [M + Na] + , 1152.3 [2M +Na] + . (Found: [ M + Na] + , 583.1617, 
C,9H2505N4F9Na requires [ M + Na] + , 583.1579). 
l-ter/-Butoxycarbonyl- 1, 4, 7,10-tetraazacyclododecane (20) 
H H 
N N 
tBuO H 
O 
20 
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19 (1.60 g, 0.0028 mmol) was dissolved in MeOH (20 mL) and water (5 mL). 
Aqueous KOH solution (2 M , 1.0 mL) was added and the mixture was stirred for 3 h 
at room temperature. The solvent was removed under reduced pressure and a pale 
yellow oil was obtained. This crude material was suspended in CH2CI2 (50 mL), 
washed with saturated N a H C 0 3 solution (10 mL) and then with saturated aqueous 
NaCl solution (10 mL). The organic layer was dried over K 2 C 0 3 and solvent 
removed by reduced pressure to yield the product as a clear oil (0.75 g, 98%). 5H 
(CDCb, 400 MHz): 1.21 (9H, s, C(C/ / 3 ) 3 ) , 2.45 (4H, br m, NCH 2 ) , 2.56 (8H, br m, 
NCH 2 ) , 3.17 (4H, br m, NCH 2 ) , 3.37 (3H, br s, NH) . Sc (CDCb, 100.6 MHz) : 28.29 
(C(CH 3 ) 3 ) , 46.46 (NCH 2 ) , 48.06 (NCH 2 ) , 48.56 (NCH 2 ) , 48.68 (NCH 2 ) , 48.94 
(NCH 2 ) , 79.38 (q, C(CH 3 ) 3 ) , 156.38 ( C O ) . ES-MS: m/z 295.1 [M + N a ] + (Found: 
[ M ] + , 273.2302, C i 3 H 2 9 0 2 N 4 requires [ M ] + , 273.2291). 
l-fer/-Butoxycarbonyl-4,7,10-tris-ethyl-2-bromo-5-(diethoxy-phosphonyl-
pentanoate-l,4,7,10-tetraazacyclododecane (21) 
To a suspension o f 1 -/-butoxycarbonyl-1,4,7,10-tetraazacyclododecane (20) (0.17 g, 
0.65 mmol) in dry MeCN, Cs 2 C0 3 (0.74g, 2.27 mmol) and 17 were added. The 
reaction mixture was stirred under reflux for 72 h, under an argon atmosphere. The 
particulate matter was removed by filtration and the solvent removed under reduced 
pressure. The crude mixture was purified by column chromatography (SiC>2, CH2C1 2 
3% MeOH in CH 2C1 2), to yield the product as a brown oil (150 mg, 22%). R f 
(CH 2C1 2 / MeOH 3%, S i0 2 ) = 0.62. £ W ( C D C 1 3 , 499.77 Mz): 1.24 - 1 . 3 1 (27H, m, 
EtO OEt 
O 
L.OEt EtO ' 
EtO N OEt N 
O 
l i .OEt 
° O ^ O E t ° 
fBuO 
OEt 
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18H POCH 2 C// 5 + 9H COCH 2 C / / j ) , 1.43 (9H, s, C(CH3)3), 1.74 - 1.77 (34H, m, 
16H NC/fc + 18H CH2), 4.07 (21H, m, 12H POC// 2 CH 3 + 6H COC/ / 2 CH 3 + 3H 
CH). 5Q (CDC1 3, 125.67 Mz): 13.17 (CH 3 ) , 15.46 (CH 3 J C P = 3.8 Hz), 17.21 (CH 2 ) , 
23.75 (CH 2 ) , 24.82 (CH 2 ) , 27.42 (C(CH 3 ) 3 ) , 33.76 (CH 2 ) , 60.50 - 60.55 (m, 
POCH 2 CH 3 J C P = 6.2 Hz: long range CP coupling). 8P (CDC1 3, 80.90 Mz): 31.83 -
32.66. ES-MS: m/z 1087.4 [M + Na ] + (Found: [ M + Na] + , 1087.5555, C 4 6H9iO , 7 N4 
P3Na requires [ M +Na] + , 1087.5496). 
Benzyl-2-[(ter/-butoxycarbonyl)amino]-4-oxoserinate 5 (22) 
O 
To a stirred solution of N-Boc-aspartic-acid-benzyl-ester (2.0 g, 6.20 mmol) in 
anhydrous THF (6.0 mL) cooled at -10 °C, A^-methylmorpholine (0.66 mL, 6.20 
mmol) was added dropwise. After 1 minute at -10 °C, ethyl chloroformate (1.84 mL, 
19.17 mmol) was added dropwise and the mixture stirred at -5 °C for a further 15 
min. A^-methylmorpholine hydrochloride was removed by filtration and the filtrate 
was immediately added to NaBH 4 (0.30 mg, 7.93 mmol) . The reaction mixture was 
stirred at room temperature for 4 h, cooled to 5 °C, acidified to pH ~ 4 with HC1 
( I M , a few drops) and the solvent was evaporated. The residue, a white powder, was 
dissolved in EtOAc (20 mL), washed with water and then brine, dried (Na2SO"4) and 
the solvent evaporated under reduced pressure to give a yellow oil (1.76 g). 
Purification by column chromatography (Si0 2 , EtOAc / Hex, 3 : 7) gave the product 
as a colourless oil (0.60 g, 31 % ) . R f (EtOAc / Hex 1 : 1) = 0.64 (UV) . <5w(CDCI3, 
400 MHz): 1.32 (9H, s, C (C / / j ) 3 ) , 1.61 (1H, m, CHb), 2.04 (1H, m, CHa), 3.16 (1H, 
br. s, OH), 3.57 (2H, m, C// 2 OH), 4.40 (1H, m, C//COO), 5.07 (2H, d, 2Jn a,Hb= 6.4, 
HO N O 
H' V 5 " 
O 
22 
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C// 2 Ph), 5.51 (1H, d, 3 J , , 2 = 7.6, N/7), 7.23 (5H, m, Phi/). £ C (CDC1 3 , 100.62 MHz): 
28.25 (C(CH 3 ) 3 ) , 35.54 (CH 2 CH 2 OH), 51.01 (C(CH 3 ) 3 ) , 58.34 (CH 2 OH), 65.65 
(CHNH), 80.22 (CH 2 Ph), 128.21, 128.47, 128.57 (Ph ring carbons), 135.34 
((PhQquat)), 156.27 (COCH 2 Ph), 172.68 (COO/Bu). ES-MS: m/z 332 [M + Na] + , 
641 [2xM+Na] + . 
Benzyl-2-|(te^Butoxycarbonyl)amino]-4-oxobutanoate 6 (23) 
O 
To a solution o f oxalyl chloride (34.0 uL, 0.38 mmol) in CH2CI2 (3 mL) at -78 °C 
was added DMSO (70.0 uL). To this mixture, a solution o f 22 (0.11 g, 0.35 mmol) 
in CH 2 C1 2 (2 mL) was added. After stirring for 30 min NEt 3 was added dropwise to 
the mixture, which was left to stir for 5 min at -78 °C and then allowed to warm to 
room temperature. After 2 h the reaction mixture was diluted with CH 2 C1 2 (10 mL) 
and washed with brine (10 mL). The organic layer was dried over Na 2S04, 
concentrated under reduced pressure and the crude mixture purified by column 
chromatography (S i0 2 , EtOAc / Hex, 3:7) to afford 23 (0.1 g, 86 %) as a white 
powder. R f (EtOAc/Hex 4:6) = 0.35 (UV). M.p. 58 - 61°C (lit. 60 - 62 °C). SH 
(CDC1 3, 400 MHz): 1.35 (9H, s, C(CH3) x 3 ) , 2.96 (1H, br. dd, CHb ), 2.99 (1H, br. 
dd, CHa), 4.56 (1H, m, C//COO), 5.09 (2H, s, C// 2Ph), 5.35 (1H, br. d, ~NH), 7.23 
(5H, m, Ph//), 9.63 (1H, s, C/ /0) . <5t(CDCl3, 100.62 MHz): 28.25 (C(CH 3 ) 3 ) , 45.97 
(CH 2 COH), 48.81 (C(CH 3 ) 3 ) , 67.55 (*CHNH), 80.27 (CH 2Ph), 128.25, 128.48, 
128.60 (Ph ring carbons), 135.14 (PhQquat)), 155.36 (COOCH 2Ph), 170.88 
(CONH), 199.23 (COH). ES-MS: m/z 330 [M+ Na] + , 639 [2xM+ Na] + . 
X 3 H N H' Y" 
O 
23 
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Benzyl-2-[(te^Butoxycarbonyl)amino]-4-oxobutanoate7 (24) 
CI O 
^ ^ ^ ^ ^ o 5^ 
OEt N 
H' Y 
24 
To a suspension o f NaH (0.22 g, mol) in THF (20 mL) at 0 °C, triethyl-2chloro-
phosphonoacetate (1.9 mL, 6.17 mmol) was added and the mixture was stirred at 
room temperature. After 30 min, a solution o f the aldehyde 23 (0.88 g, 2.83 mmol) 
in THF (7 mL) was added to the reaction mixture at 0 °C , then stirred at room 
temperature for 2 h. Saturated aqueous NaHCC>3 (15 mL) and aq. Na2S203 (10 mL) 
were added, and the mixture extracted with Et20 (20 mL x 2). The organic layer was 
washed with brine (10 mL x 2), dried over Na2SC>4, filtered and the solvent 
evaporated to dryness to give the crude mixture. Purification by column 
chromatography (EtOAc / Hex 9 : 1 —> EtOAc / Hex 8 : 2) afforded the product 24 
as a pale brown oil (0.24 g, 21%). 8H (CDC1 3, 300 MHz): 1.30 (3H, t, J = 7, 
OCH 2 C// i ) , 1.43 (9H, s, C(C/ / 3 ) 3 ) , 2.65-3.04 (2H, m, NCHC/ / 2 ) , 4.24 (2H, q, J = 7, 
OC/ / 2 CH 3 ) , 4.52 (1H, br. m, NC/ / ) , 5.17 (3H, s, N / / , C// 2Ph), 6.98 (1H, t, J = 7 Hz, 
C//=CCI), 7.34 (5H, s, Ph). <5t(CDCl3, 75 MHz): 14.00 (CH 3 CH 2 ) , 28.23 (C(CH 3 ) 3 ) , 
32.81 (OCH 2 ) , 52.20 (C(CH 3 ) 3 ) , 62.22 (CHN), 67.56 (CH 2 CHN), 80.27 (CH 2Ph), 
127.58, 128.38, 128.55 (Ph ring carbons), 135.74 (C1C=CH), 137.94 (C1C=C), 
155.07 (C=OCH 2Ph), 161.81 (C=OOEt), 171.11 (C=00/Bu) . ES-MS: m/z 434.2 [M 
+ Na] + . 
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(Hydroxymethylene)methyl-phosphinic acid ethyl ester 1 0 (25) 
q, ,oa 
25 
A suspension o f methyldiethoxyphosphine (2.00 g, 14.70 mmol) and an excess o f 
paraformaldehyde (0.55 g, 18.33 mmol) in THF (10 mL) over molecular sieves was 
stirred overnight at 50 °C under an argon atmosphere. After 15 h, the solvent was 
removed under reduced pressure and the residue dissolved in CH2CI2. Salts were 
filtered o f f and the filtrate evaporated to dryness to give the crude product, which 
was purified by column chromatography (AI2O3, CH2CI2 —> C H 2 C 1 2 / MeOH 1.5 % ) , 
to afford the product as a colourless oil (1.12 g, 65%). R f (CH 2 C1 2 / MeOH 3 % , 
S i0 2 ) = 0.30. SH (CDCI3, 200 MHz): 1.29 (3H, t, J = 7, OCH 2 C/ / j ) , 1.50 (3H, d, J = 
13.8, CH3P\ 3.81 (2H, m, PCtf 2 OH), 4.07 (2H, m, OC/ / 2 CH 3 ) . Sc (CDCI3 , 100 
MHz): 12.82 (d, J = 96 Hz, PCH 3), 16.45 (OCH 2 CH 3 ) , 63.63 (OCH 2 CH 3 ) , 63.68 (d, 
J = 98 Hz, CH 2 OH). 3 1 P N M R (CDCI3, 161.97 MHz,) 6 P: 53.15. ES-MS: m/z 161.0 
[M+Na] + . 
(O-Mesylmethylene)methylphosphinic ethyl ester (26) 
O 
O s OEt 
> ^ o ^ o 
26 
To a suspension o f 25 (1.12 g, 8.11 mmol) and Et3N (2.01 g, 19.90 mmol) in THF 
(50 mL) at 0 °C, MsCl (2.3 g, 20.17 mmol) was added dropwise and the reaction 
mixture was left stirring for 2 h. The reaction was quenched with EtOH (10 mL) and 
left stirring for a further 20 min, then the solvents removed under reduced pressure. 
The residue was dissolved in EtOAc (25 mL), the salts were filtered o f f and the 
solvent evaporated to dryness, to give the crude product. Purification by column 
chromatography (Si0 2 , EtOAc) afforded the desired product as a pale brown oil 
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(1.22 g, 70%). Rf (EtOAc, S i0 2 ) = 0.30 (permanganate). £„ (CDC1 3 , 400 MHz): 1.29 
(3H, br. t, O C H 2 C / / j ) , 1.56 (3H, br. d, J = 13.80, C//jP), 3.08 (3H, s, OCH2?), 4.07 
(2H, m, OS0 2 C/ / 3 ) , 4.37 (2H, m, OC// 2 CH 3 ) . 8c (CDCI3 , 100.61 MHz): 12.31 (d, 
JCp = 100 Hz, PCH3), 16.43 (OCH 2 CH 3 ) , 37.57 (CH 3S), 61.84 (OCH 2 CH 3 ) , 63.02 (d, 
J C P = 106 Hz, CH 2 OMs). 3 1 P N M R (CDC1 3, 161.97 MHz,) 5 P: 45.00. ES-MS: m/z 
217 [ M + H ] + . 
l,4-Dibenzyl-6-methyl-6-nitroperhydro-l,4-diazepine 8 (27) 
N 0 2 
A suspension of A^^V'-dibenzylethylenediamine (5.0 mL, 0.02 mol) and para-
formaldehyde (1.91 g, 0.06 mmol) in EtOH (50 mL) was refluxed for 6 h. 
Nitroethane (1.52 mL, 0.02 mol) was added dropwise, and the reaction mixture was 
heated at reflux overnight, under an argon atmosphere. The progress of the reaction 
was monitored by TLC, and after 16 h the solvent removed under reduced pressure 
and the residue partitioned between C H 2 C 1 2 / sat. aq. N a 2 C 0 3 . The organic extracts 
were washed with water, dried, filtered, evaporated and purified through column 
chromatography (S i0 2 , CH 2C1 2) to afford a light brown waxy solid (6.50 g, 96 % ) as 
the product o f reaction. R f ( C H 2 C l 2 , S i0 2 ) = 0.4 (UV) . m.p. 49.5 - 50 °C. <SW(CDCI3, 
300 MHz): 1.34 (3H, s, C / / j C ( q u a l ) ) , 2.59 (4H, m, 2 x C / / 2 N), 2.95 (2H, d, 14.1), 
3.60 (2H, d, J = 14.1), 3.65 (2H, d, J = 13.2), 3.78 (2H, d, J = 13.2), 7.26-7.33 (10H, 
m, 2 x Ph-//). ES-MS: m/z 339.3 [ M ] + , 340.3 [ M + H ] + , 361.4 [M+Na] + . 
Ph r 
N 
Ph 
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6-Amino-6-methylperhydro-l,4-diazepine (AMPED) (28) 
- V . 
NH 
N 
H 
28 
A suspension of 27 (2.27 g, 6.69 mmol) in MeOH (10 mL) and 20% Pd(OH) 2/C 
(1.88 g, 13.4 mmol) was hydrogenated overnight using a Parr hydrogenator (10 psi 
H 2 ) . The reaction mixture was filtered over Celite, the solvent was evaporated under 
reduced pressure and a yellow oil (0.850 g, 98 % ) was obtained as the only product 
of reaction. R f (CH 2 C1 2 / MeOH 19% / N H 3 1%, S i0 2 ) = 0.10 (Iodine). SH (CDC1 3, 
400 MHz): 0.85 (3H, s, CH3CiquM)), 1.86 (br. s, 4H, exch. with D 2 0 ) , 2.50 (4H, m, 2 
x CH2(ring) H-5a, 5b and H-7a, 7b), 2.63 - 2.69 (2H, m, CH2(ring) H-2a, 3a), 2.74 -
2.80 (2H, m, CH2(rtttg) H-2b, 3b). J C (CDC1 3 , 100.6 MHz): 26.81 ( C H 3 C ( q u a t ) ) , 52.06 
(C-2 and C-3), 54.15 (C ( q u a t ) ) , 62.42 (C-5 and C-7). ES-MS: m/z 130 [ M + H ] + . 
6-Amino-6-methyl, 1,4-bis(ethoxymethylphosphinoxymethyl)-diazepine (29) 
To a solution of 28 (0.85 g, 6.59 mmol) in 20 mL of CH 3 CN at 85 °C, a suspension 
of paraformaldehyde (0.39 g, 13.22 mmol) in CH 3 CN (5 mL) was slowly added. 
After heating at reflux for 30 min, the solution was allowed to cool to room 
temperature and left to stir for 40 min. Methyldiethoxyphosphine (2.0 mL, 13.22 
mmol) dissolved in CH 3 CN (10 mL) was added dropwise and the reaction mixture 
was left stirring overnight at room temperature. The solvent was removed under 
reduced pressure and the resulting yellow oil purified by column chromatography 
NH 
p-OEt 
N 
P-OEt 
29 
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(S i0 2 , CH 2 C1 2 / MeOH 6% / N H 3 1% -> CH 2 C1 2 / MeOH 15% / N H 3 1%) to yield 
the desired product (1.045 g, 43 % ) as a mixture o f (RR)I(SS) and (RS)I(SR) 
stereoisomers. R f (CH 2 C1 2 / MeOH 19% / N H 3 0.5%, S i0 2 ) = 0.50 (Iodine). SH 
(CDC1 3, 300 MHz): 0.78 (3H, s, C # j C ( q u a t ) ) , 1.08 (6H, t, J = 7, 2 x OCH 2 C/ / j ), 1.27 
( 3 H , d , J = 18 Hz, ?CH3), 1.32 (3H, d, J = 18 Hz, ?CH3 ) , 2.36 - 2.84 (12H, br. m, 4 
x CH2(ring) and 2 x C/fcN ), 3.82 - 3.92 (4H, m, 2 x OC# 2 CH 3 ) . 5c (CDC1 3, 100.6 
MHz): 13.51 (d, J C P = 100 Hz, PCH 3), 16.73 (OCH 2 CH 3 ) , 21.11 ( C H 3 C ( q u a t ) ) , 52.57 
(C2 and C3), 56.51 ( C ( q u a t ) ) , 57.74 (d, J C P = 120 Hz, PCH 2 N), 60.75 (C5 and C7), 
65.89 and 66.21 (OCH 2 CH 3 ) . 3 , P N M R (CDC1 3, 121.42 MHz,) 5 P: 52.66, 52.58, 
52.45. ES-MS: m/z 370.3 [ M + H ] + . (Found: [ M + H ] + , 370.2020. C, 4 H 3 4 N 3 0 4 P 2 
requires 370.2019). 
6-./V-bis(f-Butoxycarbonylniethyl)-6-meth.yl 
l,4bis(ethoxymethylphosphinoxymethyl)-diazepine (30) 
/-Butylbromoacetate (0.85 mL, 5.82 mmol) was added dropwise to a stirred solution 
of 29 (0.86 g, 2.33 mmol), K 2 C 0 3 (0.69 g, 4.99 mmol) and Na 2 S0 4 (0.46 g, 3.24 
mmol) in CH 3 CN (20 mL) cooled to 0 °C. After the addition, the reaction mixture 
was allowed to warm to room temperature and then heated at reflux overnight. The 
solvent was then removed under reduced pressure and the residue suspended in 100 
mL of petroleum ether / EtOAc (8 : 2). Salts were filtered o f f and the filtrate 
evaporated to dryness. The crude of the reaction was purified by column 
chromatography (Si0 2 , CH 2 C1 2 / MeOH 5%), to afford the product as a pale brown 
oil (0.53 g, 38%). R f ( C H 2 C I 2 / MeOH 10%, S i0 2 ) = 0.45 (Iodine). £ W ( C D C 1 3 , 300 
fi-OEt 
ffiuOOC N 
N 
fBuOOC 
P=0 
I 
OEt 
30 
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MHz): 1.14 (3H, s, C / / jC ( q U B t ) ) , 1.34 (6H, br. t, 2 x OCH 2C / /j , ), 1.46-1.67 (24H, m, 
2 x PC//, and 2 x C(C/ / j ) 3 ) , 2.69 (4H, br.s, C / / 2 C0 2 C(CH 3 ) 3 ) , 2.80-3.08 (12H, m, 4 
* C / f y n ^ a n d 2 x C// 2P), 4.08 (4H, br. m, 2 x OC/ / 2 CH 3 ) . £ C ( C D C 1 3 , 100.6 MHz): 
13.37 (d, J C P = 91 Hz, PCH 3), 13.47 (d, J C P = 91 Hz, PCH 3), 16.64 (OCH 2 CH 3 ) , 
24.50 ( C H 3 C ( q u a t ) ) , 28.18 (C(CH 3 ) 3 ) , 51.53 (C2 and C3), 58.65 ( C ( q u a t ) ) , 59.27 
(NCH 2P), 59.81 (CJ and C7), 60.71 (OC/ / 2 CH 3 ) , 70.44 (RingNCH 2), 80.57 
(C(CH 3 ) 3 , 172.49 (C=0) . 3 I P N M R (CDC1 3, 121.42 MHz,) 5P: 53.09, 53.05, 52.80. 
m/z 598 [ M + H ] + , 620 [M+Na] + . (Found: [ M + H ] + , 598.3381. C 2 6H54N 30 8P2 
requires 598.3385). 
6-yV-bis(Hydroxycarbonylmethyl)-6-methyl-
l,4bis((hydroxymethylphosphinoxymethyl)-diazepine-dihydrochloride (31, L I ) 
TMSI (0.44 g, 2.18 mmol) was slowly added to a solution of 30 (0.07 g, 0.165 
mmol) in CH 3 CN (10 mL) cooled at 5 °C, and the reaction mixture was left to stir at 
room temperature for 36 h. The dark red solution was diluted with H 2 0 (5 mL) and 
treated with aqueous NaHS0 3 (1 M , ~ 5 mL), until the solution became yellow in 
colour. Purification through Amberlite X A D 16 (chloride form, washed with water 
until pH 7) gave the product of reaction as a white powder (0.049 g, 70 % ) . <5//(D20, 
300 MHz): 1.19 (s, 3H, CH3), 1.34 (d, 6H, J C P = 15, 2 x PC//,), 2.82 - 3.90 (m, 
16H, 4 x CH2(rmg), 2 x C// 2P, 2 x C// 2 COOH), 3.88 (br s, 4H, 2 x CH2P). 3 1 P N M R 
( D 2 0 , 121.42 MHz,) SP: 35.63. 
J p-OH HOOC N 
N 
HOOC 2HCI 
O 
o 
A OH 
31 
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E u ' " - A A Z T A [ E i T ' L l ] -
0H 2 OH o f 
P" 5 2 
0 
N 
N 
[Eu"L1 l 
A solution o f 31 (50.0 mg, 0.12 mmol) and Eu(OAc) 3 • 6 H 2 0 (100.32 mg, 0.23 
mmol) in water (4.0 mL) at pH 5.5 ca. was stirred at 60 °C for 18 h. The solvent was 
removed under reduced pressure, the residue redissolved in H 2 0 / MeOH (1 : 1, 4.0 
mL) and aqueous K O H solution (1M, 450 |J.L) was added to give a solution pH of 
ca. 9. The solution was then centrifuged, the supernatant brought back to pH 6 and 
the solvent removed under reduced pressure to yield a light brown powder (75.0 
mg). 
The compound revealed exchange broadened *H N M R signals consistent with a 
paramagnetic shift due to the presence of europium. 3 I P N M R ( D 2 0 , 121.4 MHz,) 
dp: 54.8 (broad). T(H2O) = 0.38 ms, T(D2O) = 1-25. 
A solution of 27 (0.11 g, 0.34 mmol) and GdCl 3 • 6 H 2 0 (0.19 g, 0.50 mmol) in water 
(6.0 mL) at pH 5.5 ca. was left stirring at 60 °C overnight. The solvent was removed 
under reduced pressure, the residue redissolved in 6.0 mL of H 2 0 / MeOH ( 1 : 1 ) 
Gd'"-AAZTAP ( G d i n L l ] 
O H 2 
o 
A-P ( 
O H 2 
O O N N 
£ - 4 N 
T 
[ G d m L 1 ] -
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and aqueous KOH solution (1M, 370 uL) was added to give a solution pH of ca. 9. 
The solution was centrifuged, and the supernatant readjusted to pH 6 and the solvent 
removed under reduced pressure to yield 0.13 g of a yellow-brown powder. r/p = 5.8 
m M 's"1 (20 MHz, 37 °C). 
JV-Allylbenzamide 9 (32) 
JO H N 
O 
32 
Benzoyl chloride (3.83 mL, 32.94 mmol) was slowly added to a solution of 
allylamine (2.63 mL, 35.02 mmol) and NEt 3 (9.22 mL, 66.24 mmol) in CH 2 C1 2 (25 
mL) at 0 °C. The reaction mixture was stirred for 18 h under at room temperature 
under an argon atmosphere. Extractive work-up with H 2 0 (20 mL) and aqueous 
NH4CI solution (2 x 20 mL) followed by distillation gave 7V-AIlylbenzamide (5.24 
g) as a colorless oil in 93 % yield, b.p. 101 °C, P = 0.2 atm. <5^(CDC13, 200 MHz): 
3.93 (t, 2H, J = 5.6, C/fcNH), 5.08 (br dd, 2H, CH2CH), 5.82 (m, 1H, C/ /CH 2 ) , 7.30 
(m, 3H, PhH), 7.79 (2H, dd, J = 1.2, 8 o-Ar). 
3-Benzamidopropyl(hydroxymethyl)phosphinic acid 1 0 (33) 
HO 
II OH 
NHCOPh 
O 
33 
To a solution o f N-Allylbenzamide 32 (0.6 g, 3.72 mmol) in dioxane (10 mL) 
hypophosphorous acid (0.69 g, 50 % aq. sol) and benzoyl peroxide (0.024 g, 0.01 
mmol) were added. The reaction mixture was heated to reflux for 18 h, then the 
solvent was removed under reduced pressure and the residue redissolved in dioxane 
(5 mL). Excess paraformaldehyde (1.50 g) was added and the mixture heated to 
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reflux for further 48 h. After removal of the solvent, the residue was purified by 
column chromatography (Si0 2 , CH 2 C1 2 / MeOH 28 % / 2 % aq NH4OH - » 3 % aq 
NH4OH) to yield the desired product as the ammonium salt of the acid 33, as a 
hygroscopic colourless glass, yield: 0.46 g (50 % ) . ES-MS: m/z 257 [ M ] , 256 [ M - l ] . 
J w ( D 2 0 , 200 MHz): 1.50 (2H, m, CCH2C), 1.63 (2H, m, ?CH2C), 3.24 (2H, t, J = 7 
Hz, C / / 2 N), 3.48 (2H, d, J = 6 Hz, HOC// 2 P), 7.31 (2H, t, J = 8 Hz, Ph-ro), 7.39 (1H, 
t, J = 8 Hz, Ph-p), 7.54 (2H, d, J = 8 Hz, Ph-o). Sc ( D 2 0 , 100.61 MHz) : 21.7 
(CH 2 CH 2 P), 25.0 (d, J C P = 90 Hz, CH 2P), 40.9 and 41.0 (CH 2 NHCO E and Z), 59.7 
(d, J C P = 108 Hz, PCH 2 OH), 127.0 (Ph-m), 128.7 (Ph-o), 132.0 (Ph-p), 133.7 (Ph-i), 
170.7 (CONH). 3 1 P N M R ( D 2 0 , 161.9 MHz) 6P: 40.5 (m). 
Ethyl 3-Benzamidopropyl(hydroxymethyl)phosphinate (34) 
To a solution o f the ammonium salt o f 33 (0.23 g, 0.89 mmol) in water (2 mL) was 
added a strong acid ion-exchange resin (Dowex 50W, H + form, 1.43 g) and after 
filtration and evaporation, the residue was treated with triethyl orthoformate (1.15 
mL) and the mixture was heated to reflux for 96 h. After evaporation, the residue 
was purified by column chromatography (Si0 2 , CH 2 C1 2 / MeOH 5 % —• 10 % 
MeOH), to yield the desired product 36, mixed with its orthoformate ester [ES-MS: 
m/z 387; 3 I P N M R (CDC1 3): 5 52.00]. Transesterification was performed by boiling 
the mixture in EtOH (10 mL) in the presence o f cone. H 2S04 (500 mL) for 36 h. 
Evaporation and purification by column chromatography (S i0 2 , CH 2 C1 2 / MeOH 5 
%) yielded the desired product as a pale oil (0.15 g, 60 % ) . ES-MS: m/z 286 [ M + 
H ] + . <5/,(CDCl3, 400 MHz): 1.13 (t, 3H, CH3), 1.85 (m, 4H, CH2CH2P), 3.56 (dt, 2H, 
C//2NHCO), 3.82 (br d, 2H, CH2OH), 3.90 (m, 2H, CH20), 7.25 (m, 3H), 7.77 (dd, 
2H ,o -Ar ) . 3 1 P N M R (CDC1 3, 121.42 MHz,) dp: 53.7. 
11 OEt 
O 
NHCOPh 
HO 
34 
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(±)Dimethyl-2-bromo-pentanedioate (35) 
M e O O C ^ ^ ^ C O O M e 
Br 
35 
Thionyl chloride (30 mL) was added over a period o f 20 min to monomethylglutaric 
acid (19.55 g, 146 mmol). After heating at reflux for 30 min, the reaction mixture 
was cooled to room temperature, Bromine (7.5 mL, 146 mmol) was added dropwise 
and then heated at reflux for 3 h. After cooling to 0 °C, methanol (30 mL) was added 
slowly and the solution stirred for 30 min. Water (200 mL) and Na2S203 (5 g) were 
added and the mixture was extracted sequentially with petroleum ether (150 mL), 
ether (75 mL) and CH2CI2 (75 mL). The combined organic extracts were washed 
with NaHCC>3 (2xl00mL) and brine (50 mL), dried over Na2SC>4 and evaporated 
under reduced pressure to give an oil , from which a solid separated. The oil was 
distilled using a Vigreux column at ~ 0.05 mmHg (60 - 95 °C), to give the product 
of reaction as a clear oil (12 g, 50.4 mmol, 35 % ) . ^ ( C D C 1 3 , 400.13 MHz): 2.15 -
2.22 (1H, m, C/ / a CHBr) , 2.28 - 2.34 (1H, m, C// 6 CHBr), 2.42 - 2.46 (2H, m, 
C//2COOCH3), 3.61 (3H, s, CH 2COOCrYj), 3.70 (3H, s, CHBrCOOC//j) , 4.31 (1H, 
dd, J = 6, CHBx). 8c(CDCh, 100.62 MHz): 29.5 (CH 2 CHBr), 31.2 (CH 2 CO), 44.45 
(CH2COOCH3), 51.73 (CHBrCOOCH 3), 53.3 (CHBr), 169.75 (CH 2 C=0) , 173.0 
(CHBrC=0). m/z (ES+): 261.3 [M+Na] + . (Found: [M+Na] + , 260.9733 C 7 H n 0 4 7 9 B r i 
2 3 Na, requires [ M ] + , 260.9733). 
6-Amino-6-methylperhydro-l,4-bis(l'-methoxycarbonyl-
3'methoxycarbonylpropyl)diazepine (36) 
A -COOMe 
NH2 V-COOMe 
MeOOC v COOMe 
36 
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The ester 35 (1 g, 4.18 mmol) dissolved in CH3CN (10 mL) was added over a period 
of 10 min to a suspension of AMPED, 28, (0.257 g, 1.99 mmol) and K 2 C 0 3 (0.55 g, 
3.98 mmol) in MeCN (10 mL). After 24 h stirring at 75 °C, the solvent was removed 
under reduced pressure and the residue dissolved in EtOAc (15 mL), washed with 
water/brine (80:20 v/v, 3* 15 mL) and dried over Na 2 S0 4 . Evaporation o f the solvent 
to dryness gave 36 (0.74 g, 1.66 mmol, 84 % ) as dark yellow oil . Rp 
(CHCl 3 /MeOH/NH 3 9:1:0.1, S i0 2 ) = 0.2 (UV, K M n 0 4 ) . SH (CDC1 3, 399.96 MHz): 
0.91 (3H, s, C / / j ) , 1.73 - 1.88 (2H, m, 2 * C / / a C H 2 C 0 2 C H 3 ) , 1.89 - 2.04 (2H, m, 2 
x C / / 6 C H 2 C 0 2 C H 3 ) , 2.37 - 2.42 (4H, m, 2 x C / / 2 C0 2 CH 3 ) , 2.42 - 2.80 (8H, br. m, 
4 x CH2ring), 3.15 - 3.23 (1H, br. dd, C / f t N ) , 3.23 - 3.30 (1H, br. dd, C/ / K N), 3.58 -
3.60 (12H, m, 4 x OCH3). & (CDC1 3, 75 MHz) : 24.42 (CH 3 ) , 25.0 - 25.5 
( C H 2 C H 2 C 0 2 C H 3 ) , 30.8 (CH 2 C0 2 CH 3 ) , 51.8 (OCH 3 ) , 49.9 - 55.4 ( C H 2 r i n g ) , 67.41 
(CHN), 173.0 (C=0) , 173.6 (C=0). m/z (ES+): 446.3 [ M + H ] + , 468.3 [ M + Na] + . 
(Found: [ M + H ] + , 446.2493 C 2 0 H 3 6 N 3 O 8 requires [ M + H ] + , 446.2497). 
6-Bis(^/ ,r-butoxycarbonylmethyI)amino-6-methyl-l,4-bis(r-methoxycarbonyl-
3'methoxycarbonylpropyl)- diazepine (37) 
/-Butyl bromoacetate (d = 1.321, 0.8 mL, 5.49 mmol) was added to a stirred 
suspension of 36 (0.7 g, 1.57 mmol) and K 2 C 0 3 (0.86 g, 6.20 mmol) in CH 3 CN (15 
mL) cooled to 0 °C. The reaction mixture was allowed to warm to room temperature, 
Na 2 S0 4 (0.20 g, 1.41 mmol) was added and the suspension heated at reflux 
overnight. After cooling to room temperature, salts were filtered o f f and the mother 
liquor evaporated to give the crude product (0.85 g, 1.26 mmol). Purification by 
flash chromatography (S i0 2 , 20 % EtOAc in Hexane —• 50 % EtOAc in Hexane) 
fBuOOC 
COOMe fBuOOC 
1 c COOMe 
MeOOC COOMe 
37 
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gave the product, 37, as a yellow oil (0.37 g, 0.55 mmol, 35 % ) . R f (Hexane/EtOAc 
7:3, S i0 2 ) - 0.2 (UV, Iodine). <S/,(CDC13, 399.95 MHz): 0.95 (3H, s, CH3), 1.34 -
1.35 (18H,s, C(CH3)3), 1.73 - 1.85 (2H, m, 2 x C / / 2 a C H 2 C 0 2 C H 3 ) , 1.86-1.98 (2H, 
m, 2 x C/ / 2 f ,CH 2 C0 2 CH 3 ) , 2.31 - 2.36 (4H, m, 2 x C / / 2 C 0 2 C H 3 ) , 2.36 - 3.05 (8H, 
br. m, 4 x CH2ri„g), 3.17 - 3.23 (1H, br. dd, C / f rN) , 3.26 - 3.31 (1H, br. dd, CHfN), 
3.51 (2H, d, J = 12.4, C// 2COO/Bu), 3.56 (2H, d, J = 12.4, C// 2COO/Bu), 3.56 -
3.60 (12H, m, 4 x OCT/?). <fc (CDCI 3 , 125.66 MHz): 23.9 (CH 3 ) , 24.20 
( C H 2 C H 2 C 0 2 C H 3 ) , 28.3 (CH 2 C0 2 CH 3 ) , 51.8 (OCH 3 ) , 51.40 - 51.87 (CH 2 r i ng), 54.03 
(CqmlCH3), 68.42 (CH 2COO/Bu), 68.5 (CHN), 80.71 ( C ^ C H j ) , ) , 172.6 - 172.9 
(C=0), 173.19 (C=0) , 173.75 (C=0). m/z (ES-): 674.2 [ M + H ] + , 696.3 [ M + Na] + . 
(Found: [ M + H ] + , 674.3858. C 3 2 H 5 6 0 , 2 N 3 requires [ M + H ] + , 674.3856; found: [ M 
+ Na] + , 696.3678. C 3 2 H 5 5 0 1 2 N 3 2 3 Na, requires [ M + Na] + , 696.3676). 
6-Bis(carboxymethyl)amino-6-methyl-l,4-bis[r,3'-
(dimethoxycarbonyl)propyl]- diazepine (38) 
A solution o f 37 (0.2 g, 0.29 mmol) in TFA/CH 2 C1 2 (1:1, 3.0 mL) was stirred at 
room temperature for 24 h. The solvent was removed under high vacuum (KOH 
pellets in the traps), the residue was dissolved in CH 2 C1 2 (3 mL) and the solution 
evaporated under reduced pressure. This procedure was repeated twice. The residue 
was washed twice with diethyl ether ( 2 x 2 mL) and a precipitated white solid was 
obtained (38, 0.146 g, 0.26 mmol, 90 % ) . £ W ( C D C 1 3 , 399.96 MHz): 1.2 (3H, br. s, 
CH3), 1.96 - 2.11 (4H, m, 2 x C t f 2 C H 2 C 0 2 C H 3 ) , 2.38 - 2.55 (4H, m, 2 x 
C / / 2 C 0 2 C H 3 ) , 2.80 - 3.35 (8H, br. m, 4 x CH2n„g\ 3.46 (1H, br. dd, CHxN), 3.48 
(1H, br. dd, C / / r N ) , 3.6 (2H, br. d, 2 x C// 2 COOH), 3.69 - 3.72 (12H, m, 4 x 
OCH3). 
COOMe HOOC 
HOOC COOMe 
MeOOC COOMe 
38 
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6-Bis(carboxymethyl)amino-6-methyl-l,4-bis[r,3'(dimethoxycarbonyl)propyl]-
diazepine : a statistical mixture of R R / S S andRS isomers (39, L2) 
H O O C ^ ^ C O O H 
HOOC^ COOH 
HOOC COOH 
KOD (1M solution in D 2 0 , lmL) was added to 38 (0.15 g, 0.27 mmol) and the 
solution was stirred at 40 °C. The reaction's progress was checked by ' H NMR. 
After 7 days, the solvent was removed under reduced pressure and a white glassy 
solid was obtained, which was used directly for the next complexation reaction (L2, 
0.13 g, 0.26 mmol, 96 % ) . SH ( D 2 0 , 399.96 MHz): 1.1 (3H, s, CH3), 1.6 - 1.88 (4H, 
m, 2 x C / / 2 C H 2 C 0 2 H ) , 2.03 -2.15 (4H, m, 2 x C H 2 C t f 2 C 0 2 H ) , 2.45 - 3.32 (8H, br. 
m, 4 x CH2rmg), 3.55 (1H, br. dd, C/ / X N), 3.67 (1H, br. dd, C/ / K N), 3.7 (4H, br. d, 2 
x C// 2 COOH). 
[ L n m ( G l u ) 2 r a c e m / c - A A Z T A ] 3 -
n 3 COO 
r . 0 Ln-N 
O N 
O^ 
0 0 c 
o 
[Ln mL21 
An aqueous solution o f LnCl3-6H 20 (0.8 eqv) was added dropwise to a solution o f 
39 (1 eqv, dissolved in the minimum volume of H 2 0 ) . The pH was adjusted to ~ 5.5 
with aqueous K O H solution (1M) and the mixture was left to stir at 50 °C. After 48h, 
the reaction mixture was cooled to room temperature and the pH of the solution 
raised to ~ 10 (using aqueous KOH, 1M). The white powder that precipitated was 
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isolated by centrifugation and the pH of the supernatant readjusted to ~ 5.5. Freeze 
drying o f the liquid gave the complex as a white crystalline solid, together with K G . 
The properties of the complex were examined in the presence o f the salt. 
[ Y b n , L 2 ] 3 -
m/z (TOF MS ES-): 672.5 [ M ] \ (Found: [M]", 668.4998. C2oH2 7 N 3 0 ,2 1 7 0 Yb, requires 
[M]", 668.4998 and [ M ] \ 672.5007. C 2 oH27N 3 0 1 2 1 7 4 Yb| requires [ M ] \ 672.5067). 
[Gd'"L2] 3 -
m/z (TOF MS ES-): 659.0 [ M ] \ (Found: [M]", 659.0304 C 2oH27N 3Oi2 1 5 8Gd, requires 
[ M - H ] \ 659.0309; [ M ] \ 655.0465 C 2oH27N 3Oi2 l 5 4Gdi requires [ M - H ] \ 655.0470; 
[M]", 656.0506 CzoHzvNjO^'^Gd, requires [ M - H]", 656.0510). 
Relaxivity value found by N M R D analysis: r,p = 8.02 m M ' V (20 MHz, 298 K). 
The [Gd 3 + ] was determined by mineralization with 37% HC1 at 120°C overnight. 
[Eu'"L2] 3 -
m/z (TOF MS ES-): 652.2 [M]". (Found: [ M ] \ 652.0795 C2oH270,2N 3 l 5 1Eu, requires 
[M]", 652.0798; [ M ] \ 654.0808 C 2oH270,2N 3 1 5 3Eu, requires [ M ] \ 654.0813). 
T(HiO) = 0.20, t(D20) — 0.35. 
(2S)-2-Bromo pentanedioic acid 5-(phenylmethyl)ester (40) 
B n O O C ^ ^ ) , C O O H 
Br 
40 
A solution of NaN02 (5.5 g, 80.1 mmol) in water (50 mL) was added dropwise over 
30 minutes to a mixture o f L-glutamic acid 5-benzyl ester (10.0 g, 42.1 mmol) and 
NaBr (16 g, 155.9 mmol) in 1M HBr (250 mL) cooled at -5 °C. After 7 h, cone. 
H2SO4 (4 mL) was slowly added to the solution, which was then extracted with Et20 
(3 x 300 mL). The combined organic phases were washed with brine (2 x 200 mL), 
dried (Na2S04) and evaporated under reduced pressure. The crude product was 
purified by flash chromatography (Si02, 10 % EtOAc in w-Hexane —* 20% EtOAc in 
»-Hexane) to give 40 as a light yellow oil (7.4 g, 24.6 mmol, 57.8%). Rf («-Hexane / 
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EtOAc 15%, S i0 2 ) = 0.25 (UV, K M n 0 4 ) . HPLC (Chromatographic method A2): t r: 
8.8 min. <?W(CDC13, 699.73 MHz): 2.29 - 2.34 (1H, m, C/ / 2 a CHBr) , 2.41 - 2.46 (1H, 
m, C/ / 2 6 CHBr) , 2.57 - 2.63 (2H, m, CH2CO), 4.41 (1H, dd, 3J = 6.0, 3J = 8.8, 
CfYBr), 5.14 (2H, s, C// 2Ph), 7.33 - 7.39 (5H, m, Ph-H); £ C ( C D C 1 3 , 175.95 MHz): 
29.73 (CH 2 COOBn), 31.64 (CH 2 CHBr), 44.18 (CHBr), 66.91 (CH 2Ph), 128.52 -
128.86 (Ph - Q , 135.78 ( C ( q u a t ) ) , 172.09 (COBn), 173.37 (COOH); m/z (ES+) 323.2 
[ M + Na] + ; (Found: C, 47.97; H , 4.57; Br, 26.01%. C 1 2 H , 3 B r 0 4 requires C, 47.86; H , 
4.35; Br, 26.53%). 
(2S)-2-Bromo pentanedioic acid l-(l,l-dimethylethyl) 5-(phenylmethyl) diester 
A solution o f compound 40 (2 g, 6.85 mmol) in /-butyl acetate (24 mL) and HC10 4 
70% in water (25 u.L, 0.34 mmol) was stirred at room temperature for 16 h. Water 
(35 mL) was added to the reaction mixture and the separated organic phase was 
washed successively with water (25 mL), 5 % aqueous N a 2 C 0 3 solution (25 mL, 
neutral pH) and dried over Na 2 S0 4 . After the solvent was removed under reduced 
pressure, 41 was obtained as a pale yellow oil (2.15 g; 6.03 mmol, 88%). Rp (n-
Hexane / EtOAc 5%, S i0 2 ) = 0.44 (UV, K M n 0 4 ) . HPLC (Chromatographic method 
A2): t r: 13.1 min. dH (CDC1 3, 699.73 MHz): 1.48 (9H, s, C(CH3)3 ) , 2.24 - 2.29 (1H, 
m, Ct f 2 f l CHBr) , 2.34 - 2.39 (1H, m, CH2bCHBr), 2.52 - 2.60 (2H, m, C// 2 CO), 4.25 
(1H, dd, 3 J 2 > 3 a = 5.6, 3 J 2 , 3 b = 8.4, CHBr), 5.13 (2H, s, CH2?h), 7.31 - 7.38 (5H, m, Ph 
- H); Sc (CDC1 3 , 175.95 MHz): 27.95 (C(CH 3 ) 5 ) , 29.95 (CH 2COOBn), 31.86 
(CH 2 CHBr), 46.85 (CHBr), 66.77 (CH 2Ph), 82.86 (C(qual) (CH 3 ) 3 ) , 128.46 - 128.83 
(Ph - Q , 135.94 ( Q 9 u a „ P h ) , 168.56 (COBn), 172.26 (COOH); m/z (ES+) 379.2 [ M + 
Na] + ; (Found: C, 52.73; H, 5.58; Br, 22.30%; C i 6 H 2 , B r 0 4 requires: C, 52.49; H , 
5.58; Br, 23.28%). 
(41) 
BnOOC COOfBu 
Br 
41 
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(i'/f,65)-(r-/-Butoxycarbonyl-3'-benzyloxycarbonylpropyl)-6-amino-6-
methylperhydro-l,4-diazepine, (42); ( i 7?,6J?)-r-f-butoxycarbonyI-3'-
benzyloxycarbonylpropyl) 6-amino-6-methylperhydro-l,4-diazepinc, (43); 
(R,R)- l,4-bis(l'-/-butoxycarbonyl-3'-benzyloxycarbonylpropyl)-6-amino-6-
methylperhydro-l,4-diazepine, (44) 
A suspension of 41 (2.25 g, 6.32 mmol), 28 (5.4 g, 41.82 mmol) and K 2 C 0 3 (0.87 g; 
6.32 mmol) in MeCN (80 mL) was stirred at room temperature for 18 h. The solvent 
was removed under reduced pressure and the residue dissolved in EtOAc (80 mL), 
washed with water / brine (80 : 20 v/v, 2 x 70 mL), dried over Na 2S04 and 
evaporated to dryness. The residue was dissolved in EtOAc (50 mL), washed with 
aqueous HBr (1M) (10 : 1 v/v, 3 x 40 mL), dried over Na 2S04 and evaporated to 
dryness, to give 44 as a pale brown oil (1.19 g, 1.76 mmol, 28 % ) . Concentrated 
aqueous ammonia (5.2 mL) was added dropwise to the aqueous phase (till pH ~ 9), 
which was then extracted with EtOAc (4 x 40 mL). The organic phase was washed 
with H 2 0 / brine (4 : 1 v/v, 3 x 50 mL), dried over Na 2S04 and evaporated to 
dryness to give an oil (1.5 g, 3.7 mmol), a mixture o f 42 and 43. Crystallization from 
EtOH and washing o f the precipitated solid with CH3CN gave a yellow oil (1.02 g, 
2.52 mmol, 40 % ) and a crystalline white solid (0.250 g, 0.61 mmol, 10 % ) . 
44: (R,R) l,4-Bis(l'-/-Butoxycarbonyl-3'-benzyIoxycarbonylpropyl)-6-amino-6-
methylperhydro-l,4-diazepine 
R f (CHCl 3 /EtOH/NH 3 95:5:0.1, SiOj) = 0.2 (UV, K M n 0 4 ) . 
COOBn 
NH2 (R)> nCOOfBu NH R (S) 
BnOOC R 'COOfBu BnOOC 
COOBn 
NH 2 (R)> .nCOO/Bu 
42 43 44 
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HPLC (Chromatographic method A2): 70 % (Area % ) ; t r: 14 min. <5w(CDCI3, 399.9 
MHz): 0.91 (3H, s, CH 3 ) , 1.40 (9H, s, C(CH3)3), 1.42 (9H, s, C(CH3)3), 1.82-2.19 
(4H, br. m, 2xC/ / 2 CHN), 2.35 - 2.72 (8H, m, CH2ri„g), 2.88 - 3.0 (4H, m, 
2xC//,COOBn), 3.44 - 3.5 (2H, m, 2*CHN), 5.10 (4H, d, J = 7.2, 2xC// 2Ph), 7.29 -
7.35 (10 H , m, 2xPh - H). Sc (CDCI 3 , 75 MHz): 25.10 (CH 3 ) , 26.08 (CH 2 CHN), 
28.56 (C(CH 3 ) 3 ) , 32.11 (CH 2COOBn), 49.10 ( C H 2 ( r i n g ) N ) , 51.75 ( C H 2 ( r i n g ) C q u a l ) , 
66.54 (CH 2Ph), 68.33 (CHN), 128.5 - 129.08 ( C a r o m ) , 136.33 (Cqual a r o m ) , 171.98 
(C , u a ,NH 2 ) , 173.21 (C=0B„), 174.00 (C=OlBu). m/z (ES+): 682.4 [ M + H ] + , 704.3 [ M 
+ Na] + , 626.33 [ M - tBu] + . (Found: C, 64.27; H , 8.15; N , 5.90% • VA H 2 0 ; 
C 3 8H 5 5 N 3 08 • 3/2 H 2 0 requires: C, 64.4; H , 8.19; N , 5.93%). 
42: (i'J?,65)-(l'-/-ButoxycarbonyI-3'-benzyloxycarbonylpropyl)-6-amino-6-
methylperhydro-l,4-diazepine - Diastereoisomer soluble in EtOH-
R f (CHCl 3 /MeOH/NH 3 86:12:1, S i0 2 ) = 0.35 (UV, K M n 0 4 ) . HPLC 
(Chromatographic method A2): t r: 5 min. SH (CDC1 3, 699.73 MHz): 0.94 (3H, s, 
CH3), 1.42 (9H, s, C(CH3)3), 1.81 - 1.91 (1H, m, CH2aCUN), 1.96 - 2.03 (1H, m, 
C/ / 2 6 CHN), 2.45 - 2.54 (2H, m, C// 2COOBn), 2.61 - 2.91 (8H, m, Hring), 3.14-3.19 
(1H, m, CH~N), 5.09 (2H, s, C// 2Ph), 7.31 - 7.33 (5H, m, Ph - H). <5b(CDCl3, 125.67 
MHz): 25.42 (CH 2 CHN), 25.7 (CH 3 ) , 28.44 (C(CH 3 ) j ) , 31.26 (CH 2COOBn), 49.42 
(CH 2 N), 54.3 (CH 2 N), 56.8 (C q u a t ) , 56.9 (CH 2 C q u a t ) , 60.0 (CH 2 C q u a l ) , 66.73 (CH 2Ph), 
68.7 (CHN), 82.6 (C(CH 3 ) 3 ) , 128.4 - 128.84 ( C ^ ) , 136.0 {Cqual a r o m ) , 171.01 
(C=O f t l ) , 173.0 (C=0, f l u ) . m/z (ES+): 406.2 [ M + H ] + , 428.3 [M+Na] + . 
43: (1 '/?,6^)-l'-/-butoxycarbonyl-3'-benzyloxycarbonylpropyl) 6-amino-6-
methylperhydro-l,4-diazepine - Crystalline solid insoluble in EtOH-
R f (CHCl 3 /MeOH/NH 3 86:12:1, S i0 2 ) = 0.35 (UV, K M n 0 4 ) . HPLC 
(Chromatographic method A2): t r: 5 min. m.p. 117 - 124 °C. 5H (CDC1 3, 699.73 
MHz): 0.98 (3H, s, CH3), 1.44 (9H, s, C(CH3)3), 1.82 - 1.89(1H, m, C/ / 2 f l CHN), 2.0 
- 2.07 (1H, m, CH2bCHN), 2.49 - 2.52 (2H, td, 3J = 2.8, C// 2 COOBn), 2.62 - 2.68 
(m, 5H, H„„ g), 2.71 - 2.75 (m, 1H, Uring), 2.79 - 2.83 (m, 1H, H„„ g ) , 2.91 - 2.95 (m, 
1H, Hring), 3.17 (1H, dd, 3J = 6.3, 3J = 9.1, CHN), 5.11 (2H, s, C// 2Ph), 7.33 - 7.35 
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(5H, m, Ph - H). Sc (CDCI3 , 175.95 MHz): 25.73 (CH 2 CHN), 26.41 (CH 3 ) , 28.51 
(C(CH 3 ) i ) , 31.19 (CH 2 COOBn), 51.84 (CH 2 N), 53.62 (CH 2 N), 55.5 ( C q u a l ) , 62.46 
(CH 2 C q u a t ) , 66.54 ( C H 2 C q u a l ) , 66.87 (CH 2Ph), 68.91 ( C H N ) , 81.46 (C(CH 3 ) 3 ) , 128.48 
- 128.8 (Carom), 136.13 (Cqmt ), 171.95 (C=0Bn), 173.32 ( O 0 , f l „ ) . m/z (ES+): 
406.2 [ M + H ] + , 428.3 [ M + Na] + . 
(2R)-2-Bromo pentanedioic acid 5-(phenylmethyI)ester (45) 
BnOOC ^ ^ ) , C O O H 
Br 
45 
The same experimental procedure used for the synthesis o f 40 was followed, and the 
analytical characterization of the molecule (ESMS, HNMR, l 3 C N M R ) is identical. 
(2/?)-2-Bromo pentanedioic acid l-(l,l-dimethylethyl) 5-(phenylmethyl) diester 
The same experimental procedure used for the synthesis o f 41 was followed, and the 
analytical characterization o f the molecule (ESMS, HNMR, 1 3 C N M R ) is identical. 
(46) 
BnOOC ( R lCOOfBu 
Br 
46 
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(R,S) l,4-Bis(l'-/-Butoxycarbonyl-3'-benzyloxycarbonylpropyl)-6-amino-6-
methylperhydro-l,4-diazepine (47) 
46 (0.73 g, 2.05 mmol) dissolved in CH 3 CN (lOmL) was added dropwise to a stirred 
solution o f 42 (0.83 g, 2.05 mmol), K 2 C 0 3 (0.28 g, 2.05 mmol) and Na 2 S0 4 (0.064 g, 
0.45 mmol) in C H 3 C N (10 mL) cooled at 0 °C. The reaction mixture was allowed to 
warm to room temperature and left stirring for 18 h. The solvent was removed under 
reduced pressure and the residue dissolved in EtOAc (30 mL), washed with 
water/brine (80 : 20 v/v, 2 x 30 mL), dried over Na 2 S0 4 and evaporated to dryness. 
The residue was dissolved in EtOAc (20 mL), washed with H 2 0 / HBr (1M) (10 : 1 
v/v, 3 x 20 mL), dried over Na2SC>4 and evaporated to dryness, to give 47 as a 
yellow oil (0.97 g, 1.42 mmol, 70 % ) . R f (CHCl 3 /EtOH/NH 3 95:5:0.1, S i0 2 ) = 0.2 
(UV, K M n 0 4 ) . <5w(CDCl3, 400.13 MHz): 1.40 - 1.46 (21H, br. s, 2 x C(CH3)3 + 
CH 3 ) , 1.83 - 2.03 (2H, m, CH2aCHN), 2.08 - 2.17 (2H, m, CH2bCHN), 2.33 - 3.10 
(12H, m, 2 x C/ / 2 COOBn + H„„ g), 3.46 (2H, dd, J = 6, J - 8.8, 2 x CHN), 5.10 -
5.12 (2H, s + s, 2 x C// 2Ph), 7.28 - 7.34 (10 H , m, 2 x Ph - H). Sc (CDC1 3, 100 
MHz): 24.72 (CH 3 ) , 27.72 (C(CH 3 )j) , 29.71 (CH 2 CHN), 31.63 (CH 2 COOBn), 48.8 
( C H 2 ( r m g ) N ) , 52.61 (CH2(ring)Cqua,), 66.54 (CH 2Ph), 68.21 (CHN), 127.0 - 128.75 
(Carom)j 136.0 {Cquat arom 
), 168.29 ( O 0 B „ ) , 173.01 ( C = 0 , B u ) , 173.13 ( Q u a , N H 2 ) . m/z 
(ES+): 682.4 [ M + H ] + , 704.3 [ M + N a ] + , 626.33 [ M - f B u f . 
NH2 ( s)>—COOrB u 
COOBn 
BnOOC (RfCOOfBu 
47 
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(i'/?,65)-l-(r-r-Butoxycarbonyl-3'-benzyloxycarbonylpropyl)-4-(/-
butoxycarbonylmethyl)-6-bis(/-butoxycarbonylmethyl)amino-6-
methylperhydro-l,4-diazepine, (48 and 49) 
fBuOOC 
1 r N 
/BuOOC COOBn COOfBu 
fBuOOC fBuOOC N (R)y. 'COOfBu 
BnOOC (RfCOOfBu COOfBu 
48 49 
f-Butyl bromoacetate (0.26 mL, 1.75 mmol) was added dropwise to a stirred solution 
of 48 (0.20 g , 0.5 mmol), K 2 C 0 3 (0.27 g, 1.95 mmol) and Na 2 S0 4 (0.064 g, 0.45 
mmol) in C H 3 C N (10 mL) cooled at 0°C. The reaction mixture was allowed to warm 
to room temperature, boiled under reflux for 6 h and then left stirring overnight at 
room temperature. The mixture was evaporated under reduced pressure and the 
residue treated with petroleum ether / EtOAc 8 : 2 (20 mL). Salts were filtered o f f 
and the mother liquor evaporated to give the crude product (0.6 g). Purification by 
flash chromatography (S i0 2 , 10 % EtOAc in petroleum ether —> 20 % EtOAc in 
petroleum ether) gave the product as a yellow oil (0.22 g, 0.3 mmol, 60%). Rf 
(petroleum ether/EtOAc 8:2, S i0 2 ) = 0.3 (UV, K M n 0 4 ) . HPLC (Chromatographic 
method A2): t r: 19 min. SH (CDCI3, 699.73 MHz): 0.99 (3H, s, CH3), 1.42 - 1.47 
(36H, m, C(CH3)3), 1.81 - 1.91 (1H, m, CH2ACHN), 1.94 - 2.04 (1H, m, C/ / 2 6 CHN), 
2.45 - 2.76 (8H, m, 4*CH2RING), 3.0 - 3.07 (2H, m, C/ftCOOBn), 3.13 (1H, dd, J = 
5.6, J = 10.5, CHU), 3.26 (1H, d, J = 14, CH2ANRMG), 3.33 (1H, d, J = 14, C / / 2 6 N r m g ) , 
3.67 (2H, s, C// 2COO/Bu), 3.68 (2H, s, C# 2 COO/Bu), 5.11 (2H, s, C// 2Ph), 7.31 -
7.35 (5H, m, Ph - H). 8c (CDCI3, 125.67 MHz): 24.38 (CH 3 ) , 25.11 (CH 2 CHM), 
28.4 (C(CH 3 ) j ) , 31.15 (CH 2 COOBn), 51.84 ( C n ^ H 2 N ) , 52.56 ( C „ n g H 2 N ) , 60.1 
(CH 2 C q u a t ) , 61.24 (CquaO, 62.07 (NCH 2COO/Bu), 66.52 (CH 2Ph), 67.33 
(CH 2COO/Bu), 69.33 (CHN), 80.46 (C(CH 3 ) 3 ) , 80.94 (C(CH 3 ) 3 ) , 81.21 (C(CH 3 ) 3 ) , 
128.44- 128.77 ( C a r o m ) , 136.18 {Cquat Ph), 171.24 ( O 0 B „ ) , 172.07 (C=0 B „) , 172.88 
(C=OlB«), 173.47 ( O C W . m/z (ES+): 748.4 [ M + H ] + , 770.4 [ M + N a ] + . 
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The same experimental procedure was followed using the Monoalkylated 49 as 
starting material for the reaction. Yield = 40%. 
(/f,^)l,4-Bis(r-/-butoxycarbonyl-3'-benzyloxycarbonyIpropyl)-6-bis(/-
butoxycarbonlymethyl)amino-6-methylperhydro-l,4-diazepine (50) 
HavrH»> 
fBuOOC. 7—COOBn 
1 ( H x 
f B u O O C ^ N (R)y%C00fBu 
B n ° 0 C H ? ^ v C 0 0 f B U 
50 
/-Butyl bromoacetate (0.13 mL, 0.88 mmol) was added to a stirred solution of 44 
(0.24 g; 0.35 mmol) and K 2 C 0 3 (0.1 g; 0.7 mmol) in CH 3 CN (5 mL) cooled to 0 °C. 
The reaction mixture was allowed to warm to room temperature and Na 2 S0 4 (0.025 
g, 0.17 mmol) was added. The suspension was boiled under reflux overnight and 
stirred at 60 °C for further 8 h. After addition of more /-butyl bromoacetate (0.13 
mL, 0.88 mmol), the reaction mixture was boiled under reflux again overnight, than 
cooled to room temperature and left to stir for 5 h. The suspension was filtred, the 
solvent removed under reduced pressure and the residue was treated with petroleum 
ether / EtOAc 8 : 2 ( 1 0 mL). Salts were filtered o f f and the mother liquor evaporated 
to give the crude product (0.37 g) that was purified by flash chromatography (Si0 2 , 
5 % EtOAc in petroleum ether —» 15 % EtOAc in petroleum ether) to give 50 as a 
yellow oil (0.2 g, 0.23 mmol, 65 % ) . R f (petroleum ether / EtOAc 8 : 2, S i0 2 ) = 0.5 
(UV, K M n 0 4 ) . HPLC (Chromatographic method A2): t r : 21 min. <5w(CDCl3, 699.74 
MHz): 0.99 (3H, s, CH3), 1.40 - 1.43 (36H, m, 4*C(CH3)3\ 1.82 - 1.87 (1H, m, 
C / / 2 a C H x N ) , 1.88 - 1.94 (1H, m, C / / 2 f t CH x N) , 1.98 - 2.05 (2H, m, C / ^ C H Y N ) , 
2.35 - 2.59 (8H, m, C H 2 r m g ) , 2.71 (1H, d, J = 14.7, C/ / 2 o COOBn), 2.74 (1H, d, J = 
12.6, C/ / 2 6 COOBn), 2.90 (1H, d, J = 12.6, C// 2 6 COOBn), 3.00 (1H, d, J = 14.7, 
C// 2 a COOBn), 3.14 (1H, dd, J = 5.6, J = 10, CHXN) 3.25 (1H, dd, J = 5.6, J = 10, 
C / f tN) , 3.57 (2H, d, J = 17.5, C// 2 f tCOO/Bu), 3.67 (2H, d, J = 17.5, C// 2 f lCOO/Bu), 
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5.10 (4H, m, JH 3 H b = 15, CH2(a,b)?\\ + CH2(a;b)?\\), 7.31 - 7.35 (10H, m, 2><Ph - H). 
Sc{CDCh, 125.67 MHz): 25.23 (CH 3 ) , 26.14 (CH 2 CHN), 28.32 - 28.53 (C(CH 3 ) 3 ) , 
31.13 (CH 2 COOBn), 51.7 - 54.2 ( C H 2 r ( n g ) , 61.74 ( C ^ C H a ) , 66.6 (CH 2Ph), 68.13 
(CH 2COO/Bu), 69.23 (CHN), 80.58 (C(CH 3 ) 3 ) , 81.26 (C(CH 3 ) 3 ) , 81.33 (C(CH 3 ) 3 ) , 
128.44 - 128.79 ( C a r o m ) , 136.15 (Cquat P h ) , 172.0 ( C = 0 8 „ ) , 172.21 (C=0Bn), 172.64 
(C=0, S u ) , 173.38 (C=OlBu). m/z (ES+): 910.5 [ M + H ] + , 932.5 [ M + Na] + . (Found: C, 
62.20; H, 8.10; N , 4.11 %; C 5 oH 7 5N 3 0 | 2 • 3 H 2 0 requires: C, 62.28; H, 8.41; N , 4.36 
% ) . 
(^f,5)-l,4-Bis(l'-/-butoxycarbonyl-3'-benzyloxycarbonylpropyI)-6-bis(/-
butoxycarbonylmethyl)amino-6-methylperhydro-l,4-diazepine, (51) 
/-Butyl bromoacetate (0.53 mL, 3.56 mmol) was added to a stirred solution of 47 
(0.97 g, 1.42 mmol) and K 2 C 0 3 (0.57 g, 4.12 mmo!) in CH 3 CN (10 mL) cooled to 0 
°C. The reaction mixture was allowed to warm to room temperature, Na2SC»4 (0.025 
g, 0.17 mmol) was added and then refluxed overnight and stirred for further 6 h at 60 
°C. The solvent was removed under reduced pressure and the residue treated with 
petroleum ether / EtOAc 8 : 2 ( 1 5 mL). Salts were filtered o f f and the mother liquor 
evaporated to give the crude product (1.05 g). Purification by flash chromatography 
(Si0 2 , 5 % EtOAc in petroleum ether —» 20 % EtOAc in petroleum ether) gave 51 as 
a yellow oil (0.52 g, 0.57 mmol, 40 % ) . R f (petroleum ether/EtOAc 8:2, S i0 2 ) = 0.4 
(UV, K M n 0 4 ) . £ W ( C D C 1 3 , 400.13 MHz): 1.01 (3H, s, CH3), 1.43 - 1.46 (36H, s + s, 
4*C(C// j ) 5 ) , 1.89 - 1.95 (2H, m, C//2CFTN), 1.98 - 2.10 (2H, m, C/ / 2 CHN), 2.36 -
2.57 (8H, m, CH2ring), 2.62 - 2.87 (1H, m, 2xC / / 2 COOBn), 3.01 - 3.12 (2H, m, 
2xC#N) , 3.63 (2H, d, J = 17.6, C// 2COO/Bu), 3.69 (2H, d, J = 17.6, C// 2COO/Bu), 
COOBn fBuOOC 
fBuOOC COOfBu 
BnOOC (RfCOOfBu 
51 
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5.13 (4H, d, J = 2.4, CH2(a,b)Ph + CH2(a;b)Ph), 7.30 - 7.37 (10H, m, 2><Ph - H). 5C 
(CDCI3 , 125.67 MHz): 25.22 (CH 3 ) , 25.8 (CH 2 CHN), 28.31 - 28.52 (C(CH 3 ) j) , 
31.40 (CH 2 COOBn), 31.52 (CH 2COOBn), 5 1 . 1 - 5 4 . 1 (CH 2 „„ g ) , 61.74 (C, l ( f l ,CH 3), 
66.51 (CH 2Ph), 66.73 (CH 2Ph), 68.13 (CH 2COO/Bu), 68.38 (CH 2COO/Bu), 69.23 
(CHN), 69.3 (CHN), 80.44 (C(CH 3 ) 3 ) , 80.57 (C(CH 3 ) 3 ) , 81.26 (C(CH 3 ) 3 ) , 81.33 
(C(CH 3 ) 3 ) , 128.43 - 128.78 (Com), 136.15 (CqualPh), 136.20 (CqualPh), 171.73 
(C=0Bn), 172.0 (C=0Bn), 172.64 (C=OlBu), 173.38 (C=0, B „) . m/z (ES+): 910.3 [ M + 
H ] + , 932.4 [ M + N a f . (Found: ML!*, 910.5427. C 5 oH 7 6N 3 0 1 2 requires M H + , 
910.5423; Found: [ M + Na] + , 932.5250. C 5 oH 7 5N 3 0 1 2 Na requires [ M + Na] + , 
9932.5243). 
(l/f,d/?)-6-Bis(carbonylmethyl)amino-4-[(carboxymethyl)-l(r- carbonyl)-3'-
benzyloxycarbonylpropyl)-tetrahydro -6-methyI-lH-l,4-diazepine (53 or 
G l u A A Z T A B n , L4) 
A solution o f 48 (0.10 g, 0.13 mmol) in TFA / D C M ( 1 : 1 , 5.0 mL) was stirred at 
room temperature for 24 h. The solvent was removed under high vacuum (KOH 
pellets in the traps), the residue taken up with CH 2 C1 2 (3x8 mL) and the solution 
evaporated under reduced pressure for three times. The product of reaction, 52, was 
obtained as a yellow oil (0.073 g; 0.14 mmol, 93 %). 
A solution o f 49 (0.020 g, 0.03 mmol) in TFA/DCM (1:1, 1.0 mL) was stirred at 
room temperature for 24 h. The solvent was removed under high vacuum (KOH 
pellets in the traps), the residue taken up with CH 2 C1 2 (3x2 mL) and the solution 
HOOC COOBn HOOC 
, N (R)Y„, 
"1 COOH r HOOC N HOOC COOH 
BnOOC COOH 
52 L4 
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evaporated under reduced pressure for three times. The product o f reaction, L4 , was 
obtained as a yellow oil (0.17 g, 0.33 mmol, 90 % ) . 
52 J w ( D 2 0 , 199.99 MHz): 0.95 (3H, br. s, CH3), 1.73 - 1.9 (2H, m, C/ / 2 CHN), 2.34 
- 2.40 (2H, m, C// 2 COOBn), 2.7 - 3.9 (13 H, br. m, 8xH„, l g , CHN, 2xC// 2 COOH), 
4.94 (2H, s, C// 2Ph), 7.2 (5H, br. s, Ph - H). 
53, L4 <5W(D 20, 399.96 MHz): 1.14 (3H, br. s, CH3), 2.0 - 2.15 (2H, m, C/ / 2 CHN), 
2.53 - 2.59 (2H, m, Ctf 2 COOBn), 2.96 - 3.8 (9 H , br. m, 8xH„„ g , CHU), 3.92 - 4.0 
(4H, m, 2xC// 2 COOH), 5.14 (2H, s, C/fcPh), 7.31-7.37 (5H, m, Ph - H). £ C ( C D C I 3 3 
125.67 MHz): 24.50 (CH 3 ) , 25.24 (CH 2 CHN), 31.15 (CH 2 COOBn), 52.0 ( C n n g H 2 N ) , 
52.60 (C r „ I g H 2 N) , 60.1 (CH 2 C q u a t ) , 61.24 ( C q u a t ) , 62.07 (NCH 2 COOH), 66.52 
(CH 2Ph), 67.33 (CH 2 COOH), 69.33 (CHN), 128.3 - 128.6 ( C a r o m ) , 136.18 (Cqual Ph), 
171.25 (C=O b „ ) , 173.0 (C=OOH), 172.90 (C=OOH), 173.50 (C=OOH). 
(7'^,65)-6-[Bis(carboxymethyl)]-4-[(carboxy methyl) -l-(l'-carboxy-3'-
carboxypropyl)-tetrahydro-6-amino-6-methyl-lH-l,4-diazepine (54 or 
G l u A A Z T A , L3) 
HOOC. 
^| X O O H 
H O O C ^ N I 
H O O C ^ ^ ^ C O O H 
L3 
10% Pd/C (0.005 g) was added to a solution o f compound 52 (0.05 g, 0.067 mmol) 
in EtOH (4 mL) and H 2 0 (0.5 mL). The reaction mixture was stirred under a 
hydrogen atmosphere for 48 h using a hydrogenator (30 psi H 2 ) . The catalyst was 
filtered over Celite and the solvent evaporated under reduced pressure, to afford the 
product as a white glassy solid (L3, 0.047 g, 0.07 mmol, 96%). 8H ( D 2 0 , 199.99 
MHz): 1.05 (3H, br. s, CH}), 1.92 - 2.01 (2H, m, C # 2 C H N ) , 2.42 - 2.49 (2H, br. m, 
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C// 2 COOH), 3.06 - 3.57 (8 H , br. m, 4><CH 2 n n g), 3.67 (4H, br. s, 2><C//2COOH), 3.7 
(2H, br. s, C//2COOH). m/z (ES-MS): 453 [ M + Na] \ 
(i?/J)-6-Bis(/-butoxycarbonyIniethyl)amino-4-[r-(butoxycarboxymethyl)-l(r-r-
butoxycarbonyl)-3'-carboxypropyl)-tetrahydro -6-methyI-lH-l,4-diazepine (55) 
fBuOOC. 
] X O O f B u 
f B u O O C ^ N \ 
H O O C ^ ^ ( R ) * C O O f f i u 
55 
10% Pd/C (0.005 g) was added to a solution o f compound 48 (0.05 g, 0.067 mmol) 
in EtOH (4 mL) and H2O (0.5 mL). The reaction mixture was stirred under hydrogen 
atmosphere for 48 h using a hydrogenator (30 psi H2). The catalyst was filtered over 
Celite and the solvent evaporated under reduced pressure, to afford the product o f 
reaction as a white glassy solid (55, 0.047 g, 0.07 mmol, 96%). 
<$/(CD 3OD, 199.99 MHz): 1.06 (3H, br. s, CH3), 1.46-1.48 (36H, m, 4xC(CH3)3), 
1.77 - 2.0 (4H, m, 2 x C/ / 2 CHN) , 2.39 - 2.46 (2H, m, C// 2 COOH), 3.0-3.6 (H, m, 9 
H, br. m, 8xH„> lg + CHN), 3.7 (4H, dd, 2xC / / 2 COO/Bu). m/z (ES+): 658.2 [ M + H] + . 
(/^)-6-Bis(carboxymethyI)amino-l,4-bis(l'-carboxy-3'-carboxypropyl)-
tetrahydro-6-methyl-lH-l,4-diazepine (56 or Glu A A Z T A , L3) 
HOOC. 
HOOC. 
COOH 
HOOC ^ ( R f C O O H 
L3 
A solution of 55 (0.047 g, 0.07 mmol) in TFA / CH 2 C1 2 (1 : 1, 2.5 mL) was stirred at 
room temperature for 24 h. The solvent was removed under high vacuum (KOH 
pellets in the traps), the residue taken up with CH 2 C1 2 ( 3 x 4 m L ) and the solution 
evaporated under reduced pressure for three times. The residue was washed twice 
with diethyl ether (2x2 mL) and a precipitated white solid was obtained as the 
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product o f reaction (56, 0.03 g, 0.068 mmol, 97%). SH ( D 2 0 , 399.96 MHz): 1.04 
(3H, br. s, CH3), 1.91-1.93 (2H, m, C/fcCHN), 2.41 (2H, br. m, C// 2 COOH), 3.0 -
3.49 (8 H, br. m, 4xCH 2 n „g) , 3.62 (4H, br. s, 2xC// 2 COOH), 3.82 (2H, br. s, 
C// 2 COOH). m/z (ES+): 453.4 [M + Na] + . 
(/f/?)-6-Bis(carbonylmethyl)amino-l,4-bis(r- carbonyl)-3'-
benzyloxycarbonylpropyl)-tetrahydro -6-methyl-lH-l,4-diazepine (57) 
A solution o f compound 50 (0.07 g, 0.077 mmol) in TFA and CH 2 C1 2 (1:1, 2 mL) 
was stirred at room temperature for 24 h. The mixture was then evaporated, the 
residue taken up with CH 2 C1 2 (2 mL) and the solution evaporated under reduced 
pressure. This operation was repeated three times, then the residue was washed twice 
with diethyl ether (2><2 mL) and a precipitated white solid was obtained as the 
product of reaction (57, 0.06 g, 0.087 mmol, 88%). 5H(D20, 399.96 MHz: 1.05 (3H, 
s, CH3), 1.98 - 2.06 (4H, m, 2 x C/ / 2 CHN), 2.50 - 2.80 (4H, m, 2 * C// 2COOBn), 
3.0 - 3.75 (10H, br. m, 4 x C / / 2 „ „ g + 2 x Qt fN) , 3.80 - 3.90 (4H, m, NC/ / 2 COO#) , 
5.14 (4H, d, J = 4, 2 x C// 2Ph), 7.33 - 7.36 (10H, m, 2 x Ph - H). 
(/f/?)-6-Bis(/-butoxycarbonylmethyl)amino-l,4-bis(l'-/-butoxycarbonyl)-3'-
carboxypropyl)-tetrahydro -6-methyl-lH-l,4-diazepine (58) 
COOBn HOOC 
HOOC 'COOH 
BnOOC 
57 
COOH /BuOOC 1 r 
,N (R)\.„ fBuOOC 'COOfBu 
HOOC 
58 
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10% Pd/C (0.008 g) was added to a solution o f compound 50 (0.08 g, 0.12 mmol) in 
EtOH (10 mL) and H 2 0 (1 mL). The reaction mixture was stirred under a hydrogen 
atmosphere for 48 h using a hydrogenator (30 psi H 2 ) . The catalyst was filtered over 
Celite and the solvent evaporated under reduced pressure, to afford the product o f 
reaction as a white glassy solid (0.08 g, 0.11 mmol, 92%). SH (CD 3 OD, 699.73 
MHz): 1.18 (3H, br. s, CH3), 1.48 (21H, s, C(C// , ) j ) , 1.56 (15H, m , C ( C / / j ) j ) , 1.96-
1.99 (2H, m, C/ / 2 CHN), 2.07 - 2.1 (2H, m, C /^CHN) , 2.1 - 2.18 (4H, m, 
2xCH2nng), 2.47 - 2.58 (4H, m, 2*CH2ring), 2.65 (2H, dd, J = 14, C// 2 COOH), 2.96 
(1H, d, J = 14, C/ / 2 a COOH), 3.10 (1H, d, J = 14, C t f^COOH) , 3.25 - 3.28 (2H, m, 
2xC / /N) , 3.50 (2H, d, J =17.5, Ctf 2 COO/Bu), 3.61 (2H, d, J = 17.5, Ctf 2 COO/Bu). 
£ c ( C D 3 O D , 125.67 MHz): 25.8 (CH 3 ) , 26.9 (CH 2 CHM), 27.04 - 27.31 (C(CH 3 ) 5 ) , 
29.92 (CH 2 COOH), 30.17 (CH 2 COOH), 50.68 (CH 2 „„ g ) , 65.40 (Q, r a ,CH 3 ) , 67.41 -
67.61 (CH 2COO/Bu), 82.23 (C(CH 3 ) 3 ) , 82.54 (C(CH 3 ) 3 ) , 167.45 (C=0, f l „) , 170.8 
(C=OlBu), 174.7 ( O O O H ) , 174.9 (C=OOH). m/z (ES+): 730.3 [ M + H ] + . m/z (ES-): 
728.5 [ M - H ] \ (Found: M H + , 730.4493. C 3 6 H64N 3 0, 2 requires M H + , 730.4485). 
(/?/f)-6-Bis(carboxymethyl)amino-l,4-(bisr-carboxy-3'-carboxypropyl)-
tetrahydro-6-methyl-lH-l,4-diazepine: (59 or ( G l u ) ^ - A A Z T A , L5) 
10% Pd/C (0.006 g) was added to a solution of compound 57 (0.06 g, 0.087 mmol) 
in EtOH (3 mL) and H 2 0 (0.4 mL). The reaction mixture was stirred under hydrogen 
atmosphere for 24 h using a hydrogenator (30 psi H 2 ) . The catalyst was filtered over 
Celite and the solvent evaporated under reduced pressure, to afford the product as a 
white glassy solid (L5, 0.044 g, 0.088 mmol, 98%). 5H ( D 2 0 , 399.96 MHz): 1.06 
(3H, s, CH3), 1.8 - 2.05 (4H, m, 2><C//2CHN), 2.40 - 2.55 (4H, m, 2 x C// 2 COOH), 
COOH HOOC 
HOOC COOH 
HOOC 
L5 
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2.95 - 3.40 (10H, br. m, 4 x CH2nng + 2 * CAN), 3.62 - 3.75 (4H, m, 
2xNC / / 2 COO//) . m/z (ES-): 504.3 [M - H ] \ 
(/?5)-6-Bis(/-butoxycarbonyImethyl)amino-l,4-bis(l'-t-butoxycarbonyl)-3'-
carboxypropyl)-tetrahydro -6-methyl-lH-l,4-diazepine (60) 
10% Pd/C (0.03 g) was added to a solution o f compound 51 (0.30 g, 0.33 mmol) in 
EtOH (8 mL) and H 2 0 (1 mL). The reaction mixture was stirred under hydrogen 
atmosphere for 48 h using a hydrogenator (30 psi H 2 ) . The catalyst was filtered over 
Celite and the solvent evaporated under reduced pressure, to afford the product o f 
reaction as a white glassy solid (0.48 g, 0.35 mmol, 94%). SH (CD 3 OD, 499.77 
MHz): 1.09 (3H, s, CH3), 1.48 - 1.50 (36H, m, 4^C(CH3)3), 1.85 - 1.89 (2H, m, 
C/fcCHN), 1.95 - 2.0 (2H, m, C/fcCHN), 2.36 - 2.48 (4H, m, 2xC// 2 „„ g ) , 2.66 -
2.77 (4H, m, CH2ring), 3.0 (2H, d, J = 14, CH2COOH), 3.16 (2H, d, J = 14, 
C// 2 COOH), 3.26 - 3.36 (2H, m, 2xC#N) , 3.6 (2H, d, J =17.75, C// 2COO/Bu), 3.75 
(2H, d, J = 17.75, C// 2COO/Bu). 8c (CD3OD, 125.67 MHz) : 25.7 (CH 3 ) , 26.04 
(CH 2 CHN), 27.26 - 27.43 (C(CH 3 ) j ) , 31.0 (CH 2 COOH), 51.5 - 53.68 (CH 2 „„ g ) , 
64.55 (C„„ f l,CH 3), 68.8-69.3 (CH 2COO/Bu), 67.9 (CHN), 80.73 (C(CH 3 ) 3 ) , 80.9 
(C(CH 3 ) 3 ) , 81.13 (C(CH 3 ) 3 ) , 81.37 (C(CH 3 ) 3 ) , 171.73 (O O ,* , ) , 171.95 (C=OlBll), 
173.10 (C=OOH). m/z (ES+): 730.3 [ M + H ] + , 752.4 [ M + Na] + . (Found: M H + , 
730.4475. C 3 6 H 6 4 N 3 0 , 2 requires M H + , 730.4484; Found: MNa + , 752.4303. 
C 3 6 H 6 3 N 3 0 1 2 N a requires MNa + , 752.4304). 
COOH /BuOOC 1 r 
(S)V-fBuOOC (S)>-iCOO/Bu 
HOOC 
60 
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(if5)-6-Bis(carboxymethyl)amino-l,4-(bisl'-carboxy-3'-carboxypropyl)-
tetrahydro-6-methyl-lH-l,4-diazepine: (61 or ( G l u ^ S - A A Z T A , L6) 
A solution o f 60 (0.24 g, 0.33 mmol) in TFA / C H 2 C I 2 (1:1, 4.0 mL) was stirred at 
room temperature for 24 h. The solvent was removed under high vacuum (KOH 
pellets in the traps), the residue taken up with CH 2 C1 2 (4 mL) and the solution 
evaporated under reduced pressure. This procedure was repeated three times, then 
the residue was washed twice with diethyl ether (2*2 mL) and a precipitated white 
solid was obtained as the trifluoroacetate salt o f the product (L6, 0.18 g, 0.36 mmol, 
93 % ) . SH ( D 2 0 , 499.77 MHz): 1.05 (3H, s, CH3), 1.92 - 2.06 (4H, m, 2xC/ / 2 CHN), 
2.36 - 2.50 (4H, m, 2xC// 2 COOH), 3.02 - 3.32 (8H, m, C/ / 2 r „ , g ) , 3.54 - 3.58 (2H, m, 
2xC//N), 3.59 (2H, d, J =11.5, NC// 2 COO//) , 3.65 (2H, d, J = 11.5, NC// 2 COOH). 
<5b(D20, 125.67 MHz): 22.01 (CH 3 ) , 24.37 (CH 2 CHM), 30.65 (CH 2 COOH), 50.65 -
51.61 (CH 2ri,«), 61.61 ( C ^ C H j ) , 66.17 (NCH 2 COOH), 67.81 (CHN), 173.08 
(CHC=OOH), 176.1 (NCH 2 C=OOH), 177.0 ( C H 2 ) 2 O 0 0 H ) . m/z (ES-): 504.3 [ M -
H ] \ (Found: [M-H]", 504.1835. C 2oH 3oN 30| 2requires [ M - H ] \ 504.1836). 
COOH HOOC 
HOOC COOH 
HOOC 
L6 
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L n I U complexes 
! H N M R spectra were recorded for the Eu" 1 and Yb" 1 complexes o f AMPED based 
ligands. In this section are listed selected chemical shifts corresponding to the major 
and minor isomers of each complex 
- From GluAAZTA, L3 
[ L n i n ( G l u ) A A Z T A ] 2 
o 
o •Ln' 
0 t sR i N 
.0 ooc 
o 
[Ln m L3] 2 -
An aqueous solution o f LnCl3-6H20 (0.8 eqv) was added dropwise to a solution of 
L3 in H 2 0 / MeOH 5% solution (1 eqv, dissolved in the minimum volume). The pH 
was adjusted to ~ 5.5 with aqueous KOH solution (1M) and the mixture was left to 
stir at 50 °C. After 48h, the reaction mixture was cooled to room temperature and the 
pH of the solution raised to ~ 10 (using aqueous K O H solution, 1M). The white 
powder precipitated was isolated by centrifugation and the pH of the supernatant 
readjusted to ~ 5.5. Freeze drying of the liquid gave the complex as a white 
crystalline solid, together with KC1. The properties o f the complex were examined in 
the presence of the salt. 
[Yb"'(Glu)AAZTA] 2 " or [ Y b m L 3 ] 2 " 
HPLC (Chromatographic method A l ) : 100% (Area%); t r : 1.5 min. 
m/z (ES-): 603.07 [M - H]" (Found: [ M - H ] \ 599.0737. C ^ W i o ' 7 ^ , requires 
[M - H]-, 599.0737 and [ M - H]", 603.0777. CnHzsNjO^ '^Yb, requires [ M - H ] \ 
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603.0777). S„ (Ma,* isomer) (D 20, 499.79 MHz): -36.05, -28.62, -8.72, -5.69, -5.47, -
3.84, -3.38, -2.21, -1.07, -1.17, 5.65, 6.01, 8.88, 10.66, 27.26, 29.54, 30.92, 32.51, 
36.09, 42.33. 
SH (Minor isomer) (D 20, 499.79 MHz): -41.85, -25.32, -8.14, -6.31, -3.82, -3.81, -3.62, -
2.50, -1.11, -0.89, 0.70, 7.62, 9.1, 12.03, 28.43, 33.85, 34.25, 36.23. 
[Gd"'(Glu)AAZTA] 2 " or [ G d m L 3 ] 2 -
HPLC (Chromatographic method A l ) : 100% (Area % ) ; t r: 1.5 min. m/z (ES-): 587.1 
[ M - H ] ' (Found: [ M - H]", 587.0618. C,7H23N30,o l 5 8Gd| requires [ M - H] ' , 
587.0630; [ M - H ] \ 583.0590. C,7^3^0,0'54Gdi requires [ M - H ] \ 583.0597); [ M -
H ] \ 584.0607. C n H ^ O i o ' ^ G d , requires [ M - H ] \ 584.0615). 
Relaxivity value found by N M R D analysis: r,p = 7.3 m M 's"1 (20 MHz, 298 K) . The 
[Gd 3 + ] have been determined by mineralization with 37% HC1 at 120°C overnight. 
Fitting o f the l 7 O N M R R2p vs T (K) profile gave rM= 115 ns. 
[Eu I H (Glu)AAZTA] 2 " or [ E u m L 3 ] 2 " 
T(H20) = 0.33 ns, T(D20) = 0.86 ns. 
(Major isomer) (D 20, 499.79 MHz): -14.03, -12.96, -12.34, -5.95, -5.14, -4.96, -3.33, -
2.55, -2.34, -1.20, -0.97, -0.86, -0.23, 0.28, 0.67, 1.24, 5.40, 5.45, 6.34, 6.84, 7.92, 
8.88, 10.51, 11.72, 14.31. 
SH(Minor isomer) (D20, 499.79 MHz): -10.71, -7.72, -7.23, -3.09, -1.98, 6.74, 7.08, 7.21, 
9.43,9.66, 15.01. 
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- From GluAAZTABn, L4 
[Eu , l l (Glu)AAZTABn] 
71 COOBn 
r . o 
Eu 
N \ 
N O o 
o 
o 
[Eu'"L4]-
A solution o f LnCl3-6H20 (0.8 eqv) in H2O was added dropwise to an aqueous 
solution o f L 4 ( I eqv, dissolved in the minimum volume of a solution of H 2 0 / 
MeOH 10%). The pH was adjusted at ~ 5.5 with KOH (1M). After 48h stirring at 50 
°C, the reaction mixture was cooled to room temperature, the pH raised to ~ 10 
(using aqueous KOH solution, 1M), the white powder precipitated was isolated by 
centrifugation and the pH of the supernatant was than readjusted to ~ 5.5. Freeze 
drying of the liquid gave a white glassy solid, mixture o f the complex and KCI salt. 
[Eu'"(Glu) AAZTABn]' or [Eu m L4]' 
T(H20) = 0.21 ns, T(D2O) = 0.32 ns. 
5H(Major isomer) (ViO, 499.79 MHz): -14.04, -12.96, -12.77, -7.93, -5.14, -4.31,-3.43, -
2.46, -2.06, -1.58, -0.79, 0.18, 1.30, 1.84, 3.21, 5.36, 6.24, 7.26, 8.09, 9.02, 10.39, 
11.51, 14.00. 
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- From (Glu)2(rt/?J-AAZTA, L5 
in [Ln"(Glu) 2 W - A A Z T A ] 
r i 3 6 coo r . o \ . \ <..---0 
1 .0 
OOC 
o 
[Ln i n L5] 3 
[ E u l " ( G l u ) 2 ^ > A A Z T A ] 3 - or [ E u , u L 5 ] 3 
A solution of EuCl 3 -6H 2 0 (0.018g, 0.048 mmol) in H 2 0 (1 mL) was added dropwise 
to an aqueous solution o f L 5 (0.045g, 0.053mmol in 1.5 mL H 2 0 ) . The pH was 
adjusted to ~ 5.5 using KOH (1M). After 48h stirring at 50 °C, the supernatant was 
separated from a white precipitate and freeze dried. A white crystalline solid, 
mixture o f the complex and K G salt, was obtained (0.053g, 0.08 mmol, crude yield 
60%). m/z (ES+): 652.2 [ M ] \ (Found: [ M ] \ 652.0794. C 2 oH 2 7 Oi 2 N3 l 5 1 Eu, requires 
[ M ] \ 652.0798; [M]", 654.0806 C,7H 2 7O 1 0 N 3 1 5 3 Eu, requires [ M - H ] \ 654.0813). 
T(H20) = 0.28 ns, TfDiO) = 0.87 ns. 
(Major isomer) ( D 2 0 , 699.73 MHz): -14.65, -5.19, -2.21, -1.59, -1.03, -1.59, -1.03, -
0.62, 0.09, 0.43, 0.69, 1.86, 1.96, 4.90, 6.63, 7.29, 7.79, 10.29, 11.77. 
8H (Minor isomer) ( D 2 0 , 499.79 MHz): -10.27, -8.39, -5.89, -4.64, 0.09, 0.89, 2.32, 2.46, 
3.84,5.52,9.23, 13.76. 
[ G d m ( G l u ) 2 W - A A Z T A ] 3 or [ G d u l L 5 ] 3 
A solution of GdCl 3 -6H 2 0 (0.007 g, 0.017 mmol) in H 2 0 (0.5 mL) was added 
dropwise to an aqueous solution of L 5 (0.016 g, 0.019 mmol in 1.5 mL H 2 0 ) . The 
pH was adjusted to pH = 5.5 using an aqueous solution o f KOH (1M). After 48h 
stirring at 50°C, the supernatant was separated from a white precipitate and freeze 
dried, to yield a white crystalline solid, as a mixture o f the complex and the KC1 salt 
(0.024 g, 0.036 mmol, crude yield 47%). m/z (ES+): 658.9 [ M - H]" (Found: [ M - H]" 
, 659.0831. C 2 0 H 2 7 N 3 O i 2 1 5 8 G d | requires [ M - H ] \ 659.0841; [ M - H ] \ 655.0801. 
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C | 7 H27N3O 1 0 l 5 4 Gd, requires [ M - H ] \ 655.0809; [ M - H ] \ 656.0817. 
C | 7 H27N 3 Oi2 l 5 5 Gdi requires [ M - H ] \ 656.0813). 
Relaxivity value found by N M R D analysis: r l p = 8.65 mlvl 's"1 (20 MHz, 298 K) . 
The [Gd 3 + ] have been determined by mineralization with 37% HC1 at 120°C 
overnight. 
Fitting of the l 7 0 N M R R2pvs T (K) profile gave xM= 720 ns. 
[Yb m (Glu ) 2 ( f tR) -AAZTA] 3 or [ Y b i n L 5 ] 3 " 
The same experimental procedure followed for the synthesis o f [ G d n i L 5 ] 3 " was used 
in the synthesis o f [Yb'"L5] 3~, and approximately the same crude yield (50%) was 
obtained. 
SH (Major isomer) ( D 2 0 , 699.73 MHz): -50.83, -26.87, -18.45, -17.30, -9.92, -8.53, -8.08, 
-7.41, -5.43, -4.29, -1.62, -0.79, 10.41, 14.03, 28.65, 30.38, 32.69, 40.18, 42.95, 
48.55. 
SH(Mmor isomer) ( D 2 0 , 499.79 MHz): -36.32, -33.80, -22.23, -14.76,-13.55, -9.22, 9.64, 
16.31,22.93, 24.27,33.87, 36.58. 
- From (Glu)2tf?S;-AAZTA, L6 
[Ln l "(Glu) 2 (K5>AAZTA] 3 " 
coo 
o o 
.0 
ooc 
o 
[Ln'"L6]3-
A solution of LnCl3 -6H 2 0 (0.8 eqv) in H 2 0 was added dropwise to an aqueous 
solution o f L 6 (1 eqv, dissolved in the minimum volume o f a solution H2O / MeOH 
5%). The pH was adjusted to ~ 5.5 with KOH (1M). After 48h stirring at 50 °C, the 
reaction mixture was cooled to room temperature, the pH raised to ~ 10 (using an 
aqueous KOH solution, 1M), the white powder precipitated was isolated by 
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centrifugation and the pH o f the supernatant was than readjusted to ~ 5.5. Freeze 
drying o f the liquid gave the complex as a white crystalline solid, plus KCI salt. 
[ G d l " ( G l u ) 2 f * S M A Z T A ] 3 - or [ G d m L 6 ] 3 -
Crude yield: 50%. HPLC (Chromatographic method A l ) : t r: 1.55 min. m/z (ES-): 
659.2 [ M - H ] \ (Found: [ M - H ] \ 659.0845. C2oH27N30 1 2 1 5 8 Gd, requires [ M - H ] \ 
659.0841). 
Relaxivity value found by NMPJD analysis: r l p = 7.5 mlvl 's"1 (20 MHz, 298 K) . The 
[Gd 3 + ] have been determined by mineralization with 37% HC1 at 120°C overnight. 
Fitting o f the 1 7 0 N M R R2p vs T (K) profile gave tM= 246 ns. 
[Yb i n (Glu)2r/?5>AAZTA] 3 " or [ Y b m L 6 ] 3 " 
Crude yield: 60%. m/z (ES-): 675.3 [ M ] \ (Found: [M]", 675.0996. 
C 2oH27N 3Oi2 1 7 4Yb, requires [M-H]", 675.0989). 
5H (Major isomer) (D 20, 699.73 MHz): -51.48, -37.01, -35.99, -26.08, -19.10, -16.28, -
11.24, -9.67, -9.27, -7.18, -4.77, -2.69, -1.48, 0.23, 0.64, 0.82, 1.88, 3.56, 7.25, 
10.10, 10.98, 14.85, 24.39, 28.16, 33.13, 35.07, 37.44, 43.18, 47.42, 50.24. 
SH (Minor isomer) (D 20, 699.73 MHz): -55.84, -49.92, -43.70, -38.62, -34.93, -32.15, -
21.73, -19.96, -17.60, -12.45, -10.03, -7.99, -5.87, -4.4, -0.53, 6.14, 9.00, 10.32, 
14.56, 17.59, 25.82, 29.22, 31.49, 38.50,41.43, 44.32, 52.14. 
[ E u m ( G l u ) 2 ( K S ; - A A Z T A ] 3 - or [ E u H I L 6 ] 3 -
Crude yield: 45%. T^O) = 0.38, T(c20) = I -27. 
SH (Major isomer) ( D 2 0 , 699.73 MHz): -10.32, -8.37, -6.03, -5.86, -4.54, -1.46, -1.38, -
0.85, -0.51, 0.11, 1.75, 2.07, 3.21, 3.95, 5.31, 6.38, 6.84, 7.23, 8.29, 9.17, 10.14, 
10.57, 11.45, 13.64. 
SH (Minor isomer) (D 20, 699.73 MHz): -14.66, -5.16, -2.16, -1.09, -1.04, 5.56, 8.29, 
11.83. 
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(y7?,j''5)-6-[bis[2(l,l-dimethylethoxy)-2oxoethyl]amino]-y,}''-
bis[(l,ldimethylethoxy) carbonyl]tetrahydro-6-niethyMH-l,4-diazepine-
l,4(5H)-dibutanoic acid bis ((trihydroxymethyl)aminomethane)amide (62) 
f B u O O C ^ 
1^ c;uufbu H /—UH 
wn—/ n 
62 
To a solution o f 60 (0.015 g, 0.021 mmol) in DMF (0.5 mL) , JV-methylmorpholine 
(11.5 uL, 0.12 mmol) was added and the mixture was stirred at 50 °C for 20 min. 
After cooling to 10 °C, O-benzotriazol-1 -yl-vV, N, N', N'- tetramethyluronium 
tetrafluoroborate (0.023 g, 0.072 mmol) was added and after a few minutes a 
solution o f TRIS (0.0075 g, 0.061 mmol) in DMSO (0.5 mL) was dripped into the 
reaction mixture, which was than left to stir at 40 °C for 72 h. The reaction mixture 
was cooled to room temperature and the solvent removed under reduced pressure 
(high vacuum line, 0.6 mBar, at ambient temperature). The residue was dissolved in 
CH 2 C1 2 (8 mL) and washed with HC1 0.1 M (5 mL), saturated N a H C 0 3 solution (5 
mL), H2O (2><5 mL) and brine (5 mL). Removing o f the solvent under reduced 
pressure gave 62 as a colourless oil (0.015 g, 0.016 mmol, 76%). R f (CH 2 Cl 2 /MeOH 
2%, S i0 2 ) = 0.5 (UV). £ „ ( C D 3 O D , 399.96 MHz): 1.18 (3H, s, CH3), 1.46 - 1.48 
(36H, br. s, C(CH3)3), 1.77 - 1.88 (2H, m, C/ / 2 CHN), 1.91 - 2.03 (2H, m, 
C/ / 2 CHN), 2.32 - 2.41 (4H, m, 2 x C/ / 2 „„ g ) , 2.54 - 2.70 (4H, m, 2 x CH2rtng), 2.80 -
3.10 (4H, m, 2 x C/ / 2 CONH), 3.10 - 3.30 (2H, m, 2 x C#N) , 3.60 (2H, br. d, 
C// 2COO/Bu), 3.70 (2H, br. d, C// 2COO/Bu), 3.68 - 3.75 (12H, m, 6 x C// 2 OH). 
m/z (ES-): 935 [ M ] \ 
209 
Chapter 5 
TRIS 2 (Glu ) 2 (KS>AAZTA, L 7 
HOOC 
\, COOH H /-OH 
HOOC^ N ( R ^ ^ ^ N ^ C ^ 
H /V-N~J O 
H O ^ V N T ^ J S ) " C O O H 
wn—/ n L7 
A solution of 62 (0.015 g, 0.016 mmol) in TFA / CH 2 C1 2 (1:2, 3 mL) was stirred at 
room temperature for 24 h. The solvent was removed under reduced pressure (with 
KOH pellets in the traps), the residue dissolved in CH 2 C1 2 (4 mL) and the solution 
evaporated under reduced pressure. This procedure was repeated three times, and the 
residue was washed twice with diethyl ether ( 2 x 2 mL) and a precipitated white 
powder was obtained as the product o f the reaction (L7, 0.010 g, 9.49 * 10"3 mmol, 
60%). SH ( D 2 0 , 499.79 MHz): 1.11 (3H, s, CH3), 1 .92 -2 .10 (4H, br. m, 2 * 
C/ / 2 CHN), 2.78 (4H, br. d, C// 2 CONH), 2.9 (1H, d, J = 4, C/ / a CONH), 2.93 (1H, d, 
J = 4, C/ / 6 CONH), 3.0 - 3.34 (8H, br. m, 4 x CH2ring), 3.39 - 3.47 (2H, m, 2 x 
CHN), 3.62 (4H, d, J = 2.5, 2 x C// 2 COOH), 3.67 - 3.75 (12H, m, 6 x C t f 2 OH) . m/z 
(ES-): 710.4 [ M - H ] \ (Found: [M-H] ' , 710.3105. C 2 8 H 4 8 N 5 0 , 6 requires [M-HV, 
710.3102). 
[Gd n , TRIS 2 (Glu ) 2 («5 ) -AAZTA] 
H,0 P H 2 
O -V^ 
n 
OH H Qd L(R) OH N N OH 
N H O HO N ( S ) ' f HO O HO O 
[GdmL7]-
An aqueous solution o f LnCl 3 -6H 2 0 (0.0028 g, 7.59xl0"3 mmol) was added 
dropwise to L7 (0.010 g, 9.49xl0"3 mmol) dissolved in H 2 0 (2 mL). The pH was 
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adjusted to ~ 5.5 with aqueous KOH solution (1M). After stirring at 50 °C for 48h, 
the reaction mixture was cooled to room temperature, the pH raised to ~ 10 (using 
KOH, 1M), the white precipitate was isolated by centrifugation and the pH of the 
supernatant was than readjusted to ~ 5.5. Freeze drying o f the liquid gave the 
complex as a white powder (0.005 g, 5.78 x 10° mmol, crude yield 61%). HPLC 
(Chromatographic method A l ) : t r: 1.7 min. m/z (ES-): 865.3 [M]". 
T, (60MHz, 37 °C) = 158.1 ± 0.2 ms [ G d 3 + ] , C P = 0.12 mg/mL. 
- Coupling reactions on [Ln'"(Glu)AAZTA]" complexes ([Ln l l lL3]') 
[ Y b m T R I S (G lu ) A A Z T A ] 
O H 2 ~ \ 
OsH20 H 2 0 # 
0 - - - - - J - v t i 
9 ^ ° 
Yb 
o H 
0 HO N 
(S>Y HO 
HO O 
[Yb'"L8]' 
To a solution of [Yb '"(Glu)AAZTA] 2 " ( [Yb u l L3]", 0.005 g, 8.3xlO"3 mmol) in DMF 
(0.5 mL), N-methylmorpholine (2 uL, 1.64xl0"2 mmol) was added, and the mixture 
was stirred at 50 °C for 20 min. After cooling to 10 °C, Obenzotriazol-1-yl-./V, N,N\ 
N'- tetramethyluronium tetrafluoroborate (0.0065 g, 0.021 mmol) was added and 
after a few minutes a solution of TRIS (0.003 g, 2.5x10"2 mmol) in DMF (0.5 mL) 
was dripped into the reaction mixture, which was than left to stir at 40 °C for 10 
days. The reaction mixture was cooled to room temperature, transferred in a small 
flask containing EtOH (7 mL) and the solid precipitated was separated from the 
supernatant, and a white powder was isolated as the product of reaction (0.008 g, 
0.007 mmol, 10%), together with some starting material ( [Yb i n L3]") and KC1 salt. 
m/z (ES-): 705.9 [M]". (Found: [ M ] \ 706.5033 C 2 iH32N 4 Oi2 1 7 4 Ybi requires [ M ] \ 
706.5033). 
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[Yb , n (Gluco)GluAAZTA] 
HO 
[Yb'"L9]-
To a solution o f [Yb '"(Glu)AAZTA] 2 " ([Yb'"L3]", 0.0058 g, 9.6xl0" 3 mmol) in 
DMSO (0.5 mL), jV-methylmorpholine (20 uL, 1.8X10"4 mmol) was added, and the 
mixture was stirred at 50 °C for 20 min. After cooling to 10 °C, O-benzotriazol-l-yl-
N, N, N', N'- tetramethyluronium tetrafluoroborate (0.0077 g, 0.024 mmol) was 
added and after a few minutes a solution of N-[tris(/?-
glucopyranosyloxymethyl)methyl]glycinamide (10, 0.012 g, 0.019 mmol) in DMSO 
(0.5 mL) was dripped into the reaction mixture, which was than left to stir at 40 °C 
for 3.5 weeks. The reaction mixture was cooled to room temperature, transferred in a 
small flask containing EtOH (7 mL) and the solid precipitated was separated from 
the supernatant, dissolved in water and purified by HPLC, to obtain a light yellow 
solid as product o f reaction (0.008 g, 0.007 mmol, 61%). m/z (ES-): 1192.5 [M]". 
(Found: [ M ] \ 1192.3042. C39H62N4027Yb, requires [M]", 1192.2995; [ M + H ] \ 
1193.3068. C j g H s j N ^ Y b , requires [ M + H ] \ 1193.3073). HPLC 
(Chromatographic method A l ) : 100% (Area % ) ; t r: 1.5 min. 
SH (Major isomer) ( D 2 0 , 399.95 MHz): -39.95, -35.22, -29.34, -26.59, -8.32, -5.97, -5.37, 
-4.74, -3.67, -2.84, -1.28, 1.00, 6.73, 7.25, 8.94, 9.59, 11.20, 29.00, 29.51, 30.19, 
36.32, 42.15. 
SH isomer) ( D 2 0 , 399.95 MHz): -41.50, -41.26, -27.88, -23.78, -18.17, -12.56, -
8.83, -6.32, -5.23, -4.37, -2.42, -0.41, 0.10, 8.72, 10.03, 16.10, 27.37, 28.20, 36.02, 
42.72. 
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(Gd'"(Gluco)GluAAZTA] 
H 20 HO 
4 o m n HO HO P ^ 0 HO 
A HO ^ N-HO O H ^ S ) \ - N ^ T 
9 -
HO O 
HO R 
O HO 
HO HO HO 
[Gd L9] 
To a solution of [Gd'"(Glu)AAZTA] 2 " ([Gd H I L3]", 0.0068 g, 11.5 x 10"3 mmol) in 
DMSO (0.5 mL), 7V-methylmorpholine (20 uL, 1.8 * 10"4 mmol) was added, and the 
mixture was stirred at 50 °C for 20 min. After cooling to 10 °C, 0-benzotriazol-l-yl-
N, N,N', N'- tetramethyluronium tetrafluoroborate (0.009 g, 0.028 mmol) was added 
and after a few minutes a solution o f the amine 10 (0.014 g, 0.023 mmol) in DMSO 
(0.5 mL) was dripped into the reaction mixture, which was than left to stir at 40 °C 
for 2 weeks. The reaction mixture was cooled to room temperature, transferred in a 
small flask containing EtOH (7 mL) and the solid precipitated was separated from 
the supernatant, dissolved in water and freeze dried, to give the product as a light 
yellow solid (0.007 g, 5.95x10° mmol, 52%). HPLC (Chromatographic method 
A l ) : 80% (Area % ) ; t r : 1.5 min. m/z (ES-): 1175.6 [ M ] \ (Found: [ M ] \ 1175.5205. 
C 39H62N 4027 1 5 8Gd requires [ M ] \ 1175.5206). Relaxivity value found by NlvlRD 
analysis: r,p = 3.36 mlvl 's"1 (20 MHz, 298 K) . The [Gd 3 + ] was determined by 
mineralization with 37% HC1 at 120°C overnight. Measurements performed in 
University o f Turin (Italy): [Gd 3 + ] = 0.23 mM; R , o b s - 1.15 s"1 (25 °C, 20MHz). r,p= 
3.36 mM"'s"'. 
Measurements in Durham (U.K.): [ G d 3 + ] i C P = 0.426 m M ; T,(60MHz) = 430 ms. R, p 
( l / 7 > RD0.25) = 2.07 s"1. r,p= 4.87 mM"'s"'. 
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-Coupling reaction on [Gd"l(Gluco)2(Glu)2(,/?S>)-AAZTA]" complexes 
([Gd'"L6]-) 
[Gd I I , (Gluco) 2 (Glu) 2 AAZTA]-
HO 
[Gd'"L10]-
To a solution o f [Gd m (G lu ) 2 (7 t f j -AAZTA] 3 " ( [Gd i n L6]", 0.0015 g, 0.023 mmol) in 
DMSO (0.5 mL), N-methylmorpholine (60 uL, 5.4 x 10"4 mmol) was added, and the 
mixture was stirred at 50 °C for 20 min. After cooling to 10 °C, O-benzotriazol-l-yl-
N, N,N', N'- tetramethyluronium tetrafluoroborate (0.033 g, 0.103 mmol) was added 
and after a few minutes a solution of the amine 10 (0.056 g, 0.092 mmol) in DMSO 
(0.5 mL) was dripped into the reaction mixture, which was than left to stir at 40 °C 
for 2 weeks. The reaction mixture was cooled to room temperature, transferred in a 
small flask containing EtOH (7 mL) and the solid precipitated was separated from 
the supernatant, dissolved in water and freeze dried, to give the product, a light 
yellow solid (0.014 g, 0.0076 mmol, 33%). HPLC (Chromatographic method A l ) : 
100% (Area % ) ; t r : 1.6 min. m/z (TOF MS ES-): 1837.4 [ M + 3 H ] \ 918.4 [ M / 2 ] \ 
(Found: [ M ] \ 1834.5304 C^H^NsGV^Gdrequi res [M]\ 1834.5262). 
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A^Butyloxycarbonyl)tris(acetoxymethyI)methylamine 
O 
\ H 
N 
0 1 
0 
64 
A solution o f Boc-protected TRIS (1 g, 4.53 mmol) in CHC1 3 (5 mL) was cooled to 
0 °C and A c 2 0 (1.30 mL, 13.6 mmol) and Py (1.09 mL, 13.6 mmol) were slowly 
added. After 18 h stirring at room temperature, aqueous CUSO4 solution (0.25 M , 
3x8 mL) was added to the reaction mixture and the organic phase was separated, 
dried over Na2SC>4 and evaporated to dryness, to give 64 as a clear oil (1.96 g, 5.66 
mmol, 80%). R f (Hex/EtOAc 1:1, S i0 2 ) = 0.5 (UV, Iodine). 8H (CDCI3 , 399.96 
MHz): 1.35 (9H, s, 1*CH3), 2.01 (9H, s, C(CH3)3), 4.28 (6H, s, 3*CH20). Sc 
(CDCb, 125.67 MHz): 20.92 (3xCH 3 ), 28.41 (C(CH 3 ) i ) , 31.08 (Q, , a /But) , 56.73 
(CquatNH), 63.05 (3xCH 2 0) , 154.42 (C=ONH), 170.63 (C=OCH 3 ) . m/z (ES-): 348.2 
[ M + H ] + . (Found: [M+Na] + , 370.1473. C| 5 H25N |0 8 2 3 Nai requires [M+Na] + , 
370.1472). 
2-Bromo-4-(l,3-dioxo-l,3-dihydro-isoindol-2-yl)-pentanedioic acid diethyl ester 
11 (65) 
N Br 
OEt EtO 
O O 
65 
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PBr5 (4.0 g, 9.29 mmol), Br 2 (0.28 mL, 5.46 mmol) and N-phthaloyl-L-glutamic acid 
(1.0 g, 3.61 mmol) were stirred and heated (irradiated by a 200W lamp) overnight at 
65 °C. 
After cooling in an ice bath, absolute EtOH (10 mL) was added dropwise to the 
mixture under vigorous stirring and the solution was boiled under reflux for 5 h. The 
solvent was removed and the residue extracted with EtOAc (3><7 mL). The organic 
layer was washed with H 2 0 (2 x 5 mL), Na2C03 aq. ( 2 x 5 m L ) , then again with 
H 2 0 ( 2 x 5 mL), dried over MgSO*4 and concentrated under reduced pressure. 
Column chromatography (Si0 2, Hexane/EtOAc 10% —> Hexane/EtOAc 20%) of the 
residue, gave the two separated diastereomers (erythro, S/R) 65a (0.526 g, 24 %) and 
(threo S/S) 65b (0.154g, 11 %) as light yellow oils. 
m/z 598 [M+H] + , 620 [M+Na] +. 
R,-(Hexane/EtOAc 20%, Si0 2) = 0.4 65a and 65b 0.45 (UV). 
Erythro (S/R) 
SH(CDC\3, 500 MHz): 1.22 (6H, m, 2 x OCH 2C//j), 2.90-3.05 (2H, m, C// 2C ( q u a t )), 
4.08-4.22 (5H, m, 2 x OCH 2C// 3), 4.36 (1H, t, J = 10, H4), 4.98 (H2), (1H, dd, H-
2), 7.72-7.86 (4H a r o m , m). Sc (CDC13, 100.61 MHz): 14.1 (Me), 14.3 (Me), 33.7 
(CH2), 42.7 (CH2CHBr), 50.5 (CHN), 62.5 (OCH2), 123.9 (CHC q u a t), 131.8 (C q u a t ), 
134.7 (CHCHC q u a l), 167.7 (NCO), 168.4 (NCO), 169.0 (C=0), 169.1 (C=0). 
Threo (SIS) 
SH(CDCh, 500 MHz): 1.22 (6H, m, 2 x OCH 2C//j), 2.90-3.05 (2H, m, C// 2 C ( q u a t ) ), 
4.08-4.22 (5H, m, 2 x OCH 2C//j and H4), 5.13 (H2) (1H, dd, H-2), 7.72-7.86 
(4H a r o m , m). Sc (CDCI3, 100.61 MHz): 14.1 (Me), 14.3 (Me), 34.7 (CH 2), 42.1 
(CH2CHBr), 50.0 (CHN), 62.5 (OCH2), 123.9 (CHC q u a t), 131.8 (C q u a t ) , 134.7 
(CHCHC q u a t), 167.5 (NCO), 168.2 (NCO), 169.0 (C=0), 169.1 (C=0). 
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Appendix 
In this appendix are displayed the ES-MS, l H NMR and l H - *H COSY NMR 
spectra which were used in the characterization of selected lanthanide 
complexes discussed in Chapter II, III and IV. 
218 
Appendix 
Tetraamide dendrimer [GdgDOTAGIu12Gly4(H20)]' 
™ ° \ H H O ° H O H HO OH 
„ . HO J 
HO ^ O 
HHO^^Ji---0 
0 O - C - G d ^ O 
N N 
0 /.OH 
HO^<33H 
HO OH HOHJ,OH H Q b H n 
E E 1_60 
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Figure 1: E S - MS spectrum of dendrimer |GdgDOTAGIu l 2Gly4(H 20)r 
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E E _ 1 60_High # 1 5 - 3 6 R T : 0 .47 -1 .05 A V : 22 N L : 9 . 3 1 E 3 
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Figure 2: Expansion of the ES - MS spectrum of dendrimer |GdgDOTAGlu 1 2Gly 4(H 20)r. 
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Figure 3: Expansion of the ES - MS spectrum of dendrimer |GdgDOTAGIu, 2 Gly 4 (H 2 0)r 
highlighting the isotopic pattern of the molecular ion. 
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[Lnm(Glu)2race/n/c-AAZTA]3- or [Ln"'L2]*- systems Mil 
lEu m (Glu ) 2 racem/c -AAZTA] 3 -
E E _ 2 _ 1 2 5 acc#11-45 RT: 0.31-1.06 AV: 35 NL: 1.34E4 
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Figure 4: ES - MS spectrum of |Eu l"(Glu) 2rac£/w/c-AAZTA| 3. 
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Figure 5: ES - MS spectrum of |Eu I I I(Glu) 2rflce/n/c-AAZTAl 3 
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Figure 6: ES - MS spectrum of |Eu l"(Glu) 2face»i/c-AAZTA] 3': expansion highlighting the 
isotopic pattern of the molecular ion. 
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[Lnm(Glu) 2(/?r?MAZTA] 3- or [Ln'"L3] z- systems .nil 
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Figure 7: ES - MS spectrum of [Gd n i(Glu) 2(flJ?)-AAZTA| 3-. 
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Figure 8: Expansion of the ES - MS spectrum of [Gd M , (Glu) 2 (/?Jf)-AAZTA] 3 , highlighting 
the isotopic pattern of the molecular ion. 
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coo-
o o 
O O C -
o 
-1 1 r -
-> 
—1 1 1 r 
-15 OBI* 
Figure 9: ' H NMR spectrum of [Eu U I(Glu)2tfrlt)-AAZTAf (700 MHz, D 2 0 , pD 5.4,24 Q . 
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Figure 10: ! H - *H C O S Y NMR spectrum of [Eu I l l (Glu) 2 (K*>AAZTA] 3 " (700 MHz, D 2 0 , pD 
5.4,24 °C). 
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Figure 11: ES - MS spectrum of [Eu'"(Glu) 2(/?/f)-AAZTAr. 
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Figure 12: Expansion of the ES - MS spectrum of |Eu'"(Glu) 2(J?/f)-AAZTAl 3 , highlighting 
the isotopic pattern of the molecular ion. 
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[Ln'"(Glu)AAZTA]2 or [Ln m L3] 2 systems 
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Figure 13: ES - MS spectrum of |Yb m (GIu)AAZTA]^. 
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In the next two pages are shown the ' H N M R and ! H - *H COSY spectra o f the 
complex [Yb ' " (G lu )AAZTA] 2 " and o f the analogue europium complex 
[ E u m ( G I u ) A A Z T A ] 2 \ both registered at in D 2 0 , 500 MHz, 20 °C, pD 5.4. 
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Figure 14: *H NMR spectrum of |Yb'"(Glu)AAZTA] 2 . 
Cppm)-
F1 (p p m) 
Figure 15: *H - ' h COSY NMR spectrum of | Y b m ( G l u ) A A Z T A | 2 
[Yb'"(Glu)AAZTA] 2- or [ Y b m L 3 ] 2 \ 
227 
Appendix 
0 = 0 , o 
N 
N 
Me 
1 00c R 
5 1 
1 •Lib 1 
15 10 p p m 10 15 
Figure 16: ! H NMR spectrum of [ E u ^ G l ^ A A Z T A ] 2 - . 
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Figure 17: 'H - 'H COSY NMR spectrum of [Eu I l l(Glu)AAZTA] 2-. 
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in in [Gd"'(Glu)AAZTAr or [Gd , , , L3] 
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Figure 18: ES - MS of |Yb"'(Glu)AAZTA| 2 ': a comparison between the measured (top) and 
the theoretical (bottom) mass-spectra. 
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[Lnm(Glu)2fKSMAZTA]3- or [Ln ,"L3] i£' systems -
[Gd , I I(Glu) 2(R5>AAZTA] 3^ 
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Figure 19: ES - IMS of | G d ' " ( G l u ) j ^ - A A Z T A | 
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Figure 20: Expansion of ES-MS of IGd'^GIu^/ tSj -AAZTAI 3 
highlighting the isotopic pattern of the molecular ion (top); a comparison between the 
measured and the theoretical mass-spectra (bottom part of the page). 
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[Yb'"(Gluco)GluAAZTA]- or [Yb L9]~ 
H-,0 HO 
0 H 20 HO O 
HO ,0 
O O 
N HO \ ^ H O ^ H  O N 
HO H t S ) ^ - N - J O 
9 -
HO o N 
HO 
HO O O • — \ . u 
HO HO HO 
EE_2_137_yb3+_stronger#92-345 RT: 0.33-1.06 AV: 254 NL: 1.66E5 
T: fTMS - C E S I Full ms [200.00-2000.00] 
1192.5 
652.3 
603.4 
1158.8 
1440.8 
785.4 
1501.0 1026.7 
12J8.9 
1085.6 1248.5 966.7 
1279.2 
1308.4 
1722.8 1560.9 
787.4 516.4 1843.8 
1903.0 
1650.2 
470.5 
301.3 
200 400 600 800 1000 1200 
m/z 
1400 1600 1800 2000 
Figure 21: ES-MS of |Yb n i (Gluco)GluAAZTA]. 
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Figure 22: Expansion of ES-MS of |Yb'"(Gluco)GluAAZTAl highlighting the isotopic 
pattern of the molecular ion (top); a comparison between the measured and the theoretical 
mass-spectra (bottom part of the page). 
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Figure 23: 'H NMR spectrum of |Yb'"(Gluco)Glu-AAZTAr (D 2 0, 400 MHz, ambient 
temperature, pD 5.4). 
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[Ybm(Gluco) 2(Glu) 2( r/?S>AAZTA]- or [Yb L9] 
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Figure 24: ES-MS of [Yb'^GIucoMGIuhtftty-AAZTAr. 
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Figure 25: Expansion of ES-MS of | Yb l l ,(Gluco) 2(Glu) 2(7?^-AAZTA) highlighting the 
isotopic pattern of the molecular ion (top); a comparison between the measured and the 
theoretical mass-spectra (bottom part of the page). 
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